Protein Atlas version 16.1

• Removal and update of incorrect data. Adjustments of antibody scoring and gene scoring (reliability score), including changes to score names and layout fixes on antibody validation page.

• No changes

• HPA027641 has been omitted due to qualitative reasons.
• HPA051261 has been omitted due to qualitative reasons.
• HPA043666 has been omitted due to qualitative reasons.
• HPA050552 has been omitted due to qualitative reasons.
• HPA020983 has been omitted due to qualitative reasons.
• HPA049276 has been omitted due to qualitative reasons.
• HPA018686 has been omitted due to qualitative reasons.
• HPA021149 has been omitted due to qualitative reasons.
• HPA056185 has been omitted due to qualitative reasons.
• HPA046514 has been omitted due to qualitative reasons.
• HPA075183 has been omitted due to qualitative reasons.
• HPA014066 has been omitted due to qualitative reasons.
• HPA040353 has been omitted due to qualitative reasons.
• HPA060903 has been omitted due to qualitative reasons.
• HPA063217 has been omitted due to qualitative reasons.
• HPA053635 has been omitted due to qualitative reasons.
• HPA003403 has been omitted due to qualitative reasons.
• HPA068294 has been omitted due to qualitative reasons.
• HPA000905 has been omitted due to qualitative reasons.
• HPA028398 has been omitted due to qualitative reasons.
• HPA042775 has been omitted due to qualitative reasons.
• HPA048147 has been omitted due to qualitative reasons.
• HPA054823 has been omitted due to qualitative reasons.
• HPA062904 has been omitted due to qualitative reasons.
• HPA055936 has been omitted due to qualitative reasons.
• HPA047680 has been omitted due to qualitative reasons.
• HPA052569 has been omitted due to qualitative reasons.
• HPA060282 has been omitted due to qualitative reasons.
• HPA075435 has been omitted due to qualitative reasons.
• HPA060345 has been omitted due to qualitative reasons.
• HPA035333 has been omitted due to qualitative reasons.
• HPA016713 has been omitted due to qualitative reasons.
• HPA006700 has been omitted due to qualitative reasons.
• HPA046794 has been omitted due to qualitative reasons.
• HPA022925 has been omitted due to qualitative reasons.
• HPA056854 has been omitted due to qualitative reasons.

Protein Atlas version 16

• Sixteenth major release of the Human Protein Atlas with more than 25,000 antibodies, targeting proteins from more than 17,000 human genes (~86% of the human protein-coding genes).
• A new Cell Atlas is released with spatial location of more than 12,000 genes to 30 different organelles and cellular structures. The data is described on knowledge pages for the Subcellular proteomes (organelle proteome, cell cycle dependent proteome, cell line transcriptome, and multilocalizing proteome), and the Organelle proteomes.
• The Tissue Atlas is complemented with CAGE data from FANTOM5 and extended with antibody staining on the following tissues: extended brain samples, mouse brain, eye, lactating breast, hair, extended skin samples, and full section adrenal gland.
• The antibody validation information has been complemented with formal validations based on the pillars presented in A proposal for validation of antibodies by Uhlen et al (2016).

• CAB000135 (keratin 15, type I) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA000414 (palmitoyl-protein thioesterase 2) has been omitted due to inconsistency with RNA-seq data.
• CAB000462 (galanin/GMAP prepropeptide) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA000549 (arylsulfatase F) has been omitted due to inconsistency with gene/protein characterization data.
• HPA000555 (discs and large homolog 5 (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
• HPA000564 (interleukin 1 receptor accessory protein-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA000567 (makorin ring finger protein 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA000644 (CLOCK-interacting pacemaker) has been omitted due to inconsistency with gene/protein characterization data.
• HPA000645 (cyclin K) has been omitted due to inconsistency with RNA-seq data.
• HPA000688 (regulator of G-protein signaling 7) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA000734 (guanylate cyclase 2F, retinal) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA000760 (FERM and RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)) has been omitted due to inconsistency with RNA-seq data.
• HPA000815 (l(3)mbt-like 2 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA000837 (transcobalamin II) has been omitted due to inconsistency with RNA-seq data.
• HPA000850 (NOP9 nucleolar protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA000853 (coiled-coil domain containing 116) has been omitted due to inconsistency with RNA-seq data.
• HPA000880 (autophagy related 2B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA000884 (membrane protein, palmitoylated 1 and 55kDa) has been omitted due to inconsistency with gene/protein characterization data.
• HPA000924 (interleukin-1 receptor-associated kinase 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA000932 (low density lipoprotein receptor-related protein 10) has been omitted due to inconsistency with RNA-seq data.
• HPA000988 (kelch-like family member 28) has been omitted due to inconsistency with RNA-seq data.
• HPA001008 (interleukin 13 receptor, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001039 (SLIT and NTRK-like family, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA001045 (malignant T cell amplified sequence 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001149 (chromosome 22 open reading frame 23) has been omitted due to inconsistency with RNA-seq data.
• HPA001206 (family with sequence similarity 71 and member D) has been omitted due to inconsistency with RNA-seq data.
• HPA001256 (sushi-repeat containing protein and X-linked) has been omitted due to inconsistency with RNA-seq data.
• HPA001271 (apoptosis-inducing factor, mitochondrion-associated, 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001299 (methyltransferase like 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001394 (syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001407 (RAB guanine nucleotide exchange factor (GEF) 1) has been omitted due to inconsistency with other antibody targeting the same gene.
• HPA001438 (hes-related family bHLH transcription factor with YRPW motif-like) has been omitted due to inconsistency with gene/protein characterization data.
• HPA001502 (connector enhancer of kinase suppressor of Ras 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA001546 (ankyrin repeat and SOCS box containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001587 (interleukin 13 receptor, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001669 (solute carrier family 8 (sodium/calcium exchanger) and member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA001741 (potassium channel regulator) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001821 (regulator of G-protein signaling 5) has been omitted due to inconsistency with RNA-seq data.
• HPA001823 (sphingomyelin phosphodiesterase 1 and acid lysosomal) has been omitted due to inconsistency with gene/protein characterization data.
• CAB001998 (protein kinase C, eta) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA002020 (intercellular adhesion molecule 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002103 (transcription factor 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002314 (leucine rich repeat containing 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002354 (HMG box domain containing 3) has been omitted due to inconsistency with RNA-seq data.
• HPA002385 (CXADR-like membrane protein) has been omitted due to inconsistency with gene/protein characterization data.
• HPA002386 (deafness, autosomal recessive 31) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002652 (secreted frizzled-related protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002704 (mitogen-activated protein kinase 15) has been omitted due to inconsistency with RNA-seq data.
• CAB002768 (matrix metallopeptidase 23B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002871 (zinc finger protein 410) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002918 (integral membrane protein 2A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002942 (transmembrane protein 179) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA002959 (phosphoinositide-3-kinase interacting protein 1) has been omitted due to inconsistency with RNA-seq data.
• HPA002966 (mitochondrial transcription termination factor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003098 (EF-hand calcium binding domain 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003099 (tetratricopeptide repeat domain 28) has been omitted due to inconsistency with gene/protein characterization data.
• HPA003173 (ZNF680, ZNF92) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003175 (BTB and CNC homology 1, basic leucine zipper transcription factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003266 (synuclein, alpha interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003296 (splA/ryanodine receptor domain and SOCS box containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA003346 (phospholipase C, eta 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003391 (ribonuclease, RNase A family, 9 (non-active)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003421 (microtubule associated monooxygenase, calponin and LIM domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA003511 (ribosomal protein L15) has been omitted due to inconsistency with RNA-seq data.
• HPA003581 (tripartite motif containing 42) has been omitted due to inconsistency with RNA-seq data.
• HPA003614 (HAUS augmin-like complex, subunit 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003626 (bombesin-like receptor 3) has been omitted due to inconsistency with RNA-seq data.
• HPA003636 (oxysterol binding protein-like 10) has been omitted due to inconsistency with gene/protein characterization data.
• HPA003865 (MALT1 paracaspase) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA003905 (G protein-coupled receptor 173) has been omitted due to inconsistency with RNA-seq data.
• HPA003962 (ubiquitin-conjugating enzyme E2N) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA003973 (IQ motif and Sec7 domain 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA004000 (ADAM metallopeptidase domain 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA004006 (mitogen-activated protein kinase kinase kinase 15) has been omitted due to inconsistency with gene/protein characterization data.
• HPA004063 (aryl hydrocarbon receptor interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA004131 (CD300 molecule-like family member g) has been omitted due to inconsistency with gene/protein characterization data.
• HPA004178 (ankyrin repeat and SOCS box containing 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB004444 (interferon gamma receptor 1) has been omitted due to inconsistency with other antibody targeting the same gene.
• CAB004533 (protein kinase C, zeta) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB004569 (KIT ligand) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB004675 (triosephosphate isomerase 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA004731 (RP11-330H6.5, TLR9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA004739 (family with sequence similarity 71 and member D) has been omitted due to inconsistency with RNA-seq data.
• HPA004742 (catenin, beta like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB004755 (nescient helix loop helix 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA004775 (histone deacetylase 7) has been omitted due to inconsistency with gene/protein characterization data.
• HPA004933 (homeobox A1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB004987 (keratin 83, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB005057 (mechanistic target of rapamycin (serine/threonine kinase)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB005066 (arachidonate 5-lipoxygenase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA005478 (enhancer of zeste 1 polycomb repressive complex 2 subunit) has been omitted due to inconsistency with RNA-seq data and lack of appropriate tissue.
• HPA005499 (structural maintenance of chromosomes 1A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA005625 (leucine rich repeat containing 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA005782 (bromodomain adjacent to zinc finger domain and 2A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA005894 (protease, serine and 57) has been omitted due to inconsistency with RNA-seq data.
• HPA005912 (calmodulin-like 6) has been omitted due to inconsistency with gene/protein characterization data.
• HPA005960 (dopamine beta-hydroxylase (dopamine beta-monooxygenase)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA005967 (HMG box domain containing 3) has been omitted due to inconsistency with RNA-seq data.
• HPA005972 (B-cell translocation gene 1, anti-proliferative) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA006076 (death associated protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA006105 (GATA zinc finger domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA006123 (BUB1 mitotic checkpoint serine/threonine kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA006201 (lysine (K)-specific demethylase 5A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA006204 (Ts translation elongation factor, mitochondrial) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA006221 (latent transforming growth factor beta binding protein 1) has been omitted due to inconsistency with RNA-seq data.
• HPA006237 (ubiquitin specific peptidase 15) has been omitted due to inconsistency with gene/protein characterization data.
• HPA006298 (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA006316 (glypican 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA006376 (transforming growth factor beta 1 induced transcript 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA006432 (kinesin family member 2C) has been omitted due to inconsistency with RNA-seq data.
• HPA006433 (myosin VIIA and Rab interacting protein) has been omitted due to inconsistency with gene/protein characterization data.
• HPA006487 (lysine (K)-specific methyltransferase 2B) has been omitted due to inconsistency with gene/protein characterization data.
• HPA006687 (zinc fingers and homeoboxes 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA006806 (paired box 4) has been omitted due to inconsistency with gene/protein characterization data.
• CAB006813 (purinergic receptor P2X, ligand gated ion channel, 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB006838 (potassium channel, voltage gated eag related subfamily H, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA006879 (slit guidance ligand 1) has been omitted due to inconsistency with RNA-seq data.
• CAB006907 (Kv channel interacting protein 3, calsenilin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA007012 (growth factor independent 1B transcription repressor) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA007037 (transient receptor potential cation channel, subfamily M and member 6) has been omitted due to inconsistency with gene/protein characterization data.
• HPA007090 (cell migration inducing protein and hyaluronan binding) has been omitted due to inconsistency with RNA-seq data.
• HPA007158 (adhesion G protein-coupled receptor F4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA007182 (paired box 4) has been omitted due to inconsistency with gene/protein characterization data.
• HPA007247 (zinc finger protein 165) has been omitted due to inconsistency with RNA-seq data.
• HPA007314 (gastrin-releasing peptide) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
• HPA007322 (CLDN3, CLDN4, CLDN6 and CLDN9) has been omitted due to inconsistency with RNA-seq data.
• HPA007410 (transmembrane protein 59) has been omitted due to inconsistency with RNA-seq data.
• HPA007446 (cyclin-dependent kinase-like 3) has been omitted due to inconsistency with RNA-seq data.
• HPA007461 (mitogen-activated protein kinase 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA007538 (malectin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA007663 (solute carrier family 6 (neutral amino acid transporter), member 17) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA007703 (seizure related 6 homolog (mouse)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA007720 (WD repeat domain 20) has been omitted due to inconsistency with gene/protein characterization data.
• HPA007959 (SAYSVFN motif domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA007988 (DnaJ (Hsp40) homolog, subfamily C and member 15) has been omitted due to inconsistency with gene/protein characterization data.
• HPA008192 (T-box 20) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA008252 (interleukin 24) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA008255 (solute carrier family 27 (fatty acid transporter) and member 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA008266 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA008322 (acyl-CoA synthetase family member 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA008323 (acyl-CoA synthetase family member 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA008344 (Sad1 and UNC84 domain containing 3) has been omitted due to inconsistency with RNA-seq data.
• CAB008385 (family with sequence similarity 234, member B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA008419 (BUB1 mitotic checkpoint serine/threonine kinase B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA008607 (dedicator of cytokinesis 7) has been omitted due to inconsistency with gene/protein characterization data.
• HPA008614 (MCF.2 cell line derived transforming sequence-like) has been omitted due to inconsistency with RNA-seq data.
• CAB008675 (synaptotagmin VI) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA008709 (ring finger protein 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA008966 (melanocortin 2 receptor accessory protein 2) has been omitted due to inconsistency with gene/protein characterization data.
• CAB009013 (toll-like receptor 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA009042 (ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2 and6-sialyltransferase 4) has been omitted due to inconsistency with RNA-seq data.
• CAB009156 (translocase of outer mitochondrial membrane 40 homolog (yeast)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB009190 (NLR family, pyrin domain containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA009431 (leucine rich repeat neuronal 4) has been omitted due to inconsistency with RNA-seq data.
• CAB009497 (phosphodiesterase 3B, cGMP-inhibited) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA009641 (mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA009673 (keratin 9 and type I) has been omitted due to inconsistency with gene/protein characterization data.
• CAB009813 (heparanase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA010016 (G0/G1 switch 2) has been omitted due to inconsistency with RNA-seq data.
• HPA010132 (KIAA1549-like) has been omitted due to inconsistency with RNA-seq data.
• HPA010135 (tumor necrosis factor receptor superfamily and member 19) has been omitted due to inconsistency with RNA-seq data.
• CAB010166 (TTK protein kinase) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB010251 (colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB010409 (cholinergic receptor and muscarinic 3) has been omitted due to inconsistency with gene/protein characterization data.
• CAB010423 (MCF.2 cell line derived transforming sequence) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA010611 (acyl-CoA dehydrogenase, long chain) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA010628 (CD244 molecule, natural killer cell receptor 2B4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA010647 (coiled-coil domain containing 136) has been omitted due to inconsistency with RNA-seq data.
• HPA010663 (gap junction protein, beta 1 and 32kDa) has been omitted due to inconsistency with gene/protein characterization data.
• HPA010803 (family with sequence similarity 234, member B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA010843 (progestin and adipoQ receptor family member VI) has been omitted due to inconsistency with RNA-seq data.
• HPA010872 (RAB25, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB010902 (cholinergic receptor, nicotinic and alpha 1 (muscle)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA010953 (WAP, follistatin/kazal, immunoglobulin and kunitz and netrin domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA010967 (major histocompatibility complex, class II and DQ alpha 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA011134 (T-cell lymphoma invasion and metastasis 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA011141 (unc-5 netrin receptor B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA011169 (KIAA0319-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA011219 (retinoic acid receptor responder (tazarotene induced) 3) has been omitted due to inconsistency with RNA-seq data.
• HPA011223 (wingless-type MMTV integration site family and member 9A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA011310 (roundabout guidance receptor 3) has been omitted due to inconsistency with gene/protein characterization data and lack of appropriate tissue.
• CAB011488 (forkhead box P2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA011561 (WAP, follistatin/kazal, immunoglobulin and kunitz and netrin domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA011738 (TEK tyrosine kinase, endothelial) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA011747 (AC004754.3, FAM234A) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA011913 (kalirin, RhoGEF kinase) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA011977 (natriuretic peptide receptor 2) has been omitted due to inconsistency with RNA-seq data.
• HPA011981 (ankyrin repeat domain 30A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA012000 (polymerase (DNA directed) iota) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA012043 (G protein-coupled receptor 22) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA012084 (tachykinin receptor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA012086 (unc-5 netrin receptor C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA012115 (phytanoyl-CoA dioxygenase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA012150 (chromosome 19 open reading frame 38) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA012157 (adherens junctions associated protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB012248 (endothelial PAS domain protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA012383 (solute carrier family 29 (equilibrative nucleoside transporter), member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA012385 (Sjogren syndrome antigen B (autoantigen La)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB012452 (potassium channel, inwardly rectifying subfamily J, member 6) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA012613 (son of sevenless homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA012718 (coiled-coil domain containing 141) has been omitted due to inconsistency with RNA-seq data.
• HPA012801 (carcinoembryonic antigen-related cell adhesion molecule 4) has been omitted due to inconsistency with RNA-seq data.
• HPA012845 (matrix metallopeptidase 19) has been omitted due to inconsistency with gene/protein characterization data.
• HPA012890 (spexin hormone) has been omitted due to inconsistency with RNA-seq data.
• HPA012939 (sodium channel, non voltage gated 1 alpha subunit) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB013009 (SMAD specific E3 ubiquitin protein ligase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB013284 (CDC28 protein kinase regulatory subunit 1B) has been omitted due to inconsistency with RNA-seq data.
• HPA013332 (CMT1A duplicated region transcript 1) has been omitted due to inconsistency with RNA-seq data.
• HPA013357 (insulin-like growth factor binding protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA013572 (zinc finger and CCHC domain containing 14) has been omitted due to inconsistency with RNA-seq data.
• HPA013573 (adhesion G protein-coupled receptor L2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA013609 (endo/exonuclease (5'-3') and endonuclease G-like) has been omitted due to inconsistency with gene/protein characterization data.
• HPA013661 (protein phosphatase 1, catalytic subunit and gamma isozyme) has been omitted due to inconsistency with RNA-seq data.
• HPA013699 (chromosome 17 open reading frame 78) has been omitted due to inconsistency with RNA-seq data.
• HPA013790 (neuropeptide Y receptor Y5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA013870 (CKLF-like MARVEL transmembrane domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA013892 (podocan) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014025 (purinergic receptor P2X, ligand gated ion channel, 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and lack of appropriate tissue.
• HPA014046 (WAP four-disulfide core domain 10B) has been omitted due to inconsistency with RNA-seq data.
• HPA014087 (endothelin receptor type A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA014092 (alkaline ceramidase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014159 (ADAM metallopeptidase domain 29) has been omitted due to inconsistency with RNA-seq data.
• HPA014350 (transmembrane protein 26) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA014374 (CDK5 regulatory subunit associated protein 1-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014421 (ring finger protein 133) has been omitted due to inconsistency with gene/protein characterization data.
• HPA014468 (adenomatosis polyposis coli down-regulated 1) has been omitted due to inconsistency with RNA-seq data.
• HPA014526 (V-set and immunoglobulin domain containing 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014541 (leucine rich repeat containing 19) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014574 (PX domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA014687 (family with sequence similarity 187 and member B) has been omitted due to inconsistency with RNA-seq data.
• HPA014700 (ceramide kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014709 (glutamate receptor, ionotropic and kainate 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA014713 (solute carrier family 37, member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014725 (sidekick cell adhesion molecule 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014745 (leucine rich repeat containing 8 family and member D) has been omitted due to inconsistency with gene/protein characterization data.
• HPA014775 (fatty acid hydroxylase domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA014785 (transient receptor potential cation channel, subfamily M, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA014801 (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase and polypeptide 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA014846 (gap junction protein, beta 6, 30kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014865 (zinc finger and BTB domain containing 38) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014904 (anthrax toxin receptor-like) has been omitted due to inconsistency with RNA-seq data.
• HPA014905 (phosphatidylinositol glycan anchor biosynthesis and class O) has been omitted due to inconsistency with RNA-seq data.
• HPA015050 (ARP2 actin-related protein 2 homolog (yeast)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015052 (transmembrane protein 225) has been omitted due to inconsistency with RNA-seq data.
• HPA015086 (thioredoxin domain containing 12 (endoplasmic reticulum)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015102 (GIMAP1-GIMAP5 and GIMAP5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015240 (nicotinamide nucleotide adenylyltransferase 2) has been omitted due to inconsistency with RNA-seq data.
• HPA015272 (tribbles pseudokinase 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015280 (calcium channel flower domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015297 (IKAROS family zinc finger 5 (Pegasus)) has been omitted due to inconsistency with RNA-seq data.
• HPA015305 (trinucleotide repeat containing 6A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015307 (hydroxysteroid (17-beta) dehydrogenase 3) has been omitted due to inconsistency with RNA-seq data.
• HPA015567 (pipecolic acid oxidase) has been omitted due to inconsistency with RNA-seq data.
• HPA015571 (transmembrane (C-terminal) protease and serine 12) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015573 (toll-like receptor 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015581 (protocadherin 9) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015613 (cadherin 4, type 1 and R-cadherin (retinal)) has been omitted due to inconsistency with RNA-seq data.
• HPA015692 (zinc finger protein 451) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015733 (ring finger protein 152) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA015736 (coproporphyrinogen oxidase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015796 (transmembrane protein 125) has been omitted due to inconsistency with RNA-seq data.
• HPA015816 (zinc finger and MYND-type containing 11) has been omitted due to inconsistency with gene/protein characterization data.
• HPA015890 (t-SNARE domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB015941 (tumor necrosis factor receptor superfamily, member 12A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB015944 (stomatin (EPB72)-like 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA016040 (vaccinia related kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA016418 (MGAT4 family, member C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA016435 (tetraspanin 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA016467 (gamma-aminobutyric acid (GABA) A receptor and rho 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA016506 (solute carrier family 39 (zinc transporter), member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA016507 (progestin and adipoQ receptor family member V) has been omitted due to inconsistency with RNA-seq data.
• HPA016565 (fem-1 homolog a (C. elegans)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA016567 (potassium channel, two pore domain subfamily K and member 16) has been omitted due to inconsistency with gene/protein characterization data.
• HPA016585 (transmembrane protein 179B) has been omitted due to inconsistency with RNA-seq data.
• HPA016593 (ybeY metallopeptidase (putative)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA016596 (DDB1 and CUL4 associated factor 12) has been omitted due to inconsistency with RNA-seq data.
• HPA016811 (leucine rich repeat containing 8 family and member A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA016826 (vesicular, overexpressed in cancer, prosurvival protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA016834 (TTK protein kinase) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA016856 (solute carrier family 18 (vesicular monoamine transporter) and member 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA016857 (coiled-coil domain containing 107) has been omitted due to inconsistency with RNA-seq data.
• HPA016871 (transmembrane protein 140) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA016993 (repulsive guidance molecule family member b) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017046 (Rho/Rac guanine nucleotide exchange factor (GEF) 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA017064 (testis-specific kinase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB017105 (IKAROS family zinc finger 3 (Aiolos)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB017123 (fat mass and obesity associated) has been omitted due to inconsistency with gene/protein characterization data.
• CAB017133 (kallikrein-related peptidase 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017195 (kallikrein-related peptidase 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017288 (SH3 and cysteine rich domain 2) has been omitted due to inconsistency with RNA-seq data.
• HPA017313 (fms-related tyrosine kinase 3 ligand) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017337 (arginine vasopressin receptor 1B) has been omitted due to inconsistency with gene/protein characterization data.
• HPA017344 (nuclear fragile X mental retardation protein interacting protein 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA017374 (NLR family, pyrin domain containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA017434 (methyltransferase like 7A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB017459 (exocyst complex component 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017571 (peptidase M20 domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017587 (NDRG family member 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB017619 (Fc receptor-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017636 (SLIT and NTRK-like family, member 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA017681 (mitochondrial E3 ubiquitin protein ligase 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA017740 (embigin) has been omitted due to inconsistency with RNA-seq data.
• HPA017748 (CD79a molecule, immunoglobulin-associated alpha) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB017771 (ankyrin repeat domain 30A) has been omitted due to inconsistency with gene/protein characterization data.
• CAB017792 (T-cell leukemia homeobox 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA017886 (WD repeat domain 45B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017903 (myeloid leukemia factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017914 (protein phosphatase 1 and regulatory subunit 9A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA017943 (nescient helix loop helix 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA017945 (keratin associated protein 23-1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA017948 (family with sequence similarity 26 and member F) has been omitted due to inconsistency with gene/protein characterization data.
• HPA017978 (hippocampus abundant transcript-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA017979 (solute carrier family 30 (zinc transporter) and member 2) has been omitted due to inconsistency with RNA-seq data.
• HPA018028 (sideroflexin 4) has been omitted due to inconsistency with RNA-seq data.
• HPA018032 (synaptophysin-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA018147 (lipase maturation factor 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA018209 (casein kinase 1 and gamma 1) has been omitted due to inconsistency with RNA-seq data.
• HPA018242 (ribonucleic acid export 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA018310 (myelin regulatory factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB018335 (RAP1A and member of RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data.
• CAB018369 (breast cancer 1, early onset) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA018404 (nucleoporin 214kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA018423 (solute carrier family 39 (zinc transporter) and member 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA018487 (polycomb group ring finger 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA018536 (nudE neurodevelopment protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB018599 (protein phosphatase 2, regulatory subunit A, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB018752 (protein phosphatase 1 and regulatory subunit 9A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA018946 (EF-hand calcium binding domain 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA018979 (spermatogenesis and centriole associated 1-like) has been omitted due to inconsistency with gene/protein characterization data.
• HPA019059 (solute carrier family 23 and member 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA019162 (catenin (cadherin-associated protein), alpha 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA019178 (family with sequence similarity 26 and member D) has been omitted due to inconsistency with RNA-seq data.
• HPA019239 (oxidative stress induced growth inhibitor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA019252 (defensin and beta 129) has been omitted due to inconsistency with RNA-seq data.
• HPA019253 (eukaryotic translation initiation factor 4E family member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA019362 (NADPH oxidase, EF-hand calcium binding domain 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB019438 (ubiquitin-conjugating enzyme E2R 2) has been omitted due to inconsistency with RNA-seq data.
• HPA019487 (kallikrein-related peptidase 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA019534 (keratin associated protein 15-1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA019611 (calicin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA019614 (aryl-hydrocarbon receptor repressor) has been omitted due to inconsistency with RNA-seq data.
• HPA019637 (breast cancer metastasis suppressor 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA019680 (transmembrane protein 57) has been omitted due to inconsistency with gene/protein characterization data.
• HPA019702 (interferon-related developmental regulator 2) has been omitted due to inconsistency with RNA-seq data.
• HPA019767 (HEAT repeat containing 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA019790 (Leber congenital amaurosis 5-like) has been omitted due to inconsistency with RNA-seq data.
• HPA019796 (ring finger protein 32) has been omitted due to inconsistency with RNA-seq data.
• HPA019820 (NDRG family member 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA019823 (family with sequence similarity 20, member C) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and lack of appropriate tissue.
• HPA019840 (secreted frizzled-related protein 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA019850 (amyloid beta (A4) precursor protein-binding, family A, member 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA019860 (ATPase family and AAA domain containing 2) has been omitted due to inconsistency with other antibody targeting the same gene.
• HPA019946 (BCL2/adenovirus E1B 19kD interacting protein like) has been omitted due to inconsistency with gene/protein characterization data.
• HPA019965 (DGCR8 microprocessor complex subunit) has been omitted due to inconsistency with gene/protein characterization data.
• HPA020058 (gamma-secretase activating protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA020090 (DEAD (Asp-Glu-Ala-Asp) box helicase 25) has been omitted due to inconsistency with RNA-seq data.
• HPA020122 (ubinuclein 2) has been omitted due to inconsistency with RNA-seq data.
• HPA020190 (selenocysteine lyase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA020225 (HMG-box transcription factor 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA020322 (carboxypeptidase A5) has been omitted due to inconsistency with RNA-seq data.
• HPA020380 (CDKN1A interacting zinc finger protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA020384 (CDKN1A interacting zinc finger protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA020435 (potassium channel subfamily M regulatory beta subunit 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA020446 (aspartate-rich 1) has been omitted due to inconsistency with RNA-seq data.
• HPA020472 (ubiquitin-conjugating enzyme E2U (putative)) has been omitted due to inconsistency with RNA-seq data.
• HPA020481 (DENN/MADD domain containing 1A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA020521 (calmodulin regulated spectrin-associated protein 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA020529 (calmodulin regulated spectrin-associated protein 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA020621 (IQ motif and ubiquitin domain containing) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA020631 (prostaglandin E synthase 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA020636 (family with sequence similarity 71, member F1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB020783 (LY6/PLAUR domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA020891 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 31) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA020930 (MORN repeat containing 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA021029 (surfeit 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA021068 (contactin 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021127 (ArfGAP with coiled-coil and ankyrin repeat and PH domains 1) has been omitted due to inconsistency with RNA-seq data.
• HPA021135 (adhesion G protein-coupled receptor G7) has been omitted due to inconsistency with RNA-seq data.
• HPA021158 (receptor-interacting serine-threonine kinase 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021194 (tripartite motif containing 41) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA021275 (leucine-rich repeats and guanylate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
• HPA021310 (chromosome 9 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
• HPA021315 (dynein, cytoplasmic 1, intermediate chain 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA021371 (family with sequence similarity 131 and member B) has been omitted due to inconsistency with RNA-seq data.
• HPA021409 (family with sequence similarity 71 and member F1) has been omitted due to inconsistency with RNA-seq data.
• HPA021426 (keratin 36 and type I) has been omitted due to inconsistency with gene/protein characterization data.
• HPA021431 (RAS and EF-hand domain containing) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021459 (family with sequence similarity 104 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA021480 (calpain 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021483 (aryl-hydrocarbon receptor repressor) has been omitted due to inconsistency with RNA-seq data.
• HPA021530 (diacylglycerol O-acyltransferase 2-like 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021539 (Xg blood group) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021556 (coronin 6) has been omitted due to inconsistency with RNA-seq data.
• HPA021586 (family with sequence similarity 205 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA021660 (ubiquitin-conjugating enzyme E2U (putative)) has been omitted due to inconsistency with RNA-seq data.
• HPA021661 (RecQ mediated genome instability 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA021676 (guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA021795 (PANK1, PANK2, PANK3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021802 (chromosome 9 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
• HPA021882 (leucine rich repeat containing 46) has been omitted due to inconsistency with RNA-seq data.
• HPA021913 (tensin 4) has been omitted due to inconsistency with RNA-seq data.
• HPA021946 (transmembrane and immunoglobulin domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA022029 (chromosome 9 open reading frame 131) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA022145 (aspartoacylase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB022164 (frataxin) has been omitted due to inconsistency with gene/protein characterization data.
• CAB022187 (TIMP metallopeptidase inhibitor 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA022246 (kinesin family member 27) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB022407 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA022481 (tripartite motif containing 42) has been omitted due to inconsistency with RNA-seq data.
• HPA022520 (prolyl 3-hydroxylase family member 4 (non-enzymatic)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA022533 (caspase recruitment domain family, member 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB022597 (synuclein, alpha interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB022658 (syntaxin 2) has been omitted due to inconsistency with gene/protein characterization data.
• CAB022674 (potassium channel, voltage gated eag related subfamily H, member 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA022786 (guanylyl cyclase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA022828 (transmembrane protein 99) has been omitted due to inconsistency with RNA-seq data.
• HPA022836 (F-box and WD repeat domain containing 10) has been omitted due to inconsistency with RNA-seq data.
• HPA022850 (nucleoredoxin) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA022895 (Rap guanine nucleotide exchange factor (GEF)-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA022990 (chromosome 9 open reading frame 114) has been omitted due to inconsistency with gene/protein characterization data.
• HPA023041 (notum pectinacetylesterase homolog (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
• HPA023118 (regulator of G-protein signaling 22) has been omitted due to inconsistency with RNA-seq data.
• HPA023150 (DDHD domain containing 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA023260 (tetratricopeptide repeat domain 16) has been omitted due to inconsistency with RNA-seq data.
• HPA023317 (EF-hand calcium binding domain 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA023324 (cyclin N-terminal domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA023339 (ring finger protein 113B) has been omitted due to inconsistency with gene/protein characterization data.
• HPA023387 (chromosome 17 open reading frame 104) has been omitted due to inconsistency with RNA-seq data.
• HPA023388 (caspase recruitment domain family, member 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA023435 (tumor protein D52-like 3) has been omitted due to inconsistency with RNA-seq data.
• HPA023464 (BCL2/adenovirus E1B 19kD interacting protein like) has been omitted due to inconsistency with gene/protein characterization data.
• HPA023481 (ferric-chelate reductase 1-like) has been omitted due to inconsistency with RNA-seq data.
• HPA023545 (protein phosphatase, EF-hand calcium binding domain 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA023560 (tripartite motif containing 8) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA023679 (nardilysin (N-arginine dibasic convertase)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA023779 (epoxide hydrolase 2, cytoplasmic) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA023817 (chromosome 7 open reading frame 62) has been omitted due to inconsistency with RNA-seq data.
• HPA023898 (retinoic acid induced 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA023994 (gamma-secretase activating protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024016 (family with sequence similarity 205 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA024109 (leucine rich repeat transmembrane neuronal 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024132 (UFM1-specific peptidase 1 (non-functional)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA024163 (chromosome 7 open reading frame 62) has been omitted due to inconsistency with RNA-seq data.
• HPA024170 (S100P binding protein) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA024220 (S100P binding protein) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA024349 (coiled-coil domain containing 42) has been omitted due to inconsistency with RNA-seq data.
• HPA024354 (dynein, axonemal, heavy chain 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024394 (ras homolog family member D) has been omitted due to inconsistency with RNA-seq data.
• HPA024405 (MYCBP associated protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA024429 (matrix metallopeptidase 21) has been omitted due to inconsistency with RNA-seq data.
• HPA024511 (collectin sub-family member 10 (C-type lectin)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024516 (Sp6 transcription factor) has been omitted due to inconsistency with RNA-seq data.
• HPA024562 (transmembrane protein 52) has been omitted due to inconsistency with RNA-seq data.
• HPA024584 (leucine-rich repeats and guanylate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
• HPA024601 (LSM1 homolog and mRNA degradation associated) has been omitted due to inconsistency with RNA-seq data.
• HPA024626 (Fanconi anemia core complex associated protein 100) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024658 (KIAA1456) has been omitted due to inconsistency with RNA-seq data.
• HPA024660 (KIAA1456) has been omitted due to inconsistency with RNA-seq data.
• HPA024680 (lipocalin 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024708 (RAD52 motif containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA024728 (ubiquitin protein ligase E3 component n-recognin 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024794 (RAD52 motif containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA024797 (CDC42 effector protein (Rho GTPase binding) 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB024870 (reticulon 4 receptor-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA025225 (trafficking protein particle complex 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA025246 (trafficking protein particle complex 9) has been omitted due to inconsistency with RNA-seq data.
• CAB025355 (ectonucleoside triphosphate diphosphohydrolase 6 (putative)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB025453 (kallikrein-related peptidase 13) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB025499 (vascular endothelial growth factor B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA025706 (smoothelin-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA025829 (glutathione peroxidase 7) has been omitted due to inconsistency with RNA-seq data.
• CAB025868 (mitogen-activated protein kinase 4) has been omitted due to inconsistency with RNA-seq data.
• HPA026100 (DENN/MADD domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB026176 (solute carrier family 2 (facilitated glucose/fructose transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB026377 (MAM domain containing 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA026434 (kinesin family member 1B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA026438 (MRT4 homolog and ribosome maturation factor) has been omitted due to inconsistency with gene/protein characterization data.
• HPA026482 (zinc finger and C2HC-type containing 1B) has been omitted due to inconsistency with RNA-seq data.
• HPA026522 (minichromosome maintenance domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA026559 (tubulin folding cofactor E) has been omitted due to inconsistency with RNA-seq data.
• HPA026579 (trafficking protein particle complex 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026587 (cell division cycle associated 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026633 (ubiquitin-like with PHD and ring finger domains 2 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA026637 (coiled-coil domain containing 158) has been omitted due to inconsistency with RNA-seq data.
• HPA026658 (potassium channel, two pore domain subfamily K, member 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026680 (thyroid stimulating hormone receptor) has been omitted due to inconsistency with RNA-seq data.
• HPA026697 (ubiquitin-like with PHD and ring finger domains 2 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA026714 (acyloxyacyl hydrolase (neutrophil)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA026725 (ankyrin repeat domain 13C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026789 (ankyrin repeat and LEM domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA026825 (neuropeptide FF receptor 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA026827 (mitochondrial E3 ubiquitin protein ligase 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA026845 (thrombospondin, type I, domain containing 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026873 (FXYD domain containing ion transport regulator 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA026876 (multiple EGF-like-domains 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026877 (serine-rich single-pass membrane protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026899 (transmembrane protein 190) has been omitted due to inconsistency with RNA-seq data.
• HPA026906 (family with sequence similarity 134 and member B) has been omitted due to inconsistency with RNA-seq data.
• HPA027013 (tumor necrosis factor receptor superfamily and member 11b) has been omitted due to inconsistency with gene/protein characterization data.
• HPA027054 (keratin associated protein 8-1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA027058 (zinc finger protein 823) has been omitted due to inconsistency with gene/protein characterization data.
• HPA027085 (tuftelin interacting protein 11) has been omitted due to inconsistency with RNA-seq data and lack of appropriate tissue.
• HPA027089 (CPX chromosome region and candidate 1) has been omitted due to inconsistency with RNA-seq data.
• HPA027113 (dehydrogenase/reductase (SDR family) member 7C) has been omitted due to inconsistency with RNA-seq data.
• HPA027114 (coiled-coil domain containing 170) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA027121 (coiled-coil domain containing 170) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA027122 (opioid growth factor receptor-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA027149 (opioid growth factor receptor-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA027176 (actin-like 8) has been omitted due to inconsistency with RNA-seq data.
• HPA027186 (lymphocyte antigen 6 complex and locus E) has been omitted due to inconsistency with gene/protein characterization data.
• HPA027206 (ERBB receptor feedback inhibitor 1) has been omitted due to inconsistency with RNA-seq data.
• HPA027235 (collagen, type XVI and alpha 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA027237 (collagen, type XVI and alpha 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA027348 (stimulated by retinoic acid 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027473 (guanylate cyclase 2F, retinal) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027491 (lipocalin 8) has been omitted due to inconsistency with RNA-seq data.
• HPA027496 (von Willebrand factor A domain containing 5B1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA027516 (polymerase (RNA) III (DNA directed) polypeptide C (62kD)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA027534 (fatty acid amide hydrolase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027552 (serine palmitoyltransferase, long chain base subunit 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027572 (erythropoietin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA027612 (inhibitor of DNA binding 2 and dominant negative helix-loop-helix protein) has been omitted due to inconsistency with RNA-seq data.
• HPA027646 (thioesterase superfamily member 5) has been omitted due to inconsistency with RNA-seq data.
• HPA027751 (cyclin-dependent kinase-like 3) has been omitted due to inconsistency with RNA-seq data.
• HPA027765 (stathmin-like 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027871 (mindbomb E3 ubiquitin protein ligase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027923 (transforming growth factor and beta 3) has been omitted due to inconsistency with RNA-seq data.
• HPA027977 (protease, serine, 55) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027985 (tubulin tyrosine ligase-like family member 2) has been omitted due to inconsistency with RNA-seq data.
• HPA027992 (spermatogenesis associated 32) has been omitted due to inconsistency with RNA-seq data.
• HPA028045 (antizyme inhibitor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028079 (fibronectin type III domain containing 7) has been omitted due to inconsistency with RNA-seq data.
• HPA028138 (vav 3 guanine nucleotide exchange factor) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028146 (vacuolar protein sorting 13 homolog B (yeast)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028162 (adaptor-related protein complex 4, beta 1 subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA028181 (microtubule associated serine/threonine kinase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028197 (ring finger and WD repeat domain 2 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028262 (trafficking protein particle complex 9) has been omitted due to inconsistency with RNA-seq data.
• HPA028264 (ATR serine/threonine kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028265 (zinc finger and C2HC-type containing 1B) has been omitted due to inconsistency with RNA-seq data.
• HPA028277 (EBNA1 binding protein 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA028280 (zinc finger, CCHC domain containing 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028317 (ADAM-like, decysin 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028326 (spermatogenesis associated 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028345 (N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase)) has been omitted due to inconsistency with RNA-seq data.
• HPA028352 (protein phosphatase 1 and regulatory subunit 15B) has been omitted due to inconsistency with RNA-seq data.
• HPA028356 (phosphoprotein enriched in astrocytes 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028358 (family with sequence similarity 63, member A) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA028390 (tudor domain containing 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028399 (adaptor-related protein complex 4, beta 1 subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA028403 (coiled-coil domain containing 28B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA028405 (von Willebrand factor A domain containing 5B1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA028429 (exonuclease 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028432 (phosducin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA028442 (leucine rich repeat containing 71) has been omitted due to inconsistency with RNA-seq data.
• HPA028480 (chromosome 1 open reading frame 105) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028509 (adenosine A3 receptor) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028519 (solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA028527 (antizyme inhibitor 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028566 (adenosine A3 receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028568 (adenosine A3 receptor) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA028662 (keratinocyte differentiation factor 1) has been omitted due to inconsistency with RNA-seq data.
• HPA028681 (inhibitor of DNA binding 2 and dominant negative helix-loop-helix protein) has been omitted due to inconsistency with RNA-seq data.
• HPA028714 (tetratricopeptide repeat domain 16) has been omitted due to inconsistency with RNA-seq data.
• HPA028838 (zinc finger protein 451) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028853 (ankyrin repeat and SOCS box containing 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028857 (transmembrane protein 257) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028868 (thyrotrophic embryonic factor) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028870 (ankyrin repeat and SOCS box containing 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028878 (like-glycosyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028886 (forkhead box F1) has been omitted due to inconsistency with RNA-seq data.
• HPA028940 (heat shock factor binding protein 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028947 (transmembrane protease and serine 13) has been omitted due to inconsistency with RNA-seq data.
• HPA029014 (T-box 18) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029077 (midline 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029107 (collagen, type XXV, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029116 (myelin protein zero-like 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029202 (chromosome 14 open reading frame 105) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029206 (telomerase-associated protein 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029213 (interferon gamma receptor 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029222 (ERGIC and golgi 2) has been omitted due to inconsistency with RNA-seq data.
• HPA029266 (ribosomal protein S8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029307 (cytochrome c oxidase subunit IV isoform 2 (lung)) has been omitted due to inconsistency with RNA-seq data.
• HPA029308 (Kruppel-like factor 9) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029348 (transmembrane protein 156) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029415 (immunoglobulin-like domain containing receptor 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA029487 (mitochondrial ribosomal protein S2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA029502 (GRAM domain containing 4) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029528 (spermidine synthase) has been omitted due to inconsistency with RNA-seq data.
• HPA029544 (deiodinase, iodothyronine, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029558 (dehydrogenase/reductase (SDR family) member 7C) has been omitted due to inconsistency with RNA-seq data.
• HPA029582 (phosphate regulating endopeptidase homolog and X-linked) has been omitted due to lack of appropriate tissue.
• HPA029767 (RAB44 and member RAS oncogene family) has been omitted due to inconsistency with RNA-seq data.
• HPA029788 (chromosome 6 open reading frame 118) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA029812 (THO complex 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029814 (oncostatin M) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029821 (regulatory associated protein of MTOR, complex 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA029842 (claudin domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA029875 (cytochrome P450, family 4, subfamily F and polypeptide 22) has been omitted due to inconsistency with RNA-seq data.
• HPA029897 (TSSK6 activating co-chaperone) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029903 (neuropeptide Y receptor Y1) has been omitted due to inconsistency with RNA-seq data.
• HPA029916 (leucine-rich repeats and WD repeat domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029927 (castor zinc finger 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029950 (lipase and member I) has been omitted due to inconsistency with RNA-seq data.
• HPA029959 (nuclear fragile X mental retardation protein interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA029960 (nuclear fragile X mental retardation protein interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA029975 (forkhead box M1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029976 (forkhead box M1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029992 (family with sequence similarity 131 and member B) has been omitted due to inconsistency with RNA-seq data.
• HPA030062 (paired box 8) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA030064 (LINE-1 type transposase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA030068 (keratin 40, type I) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030089 (chromosome 1 open reading frame 168) has been omitted due to inconsistency with RNA-seq data.
• HPA030110 (sterile alpha motif domain containing 11) has been omitted due to inconsistency with gene/protein characterization data.
• HPA030116 (tumor suppressor candidate 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030179 (solute carrier family 17, member 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA030181 (kelch domain containing 8A) has been omitted due to inconsistency with RNA-seq data.
• HPA030182 (SH2 domain containing 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030183 (solute carrier family 25 (mitochondrial carrier; citrate transporter) and member 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA030185 (potassium channel and voltage gated subfamily A regulatory beta subunit 2) has been omitted due to inconsistency with RNA-seq data.
• HPA030223 (3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030275 (inositol-trisphosphate 3-kinase B) has been omitted due to inconsistency with other antibody targeting the same gene and lack of positivity.
• HPA030280 (leucine rich repeat containing 71) has been omitted due to inconsistency with RNA-seq data.
• HPA030325 (peptidase M20 domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA030354 (protein disulfide isomerase family A, member 5) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA030356 (protein disulfide isomerase family A and member 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA030398 (purinergic receptor P2Y, G-protein coupled and 14) has been omitted due to inconsistency with RNA-seq data.
• HPA030553 (zinc finger and MYND-type containing 11) has been omitted due to inconsistency with gene/protein characterization data.
• HPA030561 (sphingomyelin phosphodiesterase, acid-like 3B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030562 (cadherin 5, type 2 (vascular endothelium)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030620 (testis expressed 14) has been omitted due to inconsistency with RNA-seq data.
• HPA030721 (leptin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030798 (leucine-rich repeats and IQ motif containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA030801 (leucine-rich repeats and IQ motif containing 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA030802 (regulator of G-protein signaling 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030838 (zinc finger protein 546) has been omitted due to inconsistency with gene/protein characterization data.
• HPA030849 (calcium channel, voltage-dependent, alpha 2/delta subunit 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030850 (calcium channel, voltage-dependent and alpha 2/delta subunit 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA030872 (APEX nuclease (apurinic/apyrimidinic endonuclease) 2) has been omitted due to inconsistency with RNA-seq data.
• HPA030881 (C-type lectin domain family 4 and member F) has been omitted due to inconsistency with gene/protein characterization data.
• HPA031010 (polymerase (RNA) I polypeptide C, 30kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031074 (connective tissue growth factor) has been omitted due to inconsistency with gene/protein characterization data.
• HPA031087 (natriuretic peptide receptor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031114 (dual specificity phosphatase 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031147 (keratin associated protein 22-1) has been omitted due to lack of appropriate tissue.
• HPA031164 (distal-less homeobox 3) has been omitted due to inconsistency with RNA-seq data.
• HPA031179 (chromosome 1 open reading frame 100) has been omitted due to inconsistency with RNA-seq data.
• HPA031180 (chromosome 1 open reading frame 100) has been omitted due to inconsistency with RNA-seq data.
• HPA031190 (squamous cell carcinoma antigen recognized by T cells 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA031241 (SEC22 homolog C, vesicle trafficking protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031245 (family with sequence similarity 65 and member B) has been omitted due to inconsistency with RNA-seq data.
• HPA031325 (keratin associated protein 24-1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA031332 (adenosine deaminase, RNA-specific, B2 (non-functional)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031409 (glial cells missing homolog 2 (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
• HPA031446 (glomulin and FKBP associated protein) has been omitted due to inconsistency with gene/protein characterization data.
• HPA031447 (glomulin and FKBP associated protein) has been omitted due to inconsistency with gene/protein characterization data.
• HPA031463 (homeobox B9) has been omitted due to inconsistency with gene/protein characterization data.
• HPA031539 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA031548 (IQ motif containing with AAA domain 1) has been omitted due to inconsistency with RNA-seq data.
• HPA031602 (leucine rich repeat containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA031604 (leucine rich repeat containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA031820 (erythroid differentiation regulatory factor 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA031877 (ELOVL fatty acid elongase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031878 (ELOVL fatty acid elongase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB031933 (anti-Mullerian hormone) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031953 (synaptojanin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA032000 (neurotrophin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA032079 (spermatogenesis associated 21) has been omitted due to inconsistency with RNA-seq data.
• HPA032080 (spermatogenesis associated 21) has been omitted due to inconsistency with RNA-seq data.
• HPA032094 (exocyst complex component 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA032108 (chromosome 9 open reading frame 84) has been omitted due to inconsistency with RNA-seq data.
• HPA032151 (diaphanous-related formin 3) has been omitted due to inconsistency with RNA-seq data.
• HPA032152 (diaphanous-related formin 3) has been omitted due to inconsistency with RNA-seq data.
• CAB032507 (regulator of G-protein signaling 3) has been omitted due to inconsistency with gene/protein characterization data.
• CAB032627 (homeobox A5) has been omitted due to inconsistency with gene/protein characterization data.
• CAB033084 (docking protein 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB033438 (calpain 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB033659 (LUC7-like) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB033749 (glycerol-3-phosphate acyltransferase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB034049 (protein interacting with PRKCA 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB034141 (keratin associated protein 24-1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB034351 (hes family bHLH transcription factor 6) has been omitted due to inconsistency with RNA-seq data.
• HPA034495 (RAB3 GTPase activating protein subunit 1 (catalytic)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA034530 (sulfotransferase family, cytosolic, 1C and member 4) has been omitted due to inconsistency with RNA-seq data.
• HPA034539 (inositol polyphosphate-5-phosphatase J) has been omitted due to inconsistency with RNA-seq data.
• HPA034551 (transmembrane protein 214) has been omitted due to inconsistency with RNA-seq data.
• HPA034567 (chromosome 1 open reading frame 111) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA034573 (ATPase, class V and type 10B) has been omitted due to inconsistency with RNA-seq data.
• HPA034581 (ADAM metallopeptidase with thrombospondin type 1 motif and 7) has been omitted due to inconsistency with gene/protein characterization data.
• HPA034597 (coiled-coil domain containing 115) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA034605 (ADAM metallopeptidase with thrombospondin type 1 motif, 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA034628 (guanine nucleotide binding protein (G protein), beta polypeptide 1-like) has been omitted due to inconsistency with gene/protein characterization data, antibody titration issue and inconsistency with other antibody targeting the same gene.
• HPA034721 (lysozyme G-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA034733 (DnaJ (Hsp40) homolog, subfamily B and member 8) has been omitted due to inconsistency with RNA-seq data.
• HPA034742 (ADP-ribosylation factor-like 14) has been omitted due to inconsistency with RNA-seq data.
• HPA034752 (cyclin L1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA034778 (myotubularin related protein 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA034989 (ataxin 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA034999 (D site of albumin promoter (albumin D-box) binding protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035019 (NMD3 ribosome export adaptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035036 (HFM1, ATP-dependent DNA helicase homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035092 (translocation associated membrane protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA035108 (scavenger receptor class F, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035182 (kelch-like family member 22) has been omitted due to inconsistency with RNA-seq data.
• HPA035196 (methylmalonyl CoA epimerase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA035284 (glycerol-3-phosphate dehydrogenase 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035299 (NADPH oxidase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035300 (NADPH oxidase 1) has been omitted due to inconsistency with RNA-seq data.
• HPA035309 (acyl-CoA thioesterase 11) has been omitted due to inconsistency with RNA-seq data.
• HPA035337 (cannabinoid receptor interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA035367 (ubiquitin associated and SH3 domain containing A) has been omitted due to inconsistency with RNA-seq data.
• HPA035382 (von Willebrand factor A domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA035383 (von Willebrand factor A domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA035386 (inhibin, beta B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035557 (HFM1, ATP-dependent DNA helicase homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035615 (interleukin 36 and alpha) has been omitted due to inconsistency with RNA-seq data.
• HPA035616 (transmembrane protein 9) has been omitted due to inconsistency with gene/protein characterization data.
• HPA035676 (villin-like) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA035720 (calpain 14) has been omitted due to inconsistency with RNA-seq data.
• HPA035721 (calpain 14) has been omitted due to inconsistency with RNA-seq data.
• HPA035744 (cilia and flagella associated protein 47) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035758 (elongation factor, RNA polymerase II and 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA035820 (CDK5 regulatory subunit associated protein 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA035824 (SLAIN motif family, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035825 (NFU1 iron-sulfur cluster scaffold) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035965 (methyl-CpG binding domain protein 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA036030 (family with sequence similarity 102, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036042 (acid sensing (proton gated) ion channel family member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036068 (family with sequence similarity 229 and member B) has been omitted due to inconsistency with RNA-seq data.
• HPA036080 (mutS homolog 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036081 (mutS homolog 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036139 (fibrous sheath interacting protein 2) has been omitted due to inconsistency with RNA-seq data.
• HPA036184 (secretoglobin, family 2A, member 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA036276 (anoctamin 2, calcium activated chloride channel) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA036339 (tetratricopeptide repeat domain 26) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA036403 (oculocutaneous albinism II) has been omitted due to inconsistency with gene/protein characterization data.
• HPA036418 (zinc finger, SWIM-type containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036419 (zinc finger, SWIM-type containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036468 (dedicator of cytokinesis 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA036479 (G protein regulated inducer of neurite outgrowth 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA036516 (solute carrier organic anion transporter family and member 4C1) has been omitted due to inconsistency with RNA-seq data.
• HPA036549 (KIAA0141) has been omitted due to inconsistency with gene/protein characterization data.
• HPA036606 (tankyrase and TRF1-interacting ankyrin-related ADP-ribose polymerase 2) has been omitted due to inconsistency with RNA-seq data.
• HPA036616 (hematopoietic SH2 domain containing) has been omitted due to inconsistency with RNA-seq data.
• HPA036659 (glutamate receptor, metabotropic 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036660 (endothelial cell-specific molecule 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA036680 (solute carrier family 4 (anion exchanger), member 1 and adaptor protein) has been omitted due to inconsistency with gene/protein characterization data.
• HPA036725 (prostaglandin reductase 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA036801 (protein phosphatase 1 and regulatory subunit 36) has been omitted due to inconsistency with RNA-seq data.
• HPA036815 (DnaJ (Hsp40) homolog, subfamily C and member 27) has been omitted due to inconsistency with RNA-seq data.
• HPA036820 (cadherin-related family member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036869 (protein phosphatase 2C-like domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA036870 (protein phosphatase 2C-like domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA036884 (chromosome 10 open reading frame 62) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA036886 (macrophage erythroblast attacher) has been omitted due to inconsistency with RNA-seq data.
• HPA036931 (TBC1 domain family, member 14) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA036963 (synaptotagmin XIV) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036977 (DAB2 interacting protein) has been omitted due to inconsistency with RNA-seq data.
• CAB037029 (general transcription factor IIH and polypeptide 5) has been omitted due to inconsistency with gene/protein characterization data.
• CAB037042 (general transcription factor IIH and polypeptide 5) has been omitted due to inconsistency with gene/protein characterization data.
• CAB037055 (mindbomb E3 ubiquitin protein ligase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB037223 (sprouty-related and EVH1 domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• CAB037319 (neuroglobin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037398 (major facilitator superfamily domain containing 10) has been omitted due to inconsistency with RNA-seq data.
• HPA037486 (M-phase phosphoprotein 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037528 (polymerase (RNA) I polypeptide B and 128kDa) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037529 (polymerase (RNA) I polypeptide B and 128kDa) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037544 (dedicator of cytokinesis 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037556 (solute carrier family 22 and member 14) has been omitted due to inconsistency with RNA-seq data.
• HPA037581 (cilia and flagella associated protein 70) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037583 (pleckstrin homology domain containing and family S member 1) has been omitted due to inconsistency with RNA-seq data.
• HPA037587 (solute carrier family 16 and member 12) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037595 (leucine rich repeat containing 27) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037596 (leucine rich repeat containing 27) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037653 (family with sequence similarity 175, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA037692 (cytochrome P450, family 2, subfamily S and polypeptide 1) has been omitted due to inconsistency with RNA-seq data.
• HPA037711 (Ras association (RalGDS/AF-6) domain family member 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037742 (allantoicase) has been omitted due to inconsistency with RNA-seq data.
• HPA037743 (allantoicase) has been omitted due to inconsistency with RNA-seq data.
• HPA037761 (death domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA037762 (death domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA037774 (nucleoporin 155kDa) has been omitted due to inconsistency with RNA-seq data.
• HPA037798 (spermatogenic leucine zipper 1) has been omitted due to inconsistency with RNA-seq data.
• HPA037840 (exophilin 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037853 (patatin-like phospholipase domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037859 (chromosome 1 open reading frame 186) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037924 (oligonucleotide/oligosaccharide-binding fold containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037925 (oligonucleotide/oligosaccharide-binding fold containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037927 (polymerase (RNA) III (DNA directed) polypeptide A, 155kDa) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA037935 (sestrin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037936 (sestrin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037943 (shootin 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA037955 (coiled-coil domain containing 172) has been omitted due to inconsistency with gene/protein characterization data.
• HPA037956 (coiled-coil domain containing 172) has been omitted due to inconsistency with RNA-seq data.
• HPA037985 (feline leukemia virus subgroup C cellular receptor family, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA038066 (WD repeat domain 63) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA038167 (family with sequence similarity 60, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038200 (UbiA prenyltransferase domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038203 (transformation/transcription domain-associated protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038255 (DEP domain containing 1B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038287 (family with sequence similarity 216, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038372 (inner mitochondrial membrane peptidase subunit 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038381 (centrosomal protein 126kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038385 (mitochondrial carrier 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA038392 (cytoplasmic polyadenylation element binding protein 4) has been omitted due to inconsistency with RNA-seq data.
• HPA038399 (centrosomal protein 126kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038413 (fibronectin type III and ankyrin repeat domains 1) has been omitted due to inconsistency with RNA-seq data.
• HPA038415 (xylulokinase homolog (H. influenzae)) has been omitted due to inconsistency with other antibody targeting the same gene.
• HPA038434 (ELMO/CED-12 domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038435 (ELMO/CED-12 domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA038570 (carnosine synthase 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA038615 (nucleosome assembly protein 1-like 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038626 (chromosome 12 open reading frame 10) has been omitted due to inconsistency with RNA-seq data.
• HPA038630 (NLR family member X1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA038682 (RAD9-HUS1-RAD1 interacting nuclear orphan 1) has been omitted due to inconsistency with RNA-seq data.
• HPA038701 (vacuolar protein sorting 33 homolog A (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038702 (vacuolar protein sorting 33 homolog A (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038864 (zinc finger CCHC-type and RNA binding motif 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038889 (heat shock 27kDa protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038890 (heat shock 27kDa protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038935 (neuregulin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA039048 (coiled-coil domain containing 60) has been omitted due to inconsistency with RNA-seq data.
• HPA039051 (glycosyltransferase 1 domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA039052 (glycosyltransferase 1 domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA039112 (ubiquilin-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039115 (peroxisomal biogenesis factor 11 alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039144 (oxysterol binding protein-like 11) has been omitted due to inconsistency with gene/protein characterization data.
• HPA039265 (metallophosphoesterase domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039268 (chaperonin containing TCP1 and subunit 8 (theta)-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA039294 (chromosome 12 open reading frame 74) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA039300 (coiled-coil domain containing 7) has been omitted due to inconsistency with RNA-seq data.
• HPA039305 (coiled-coil domain containing 38) has been omitted due to inconsistency with RNA-seq data.
• HPA039311 (cyclin-dependent kinase inhibitor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039350 (autophagy related 13) has been omitted due to inconsistency with RNA-seq data.
• HPA039356 (spindle and kinetochore associated complex subunit 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA039386 (zwilch kinetochore protein) has been omitted due to inconsistency with RNA-seq data.
• HPA039388 (exonuclease 3'-5' domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA039416 (interactor of little elongation complex ELL subunit 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039443 (protein phosphatase 1 and regulatory subunit 12A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA039474 (X-ray radiation resistance associated 1) has been omitted due to inconsistency with RNA-seq data.
• HPA039496 (PIH1 domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA039589 (Rho GTPase activating protein 10) has been omitted due to inconsistency with gene/protein characterization data.
• HPA039630 (leucine rich repeat containing 20) has been omitted due to inconsistency with RNA-seq data.
• HPA039668 (thymocyte expressed, positive selection associated 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039691 (adrenomedullin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039707 (coiled-coil domain containing 83) has been omitted due to inconsistency with RNA-seq data.
• HPA039798 (keratin 86, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA039823 (peptidase domain containing associated with muscle regeneration 1) has been omitted due to inconsistency with RNA-seq data.
• HPA039844 (butyrophilin-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039882 (coiled-coil domain containing 83) has been omitted due to inconsistency with RNA-seq data.
• HPA039909 (chromosome 12 open reading frame 42) has been omitted due to inconsistency with RNA-seq data.
• HPA039921 (chromosome 11 open reading frame 85) has been omitted due to inconsistency with RNA-seq data.
• HPA039941 (meiotic nuclear divisions 1) has been omitted due to inconsistency with RNA-seq data.
• HPA039991 (syntaxin binding protein 5 (tomosyn)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039997 (lipase, family member N) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040042 (doublecortin domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA040049 (chromosome 3 open reading frame 20) has been omitted due to inconsistency with RNA-seq data.
• HPA040058 (interactor of little elongation complex ELL subunit 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040083 (methyltransferase like 21C) has been omitted due to inconsistency with RNA-seq data.
• HPA040089 (thymus, brain and testes associated) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040103 (non-SMC condensin I complex, subunit G) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA040117 (leucine rich repeat containing 10) has been omitted due to inconsistency with RNA-seq data.
• HPA040159 (leucine rich repeat containing 10) has been omitted due to inconsistency with RNA-seq data.
• HPA040188 (DENN/MADD domain containing 4B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040192 (chromosome 7 open reading frame 34) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040203 (lemur tyrosine kinase 3) has been omitted due to inconsistency with RNA-seq data.
• HPA040230 (radial spoke 3 homolog (Chlamydomonas)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040264 (smoothelin-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA040279 (PCF11 cleavage and polyadenylation factor subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040284 (chromosome 11 open reading frame 65) has been omitted due to inconsistency with RNA-seq data.
• HPA040315 (solute carrier family 4 (anion exchanger) and member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA040330 (keratin 32 and type I) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040332 (alkylglycerol monooxygenase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040336 (ATP-binding cassette, sub-family D (ALD) and member 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040364 (otogelin-like) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA040373 (transaldolase 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040399 (UHRF1 binding protein 1-like) has been omitted due to inconsistency with RNA-seq data.
• HPA040402 (SDS3 homolog, SIN3A corepressor complex component) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040455 (testis expressed 26) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040458 (isochorismatase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA040461 (bromo adjacent homology domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040467 (exostosin-like glycosyltransferase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040483 (elaC ribonuclease Z 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040639 (serine/threonine/tyrosine interacting protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA040677 (N-acetyltransferase 8-like (GCN5-related and putative)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040682 (StAR-related lipid transfer (START) domain containing 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040704 (chromosome 18 open reading frame 54) has been omitted due to inconsistency with RNA-seq data.
• HPA040724 (protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040750 (protease, serine, 54) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040766 (kelch-like family member 22) has been omitted due to inconsistency with RNA-seq data.
• HPA040782 (keratin 80, type II) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040783 (potassium channel, voltage gated eag related subfamily H, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040785 (testis expressed 26) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040798 (SLAIN motif family and member 1) has been omitted due to inconsistency with RNA-seq data.
• HPA040814 (tRNA methyltransferase 2 homolog B) has been omitted due to inconsistency with RNA-seq data.
• HPA040848 (lysine-rich nucleolar protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040852 (phosphomannomutase 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040879 (ADP-ribosyltransferase 4 (Dombrock blood group)) has been omitted due to inconsistency with RNA-seq data.
• HPA040890 (elastin microfibril interfacer 2) has been omitted due to inconsistency with RNA-seq data.
• HPA040908 (coiled-coil domain containing 178) has been omitted due to inconsistency with RNA-seq data.
• HPA040923 (proline-serine-threonine phosphatase interacting protein 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA040929 (pancreatic progenitor cell differentiation and proliferation factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040931 (SCP2 sterol-binding domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA041018 (chromosome 16 open reading frame 86) has been omitted due to inconsistency with gene/protein characterization data.
• HPA041028 (interferon, epsilon) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041098 (chromosome 18 open reading frame 54) has been omitted due to inconsistency with RNA-seq data.
• HPA041101 (ring finger protein 138 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA041152 (metallothionein 1E) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041159 (family with sequence similarity 45 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA041186 (coiled-coil domain containing 78) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041196 (bromo adjacent homology domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041204 (beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041254 (isopentenyl-diphosphate delta isomerase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041259 (transmembrane 4 L six family member 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA041336 (chaperonin containing TCP1 and subunit 8 (theta)-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA041340 (family with sequence similarity 45, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041341 (chromosome 20 open reading frame 195) has been omitted due to inconsistency with RNA-seq data.
• HPA041373 (ring finger protein 138 and E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA041376 (tumor necrosis factor (ligand) superfamily, member 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041383 (FANCD2/FANCI-associated nuclease 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041384 (coiled-coil domain containing 78) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041426 (Fc receptor-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041494 (RIMS binding protein 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA041520 (forkhead box N1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041577 (SIGLEC family like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA041633 (myosin IA) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA041640 (SRY (sex determining region Y)-box 8) has been omitted due to inconsistency with RNA-seq data.
• HPA041649 (transglutaminase 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041682 (WW domain containing E3 ubiquitin protein ligase 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA041691 (myogenic factor 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041744 (pleckstrin homology domain containing and family G (with RhoGef domain) member 4) has been omitted due to inconsistency with gene/protein characterization data.
• HPA041765 (coiled-coil domain containing 63) has been omitted due to inconsistency with RNA-seq data.
• HPA041778 (carbonic anhydrase XI) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041780 (chromosome 15 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
• HPA041789 (chromosome 18 open reading frame 63) has been omitted due to inconsistency with RNA-seq data.
• HPA041827 (synaptotagmin IX) has been omitted due to inconsistency with RNA-seq data.
• HPA041894 (cytosolic thiouridylase subunit 2 homolog (S. pombe)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041919 (REC114 meiotic recombination protein) has been omitted due to inconsistency with RNA-seq data.
• HPA041941 (chromosome 15 open reading frame 43) has been omitted due to inconsistency with RNA-seq data.
• HPA041963 (RAS-like and family 12) has been omitted due to inconsistency with RNA-seq data.
• HPA041976 (cholecystokinin B receptor) has been omitted due to inconsistency with RNA-seq data.
• HPA041983 (DCN1, defective in cullin neddylation 1, domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA041992 (ATPase, aminophospholipid transporter, class I, type 8B and member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA042004 (leukocyte receptor cluster (LRC) member 8) has been omitted due to inconsistency with RNA-seq data.
• HPA042063 (homeobox B6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042129 (BIRC8 and XIAP) has been omitted due to inconsistency with RNA-seq data.
• HPA042137 (PARK2 co-regulated-like) has been omitted due to inconsistency with RNA-seq data.
• HPA042142 (ATP5E, ATP5EP2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042150 (chromosome 16 open reading frame 78) has been omitted due to inconsistency with RNA-seq data.
• HPA042153 (coiled-coil domain containing 79) has been omitted due to inconsistency with RNA-seq data.
• HPA042161 (meiosis specific with OB domains) has been omitted due to inconsistency with RNA-seq data.
• HPA042173 (FAM127A, FAM127B and FAM127C) has been omitted due to inconsistency with RNA-seq data.
• HPA042195 (IZUMO family member 2) has been omitted due to inconsistency with RNA-seq data.
• HPA042233 (chromosome 18 open reading frame 63) has been omitted due to inconsistency with RNA-seq data.
• HPA042274 (BTAF1 RNA polymerase II, B-TFIID transcription factor-associated and 170kDa) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042277 (integrin and beta 7) has been omitted due to inconsistency with RNA-seq data.
• HPA042293 (testis expressed 29) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042344 (axin 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA042359 (transmembrane protein 127) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042374 (retinal pigment epithelium-derived rhodopsin homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042386 (zinc finger and BTB domain containing 40) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042391 (Kell blood group and metallo-endopeptidase) has been omitted due to inconsistency with RNA-seq data.
• HPA042421 (interleukin 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042457 (PDZ domain containing 9) has been omitted due to inconsistency with RNA-seq data.
• HPA042468 (potassium channel tetramerization domain containing 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042474 (gametocyte specific factor 1-like) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA042479 (deoxynucleotidyltransferase, terminal, interacting protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA042480 (LRRN4 C-terminal like) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA042489 (SRSF protein kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042493 (HRAS-like suppressor family and member 5) has been omitted due to inconsistency with RNA-seq data.
• HPA042501 (cilia and flagella associated protein 221) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042506 (alkaline ceramidase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042520 (family with sequence similarity 228 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA042521 (BIRC8, XIAP) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042547 (meiosis specific with OB domains) has been omitted due to inconsistency with RNA-seq data.
• HPA042552 (REX1, RNA exonuclease 1 homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA042569 (family with sequence similarity 71 and member C) has been omitted due to inconsistency with RNA-seq data.
• HPA042571 (chromosome 1 open reading frame 185) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042583 (StAR-related lipid transfer (START) domain containing 6) has been omitted due to inconsistency with RNA-seq data.
• HPA042605 (inositol polyphosphate-5-phosphatase F) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042621 (deafness and autosomal recessive 59) has been omitted due to inconsistency with RNA-seq data.
• HPA042625 (RAD51 associated protein 2) has been omitted due to inconsistency with RNA-seq data.
• HPA042642 (RABL2A, RABL2B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042684 (tudor domain containing 12) has been omitted due to inconsistency with RNA-seq data.
• HPA042709 (cation channel, sperm associated 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042756 (family with sequence similarity 209 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA042765 (RABL2A, RABL2B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042778 (Bet1 golgi vesicular membrane trafficking protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042793 (zinc finger protein 706) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042799 (stromal cell-derived factor 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042821 (FAM24A and FAM24B) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042951 (transmembrane protease and serine 11B) has been omitted due to inconsistency with RNA-seq data.
• HPA042970 (ring finger protein 166) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042972 (zinc finger and CCHC domain containing 3) has been omitted due to inconsistency with RNA-seq data.
• HPA042982 (lipoxygenase homology domains 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043005 (cytochrome P450, family 4, subfamily Z, polypeptide 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043007 (maestro heat-like repeat family member 7) has been omitted due to inconsistency with RNA-seq data.
• HPA043012 (TUBG1 and TUBG2) has been omitted due to inconsistency with RNA-seq data.
• HPA043022 (chromosome 10 open reading frame 82) has been omitted due to inconsistency with RNA-seq data.
• HPA043045 (mesoderm induction early response 1 and family member 2) has been omitted due to inconsistency with RNA-seq data.
• HPA043064 (WD repeat domain 70) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043073 (zinc finger and RAN-binding domain containing 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043108 (paraneoplastic Ma antigen family-like 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043109 (sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043181 (proprotein convertase subtilisin/kexin type 7) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043248 (zinc finger and CCCH-type with G patch domain) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043250 (transmembrane protein 203) has been omitted due to inconsistency with RNA-seq data.
• HPA043262 (family with sequence similarity 71 and member E1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043301 (zinc finger and RAN-binding domain containing 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043330 (cadherin-related family member 4) has been omitted due to inconsistency with RNA-seq data.
• HPA043356 (vacuolar protein sorting 13 homolog C (S. cerevisiae)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043363 (family with sequence similarity 205 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA043371 (germ cell associated 1) has been omitted due to inconsistency with RNA-seq data.
• HPA043419 (death effector domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043429 (butyrophilin-like 9) has been omitted due to inconsistency with RNA-seq data.
• HPA043486 (TEN1 CST complex subunit) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043514 (MARVEL domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043554 (death effector domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043577 (protein phosphatase, Mg2+/Mn2+ dependent and 1N (putative)) has been omitted due to inconsistency with RNA-seq data.
• HPA043578 (tektin 5) has been omitted due to inconsistency with RNA-seq data.
• HPA043582 (ATPase, aminophospholipid transporter, class I, type 8B and member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA043617 (COX20 cytochrome c oxidase assembly factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043626 (inositol 1,4,5-trisphosphate receptor interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043638 (kinesin family member 19) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043650 (FTH1 and FTMT) has been omitted due to inconsistency with RNA-seq data.
• HPA043710 (ubiquitin D) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043725 (leukocyte specific transcript 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043769 (TXK tyrosine kinase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043790 (chromosome 5 open reading frame 56) has been omitted due to inconsistency with RNA-seq data.
• HPA043794 (testis expressed 43) has been omitted due to inconsistency with RNA-seq data.
• HPA043797 (transketolase-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA043802 (lactate dehydrogenase A-like 6A) has been omitted due to inconsistency with RNA-seq data.
• HPA043811 (beta-carotene oxygenase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043848 (zinc finger and BTB domain containing 22) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043852 (myotubularin related protein 4) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043890 (spondin 2, extracellular matrix protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043908 (coiled-coil domain containing 64) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043926 (hyaluronan-mediated motility receptor (RHAMM)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043927 (coiled-coil domain containing 63) has been omitted due to inconsistency with RNA-seq data.
• HPA043935 (cysteinyl-tRNA synthetase 2, mitochondrial (putative)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043960 (outer dense fiber of sperm tails 3-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA043963 (tumor protein p53 inducible protein 13) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA043967 (TRIM64, TRIM64B, TRIM64C) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043993 (serine incorporator 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043994 (adenosine deaminase domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA044080 (adenosine deaminase domain containing 1 (testis-specific)) has been omitted due to inconsistency with RNA-seq data.
• HPA044122 (beta-gamma crystallin domain containing 3) has been omitted due to inconsistency with RNA-seq data.
• HPA044151 (lymphocyte antigen 6 complex and locus G6C) has been omitted due to inconsistency with RNA-seq data.
• HPA044152 (protamine 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044166 (transmembrane channel-like 1) has been omitted due to lack of appropriate tissue.
• HPA044172 (defensin, beta 133) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044176 (defensin and beta 135) has been omitted due to inconsistency with RNA-seq data.
• HPA044182 (kelch repeat and BTB (POZ) domain containing 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044195 (mediator complex subunit 26) has been omitted due to inconsistency with RNA-seq data.
• HPA044281 (ATPase, H+ transporting, lysosomal 21kDa and V0 subunit b) has been omitted due to inconsistency with RNA-seq data.
• HPA044298 (PR domain containing 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044305 (X-box binding protein 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA044344 (chromosome 9 open reading frame 57) has been omitted due to inconsistency with RNA-seq data.
• HPA044349 (CTS telomere maintenance complex component 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044395 (coiled-coil domain containing 27) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044402 (sterile alpha motif domain containing 8) has been omitted due to inconsistency with RNA-seq data.
• HPA044449 (zyg-11 related and cell cycle regulator) has been omitted due to inconsistency with RNA-seq data.
• HPA044460 (THAP domain containing, apoptosis associated protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044469 (Sp6 transcription factor) has been omitted due to inconsistency with RNA-seq data.
• HPA044479 (solute carrier family 17 (acidic sugar transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044491 (Rho GTPase activating protein 39) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044493 (G protein-coupled receptor 83) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044494 (defensin and beta 134) has been omitted due to inconsistency with RNA-seq data.
• HPA044497 (mitogen-activated protein kinase kinase 3) has been omitted due to inconsistency with RNA-seq data.
• HPA044523 (zona pellucida glycoprotein 1 (sperm receptor)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA044586 (heparan sulfate 6-O-sulfotransferase 1) has been omitted due to inconsistency with RNA-seq data.
• HPA044596 (transcription factor 23) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044676 (cell migration inducing protein and hyaluronan binding) has been omitted due to inconsistency with RNA-seq data.
• HPA044714 (deoxyribonuclease I-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044765 (ribonuclease, RNase A family and 8) has been omitted due to inconsistency with RNA-seq data.
• HPA044767 (lecithin-cholesterol acyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044812 (DNA-damage regulated autophagy modulator 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA044835 (zinc finger and BTB domain containing 8 opposite strand) has been omitted due to inconsistency with gene/protein characterization data.
• HPA044883 (BMP8A, BMP8B) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA044900 (ankyrin repeat and MYND domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA044969 (glycoprotein (transmembrane) nmb) has been omitted due to inconsistency with RNA-seq data.
• HPA045026 (glycerophosphodiester phosphodiesterase domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045049 (psoriasis susceptibility 1 candidate 1) has been omitted due to inconsistency with RNA-seq data.
• HPA045070 (SEC61A1 and SEC61A2) has been omitted due to inconsistency with RNA-seq data.
• HPA045074 (rhomboid domain containing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045086 (keratin associated protein 20-4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045128 (ribonuclease P/MRP 38kDa subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045151 (four and a half LIM domains 5) has been omitted due to inconsistency with RNA-seq data.
• HPA045207 (cysteine-serine-rich nuclear protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045242 (H2AFV, H2AFZ) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045260 (solute carrier family 25, member 30) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045269 (sorting nexin 29) has been omitted due to inconsistency with RNA-seq data.
• HPA045272 (transmembrane protein 252) has been omitted due to inconsistency with gene/protein characterization data.
• HPA045282 (ADAM metallopeptidase domain 22) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045285 (chromosome 16 open reading frame 92) has been omitted due to inconsistency with RNA-seq data.
• HPA045290 (defensin and beta 121) has been omitted due to inconsistency with RNA-seq data.
• HPA045293 (crystallin and beta B3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA045317 (zinc finger and BTB domain containing 8 opposite strand) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA045344 (bone morphogenetic protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045377 (melanoma antigen family A11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045405 (coiled-coil domain containing 70) has been omitted due to inconsistency with RNA-seq data.
• HPA045406 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region and candidate 11) has been omitted due to inconsistency with RNA-seq data.
• HPA045425 (LEM domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045434 (testis expressed 10) has been omitted due to inconsistency with gene/protein characterization data.
• HPA045440 (chaperonin containing TCP1 and subunit 8 (theta)-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA045447 (synaptotagmin IX) has been omitted due to inconsistency with RNA-seq data.
• HPA045494 (DENN/MADD domain containing 1B) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA045496 (deoxynucleotidyltransferase, terminal, interacting protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA045523 (RAN binding protein 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045559 (chromosome 9 open reading frame 153) has been omitted due to inconsistency with RNA-seq data.
• HPA045587 (ring finger protein 148) has been omitted due to inconsistency with RNA-seq data.
• HPA045614 (casein kinase 1 and alpha 1) has been omitted due to inconsistency with RNA-seq data.
• HPA045671 (transmembrane protein 114) has been omitted due to inconsistency with RNA-seq data.
• HPA045695 (developmental pluripotency associated 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045710 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA045722 (IZUMO family member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA045723 (four and a half LIM domains 3) has been omitted due to inconsistency with RNA-seq data.
• HPA045778 (regulation of nuclear pre-mRNA domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA045805 (chromosome 1 open reading frame 94) has been omitted due to inconsistency with RNA-seq data.
• HPA045816 (sorting nexin family member 27) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045819 (primary cilia formation) has been omitted due to inconsistency with RNA-seq data.
• HPA045820 (vasohibin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045860 (Na+/K+ transporting ATPase interacting 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045885 (RNA binding motif protein 11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045905 (bifunctional apoptosis regulator) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045913 (crystallin, beta A2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045925 (regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA045926 (kelch-like family member 30) has been omitted due to inconsistency with RNA-seq data.
• HPA045935 (coiled-coil and C2 domain containing 2B) has been omitted due to inconsistency with RNA-seq data.
• CAB046000 (protein kinase, membrane associated tyrosine/threonine 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046040 (TUBG1 and TUBG2) has been omitted due to inconsistency with RNA-seq data.
• HPA046113 (Src homology 2 domain containing F) has been omitted due to inconsistency with RNA-seq data.
• HPA046139 (suppressor of variegation 4-20 homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA046146 (RWD domain containing 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046156 (t-complex-associated-testis-expressed 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046195 (methyltransferase like 15) has been omitted due to inconsistency with RNA-seq data.
• HPA046256 (tubby like protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046274 (tryptophan hydroxylase 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA046286 (PDZ domain containing 9) has been omitted due to inconsistency with RNA-seq data.
• HPA046308 (phospholipase A2 and group IID) has been omitted due to inconsistency with RNA-seq data.
• HPA046323 (ZNF585A, ZNF585B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046331 (zinc finger and BTB domain containing 8 opposite strand) has been omitted due to inconsistency with gene/protein characterization data.
• HPA046362 (nucleolar complex associated 4 homolog) has been omitted due to inconsistency with RNA-seq data.
• HPA046419 (lin-7 homolog B (C. elegans)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046538 (regulating synaptic membrane exocytosis 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA046644 (delta(4)-desaturase and sphingolipid 2) has been omitted due to inconsistency with RNA-seq data.
• HPA046682 (lens epithelial protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046773 (transmembrane channel-like 1) has been omitted due to lack of appropriate tissue.
• HPA046776 (RAD51 associated protein 2) has been omitted due to inconsistency with RNA-seq data.
• HPA046779 (immunoglobulin lambda-like polypeptide 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046789 (SIGLEC family like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA046794 (ribosomal protein L7a) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046820 (speckle-type POZ protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046839 (patched 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046844 (thioredoxin domain containing 8 (spermatozoa)) has been omitted due to inconsistency with RNA-seq data.
• HPA046866 (MOB3A, MOB3B and MOB3C) has been omitted due to inconsistency with RNA-seq data.
• HPA046896 (protein tyrosine phosphatase and non-receptor type 20) has been omitted due to inconsistency with RNA-seq data.
• HPA046901 (KRAB box domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA046905 (COMM domain containing 5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA046913 (calsyntenin 3) has been omitted due to inconsistency with RNA-seq data.
• HPA046944 (solute carrier family 16 (monocarboxylate transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046983 (ubiquitin associated and SH3 domain containing A) has been omitted due to inconsistency with RNA-seq data.
• HPA046989 (COMM domain containing 5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA047055 (protein tyrosine phosphatase and non-receptor type 20) has been omitted due to inconsistency with RNA-seq data.
• HPA047082 (tetratricopeptide repeat domain 9) has been omitted due to inconsistency with gene/protein characterization data.
• HPA047110 (elongation factor Tu GTP binding domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA047130 (iroquois homeobox 5) has been omitted due to inconsistency with RNA-seq data.
• HPA047142 (mannosidase, beta A and lysosomal-like) has been omitted due to inconsistency with RNA-seq data.
• HPA047240 (glutamine--fructose-6-phosphate transaminase 1) has been omitted due to inconsistency with RNA-seq data.
• HPA047245 (NOMO1, NOMO2 and NOMO3) has been omitted due to inconsistency with RNA-seq data.
• HPA047288 (basic leucine zipper and W2 domains 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA047440 (KDELR1, KDELR2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA047457 (CDRT1 and FBXW10) has been omitted due to inconsistency with RNA-seq data.
• HPA047458 (leucine rich repeat containing 42) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA047472 (testis, prostate and placenta expressed) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA047476 (defensin and beta 127) has been omitted due to inconsistency with RNA-seq data.
• HPA047481 (family with sequence similarity 150 and member B) has been omitted due to inconsistency with gene/protein characterization data.
• HPA047490 (chromosome 5 open reading frame 52) has been omitted due to inconsistency with RNA-seq data.
• HPA047498 (cytohesin 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA047500 (ZRSR1 and ZRSR2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA047538 (MAX dimerization protein 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA047593 (kelch-like family member 23) has been omitted due to inconsistency with gene/protein characterization data.
• HPA047620 (vacuolar protein sorting 39 homolog (S. cerevisiae)) has been omitted due to inconsistency with RNA-seq data.
• HPA047631 (2,4-dienoyl CoA reductase 2, peroxisomal) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA047680 (transmembrane protein 220) has been omitted due to inconsistency with RNA-seq data.
• HPA047781 (isochorismatase domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA047782 (polyamine oxidase (exo-N4-amino)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA047813 (synaptonemal complex central element protein 3) has been omitted due to inconsistency with RNA-seq data.
• HPA047832 (AC133551.1, AC136612.1, TP53TG3, TP53TG3B, TP53TG3C, TP53TG3D, TP53TG3E and TP53TG3F) has been omitted due to inconsistency with RNA-seq data.
• HPA047861 (chromosome 5 open reading frame 67) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA047904 (serine hydrolase-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA047905 (AC007325.4, DGCR6, DGCR6L) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA047909 (NIPSNAP3A and NIPSNAP3B) has been omitted due to inconsistency with RNA-seq data.
• HPA047925 (NIPSNAP3A and NIPSNAP3B) has been omitted due to inconsistency with RNA-seq data.
• HPA047926 (leukemia NUP98 fusion partner 1) has been omitted due to inconsistency with RNA-seq data.
• HPA047940 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1 and 7kDa) has been omitted due to inconsistency with gene/protein characterization data.
• HPA047943 (RNA binding motif and single stranded interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA047992 (myc target 1) has been omitted due to inconsistency with RNA-seq data.
• HPA048014 (family with sequence similarity 26 and member D) has been omitted due to inconsistency with RNA-seq data.
• HPA048111 (family with sequence similarity 71 and member E1) has been omitted due to inconsistency with RNA-seq data.
• HPA048118 (CDC-like kinase 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA048133 (WSC domain containing 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA048223 (MAU2 sister chromatid cohesion factor) has been omitted due to inconsistency with gene/protein characterization data.
• HPA048253 (Cdk5 and Abl enzyme substrate 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA048255 (leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA048263 (IgLON family member 5) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA048269 (WD repeat domain 87) has been omitted due to inconsistency with RNA-seq data.
• HPA048299 (coiled-coil alpha-helical rod protein 1) has been omitted due to inconsistency with RNA-seq data.
• HPA048329 (ring finger protein 185) has been omitted due to inconsistency with RNA-seq data.
• HPA048464 (zyg-11 related and cell cycle regulator) has been omitted due to inconsistency with RNA-seq data.
• HPA048469 (LSM10 and U7 small nuclear RNA associated) has been omitted due to inconsistency with gene/protein characterization data.
• HPA048546 (interleukin 1, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA048599 (apoptosis enhancing nuclease) has been omitted due to inconsistency with gene/protein characterization data.
• HPA048621 (inositol 1,4,5-trisphosphate receptor interacting protein-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA048646 (keratin 37 and type I) has been omitted due to inconsistency with gene/protein characterization data.
• HPA048703 (YTH N(6)-methyladenosine RNA binding protein 3) has been omitted due to inconsistency with RNA-seq data.
• HPA048716 (chromosome 5 open reading frame 47) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA048727 (family with sequence similarity 19 (chemokine (C-C motif)-like), member A5) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA048739 (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) and member 10) has been omitted due to inconsistency with RNA-seq data.
• HPA048766 (purine-rich element binding protein B) has been omitted due to inconsistency with gene/protein characterization data.
• HPA048834 (inhibin, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA048851 (proprotein convertase subtilisin/kexin type 2) has been omitted due to inconsistency with RNA-seq data.
• HPA048878 (WAP four-disulfide core domain 8) has been omitted due to inconsistency with RNA-seq data.
• HPA048881 (neuron-derived neurotrophic factor) has been omitted due to inconsistency with RNA-seq data.
• HPA048898 (sex comb on midleg homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA048994 (methyltransferase like 15) has been omitted due to inconsistency with gene/protein characterization data.
• HPA049035 (transmembrane protein 202) has been omitted due to inconsistency with RNA-seq data.
• HPA049036 (nucleoporin like 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA049099 (doublesex and mab-3 related transcription factor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049122 (TBC1D26 and TBC1D28) has been omitted due to inconsistency with RNA-seq data.
• HPA049130 (transmembrane protein 247) has been omitted due to inconsistency with RNA-seq data.
• HPA049215 (porcupine homolog (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049256 (NIPSNAP3A and NIPSNAP3B) has been omitted due to inconsistency with RNA-seq data.
• HPA049280 (matrix metallopeptidase 24 (membrane-inserted)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049377 (proteasome subunit alpha 8) has been omitted due to inconsistency with RNA-seq data.
• HPA049382 (zinc finger protein 395) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049434 (differentially expressed in FDCP 8 homolog (mouse)) has been omitted due to inconsistency with RNA-seq data.
• HPA049455 (WD repeat domain 87) has been omitted due to inconsistency with RNA-seq data.
• HPA049503 (small integral membrane protein 23) has been omitted due to inconsistency with RNA-seq data.
• HPA049556 (IQ motif containing F5) has been omitted due to inconsistency with RNA-seq data.
• HPA049564 (chromosome 2 open reading frame 81) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049571 (protein phosphatase 1 and regulatory subunit 16B) has been omitted due to inconsistency with RNA-seq data.
• HPA049579 (small integral membrane protein 23) has been omitted due to inconsistency with RNA-seq data.
• HPA049588 (interferon, alpha-inducible protein 27-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049597 (adhesion G protein-coupled receptor D2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049626 (IQ motif and ubiquitin domain containing) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049847 (PRKAR1A and PRKAR1B) has been omitted due to inconsistency with RNA-seq data.
• HPA049858 (copine family member IX) has been omitted due to inconsistency with RNA-seq data.
• HPA049878 (WAP four-disulfide core domain 5) has been omitted due to inconsistency with RNA-seq data.
• HPA049881 (calcium channel, voltage-dependent and gamma subunit 7) has been omitted due to inconsistency with RNA-seq data.
• HPA049936 (SET domain containing 9) has been omitted due to inconsistency with RNA-seq data.
• HPA049946 (keratin 82 and type II) has been omitted due to inconsistency with other antibody targeting the same gene.
• HPA050011 (arylsulfatase family and member H) has been omitted due to inconsistency with RNA-seq data.
• HPA050044 (TBC1D26 and TBC1D28) has been omitted due to inconsistency with RNA-seq data.
• HPA050223 (RAB26, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA050297 (olfactomedin 3) has been omitted due to inconsistency with RNA-seq data.
• HPA050337 (5-hydroxymethylcytosine (hmC) binding and ES cell-specific) has been omitted due to inconsistency with RNA-seq data.
• HPA050370 (primary cilia formation) has been omitted due to inconsistency with RNA-seq data.
• HPA050410 (isthmin 1, angiogenesis inhibitor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA050416 (pleckstrin and Sec7 domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA050419 (chromosome 10 open reading frame 11) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA050447 (ankyrin repeat and MYND domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA050544 (SPC25 and NDC80 kinetochore complex component) has been omitted due to inconsistency with RNA-seq data.
• HPA050601 (RNA binding motif protein 46) has been omitted due to inconsistency with RNA-seq data.
• HPA050625 (ataxin 7-like 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA050682 (guanine monophosphate synthase) has been omitted due to inconsistency with gene/protein characterization data.
• HPA050784 (aralkylamine N-acetyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA050819 (chromosome 11 open reading frame 88) has been omitted due to inconsistency with RNA-seq data.
• HPA050895 (iroquois homeobox 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA050903 (DNA-damage-inducible transcript 4-like) has been omitted due to inconsistency with RNA-seq data.
• HPA050908 (RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA050929 (arrestin domain containing 5) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051003 (neuron-derived neurotrophic factor) has been omitted due to inconsistency with RNA-seq data.
• HPA051100 (leucine rich repeat containing 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051163 (epithelial membrane protein 3) has been omitted due to inconsistency with RNA-seq data.
• HPA051206 (lectin, mannose-binding, 1 like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051219 (paired immunoglobin-like type 2 receptor alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051229 (vanin 2) has been omitted due to inconsistency with RNA-seq data.
• HPA051249 (deltex 1, E3 ubiquitin ligase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051264 (proline rich 29) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051286 (uridine-cytidine kinase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051292 (FAHD2A and FAHD2B) has been omitted due to inconsistency with other antibody targeting the same gene.
• HPA051352 (phospholipid scramblase 2) has been omitted due to inconsistency with RNA-seq data.
• HPA051365 (nuclear receptor subfamily 1, group I and member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA051399 (ubiquitin-conjugating enzyme E2 and J2) has been omitted due to inconsistency with RNA-seq data.
• HPA051403 (killer cell lectin-like receptor subfamily G, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051418 (N-terminal asparagine amidase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051447 (Rho GTPase activating protein 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051458 (PHD finger protein 19) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051462 () has been omitted due to inconsistency with RNA-seq data.
• HPA051466 (lipin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051499 (RAD51 associated protein 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051582 (chondroitin polymerizing factor 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051592 (RecQ mediated genome instability 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051594 (KIAA1549-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051637 (kelch-like family member 2) has been omitted due to inconsistency with RNA-seq data.
• HPA051639 (SEC22 homolog A and vesicle trafficking protein) has been omitted due to inconsistency with RNA-seq data.
• HPA051655 (colipase-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA051715 (exostosin glycosyltransferase 2) has been omitted due to inconsistency with RNA-seq data.
• HPA051812 (prostate tumor overexpressed 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051825 (mitogen-activated protein kinase 14) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051847 (SLIT and NTRK-like family and member 2) has been omitted due to inconsistency with RNA-seq data.
• HPA051858 (RAB37 and member RAS oncogene family) has been omitted due to inconsistency with RNA-seq data.
• HPA051866 (myelin transcription factor 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051907 (BLOC-1 related complex subunit 8) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA051921 (arrestin domain containing 3) has been omitted due to inconsistency with RNA-seq data.
• HPA051932 (ATPase type 13A4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA052024 (zinc finger protein 496) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA052041 (Rab interacting lysosomal protein) has been omitted due to inconsistency with gene/protein characterization data.
• HPA052044 (chromosome 8 open reading frame 46) has been omitted due to inconsistency with RNA-seq data.
• HPA052048 (defensin and beta 112) has been omitted due to inconsistency with RNA-seq data.
• HPA052084 (AC007325.1, AC023491.2 and POM121L7) has been omitted due to inconsistency with RNA-seq data.
• HPA052246 (collagen, type XI and alpha 1) has been omitted due to inconsistency with RNA-seq data.
• HPA052257 (CTD-2313N18.7 and DEFB131) has been omitted due to inconsistency with RNA-seq data.
• HPA052282 (WAP four-disulfide core domain 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA052327 (defensin and beta 113) has been omitted due to inconsistency with RNA-seq data.
• HPA052332 (LYZL1 and LYZL2) has been omitted due to inconsistency with RNA-seq data.
• HPA052392 (methyltransferase like 23) has been omitted due to inconsistency with RNA-seq data.
• HPA052442 (FGGY carbohydrate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
• HPA052491 (CDRT1 and FBXW10) has been omitted due to inconsistency with RNA-seq data.
• HPA052506 (WAP four-disulfide core domain 9) has been omitted due to inconsistency with RNA-seq data.
• HPA052511 (retbindin) has been omitted due to inconsistency with gene/protein characterization data.
• HPA052615 (family with sequence similarity 83 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA052633 (zinc finger and BTB domain containing 32) has been omitted due to inconsistency with RNA-seq data.
• HPA052722 (chromosome 2 open reading frame 54) has been omitted due to inconsistency with RNA-seq data.
• HPA052760 (transmembrane protein 31) has been omitted due to inconsistency with RNA-seq data.
• HPA052777 (catsper channel auxiliary subunit gamma) has been omitted due to inconsistency with RNA-seq data.
• HPA052822 (testis expressed 40) has been omitted due to inconsistency with RNA-seq data.
• HPA052901 (membrane-associated ring finger (C3HC4) 5) has been omitted due to inconsistency with RNA-seq data.
• HPA052996 (membrane bound O-acyltransferase domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053024 (notum pectinacetylesterase homolog (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
• HPA053026 (regulator of G-protein signaling 22) has been omitted due to inconsistency with RNA-seq data.
• HPA053106 (eukaryotic translation initiation factor 4E family member 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA053112 (isoamyl acetate-hydrolyzing esterase 1 homolog) has been omitted due to inconsistency with gene/protein characterization data.
• HPA053209 (vacuolar protein sorting 33 homolog A (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053212 (HIG1 hypoxia inducible domain family and member 1B) has been omitted due to inconsistency with RNA-seq data.
• HPA053237 (family with sequence similarity 32, member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA053292 (sex comb on midleg homolog 1 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053514 (coiled-coil domain containing 87) has been omitted due to inconsistency with RNA-seq data.
• HPA053528 (solute carrier family 45, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053643 (epilepsy, progressive myoclonus type 2A and Lafora disease (laforin)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA053651 (chromosome 8 open reading frame 46) has been omitted due to inconsistency with RNA-seq data.
• HPA053672 (regulating synaptic membrane exocytosis 2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA053763 (mesenteric estrogen-dependent adipogenesis) has been omitted due to inconsistency with RNA-seq data.
• HPA053781 (family with sequence similarity 71 and member E2) has been omitted due to inconsistency with RNA-seq data.
• HPA053811 (frizzled class receptor 5) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA053826 (transmembrane protein 129, E3 ubiquitin protein ligase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053849 (golgin A6 family-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA053850 (AC007325.1, AC023491.2 and POM121L7) has been omitted due to inconsistency with RNA-seq data.
• HPA053860 (signal recognition particle receptor (docking protein)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053862 (EEF1A1, EEF1A2) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA053950 (3-oxoacid CoA transferase 2) has been omitted due to inconsistency with RNA-seq data.
• HPA053976 (mitochondrially encoded ATP synthase 8) has been omitted due to inconsistency with RNA-seq data.
• HPA053992 (sodium channel, voltage gated and type IV alpha subunit) has been omitted due to inconsistency with RNA-seq data.
• HPA054014 (zinc finger protein 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA054022 (retinoic acid early transcript 1E) has been omitted due to inconsistency with RNA-seq data.
• HPA054086 (polycomb group ring finger 6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA054100 (leucine rich repeat containing 52) has been omitted due to inconsistency with RNA-seq data.
• HPA054139 (ornithine decarboxylase antizyme 2) has been omitted due to inconsistency with RNA-seq data.
• HPA054379 (zinc finger protein 541) has been omitted due to inconsistency with RNA-seq data.
• HPA054427 (poly(A) polymerase beta (testis specific)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA054432 (choline/ethanolamine phosphotransferase 1) has been omitted due to inconsistency with RNA-seq data.
• HPA054441 (beta-gamma crystallin domain containing 3) has been omitted due to inconsistency with RNA-seq data.
• HPA054474 (forty-two-three domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA054478 (crooked neck pre-mRNA splicing factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA054513 (EF-hand calcium binding domain 11) has been omitted due to inconsistency with RNA-seq data.
• HPA054552 (zinc finger and BTB domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA054625 (pleckstrin and Sec7 domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA054679 (arrestin domain containing 5) has been omitted due to inconsistency with RNA-seq data.
• HPA054729 (ceramide synthase 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA054754 (shisa family member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA054762 (zinc finger protein 571) has been omitted due to inconsistency with RNA-seq data.
• HPA054894 (importin 9) has been omitted due to inconsistency with RNA-seq data.
• HPA054923 (chromosome 1 open reading frame 168) has been omitted due to inconsistency with RNA-seq data.
• HPA054971 (FGGY carbohydrate kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
• HPA055021 (leucine-rich single-pass membrane protein 2) has been omitted due to inconsistency with RNA-seq data.
• HPA055036 (antioxidant 1 copper chaperone) has been omitted due to inconsistency with RNA-seq data.
• HPA055043 (protein phosphatase 1 and regulatory (inhibitor) subunit 1C) has been omitted due to inconsistency with RNA-seq data.
• HPA055044 (carboxypeptidase X (M14 family) and member 1) has been omitted due to inconsistency with RNA-seq data.
• HPA055054 (ring finger protein 151) has been omitted due to inconsistency with RNA-seq data.
• HPA055143 (dual specificity phosphatase 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA055180 (indolethylamine N-methyltransferase) has been omitted due to inconsistency with RNA-seq data.
• HPA055187 (WAP four-disulfide core domain 10A) has been omitted due to inconsistency with RNA-seq data.
• HPA055189 (mitochondrial calcium uniporter regulator 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA055224 (proline and serine rich 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA055344 (heparanase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA055404 (tumor protein p63 regulated 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA055411 (transmembrane protein 154) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA055468 (epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA055537 (ADAM metallopeptidase domain 19) has been omitted due to inconsistency with RNA-seq data.
• HPA055596 (tetratricopeptide repeat domain 27) has been omitted due to inconsistency with RNA-seq data.
• HPA055670 (leucine-rich repeats and death domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA055693 (retbindin) has been omitted due to inconsistency with gene/protein characterization data.
• HPA055795 (ATPase, class II, type 9A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA055834 (zinc finger protein 496) has been omitted due to inconsistency with RNA-seq data.
• HPA055837 (DNA-damage inducible 1 homolog 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA055931 (RAB40C, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA055946 (kringle containing transmembrane protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA055954 (human immunodeficiency virus type I enhancer binding protein 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA055971 (interleukin 34) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA056250 (epithelial membrane protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA056274 (EF-hand calcium binding domain 9) has been omitted due to inconsistency with RNA-seq data.
• HPA056301 (myeloid-associated differentiation marker) has been omitted due to inconsistency with RNA-seq data.
• HPA056307 (C-type lectin domain family 1 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA056344 (ribosomal modification protein rimK-like family member B) has been omitted due to inconsistency with RNA-seq data.
• HPA056347 (methyltransferase like 9) has been omitted due to inconsistency with RNA-seq data.
• HPA056362 (olfactomedin-like 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA056378 (discs, large (Drosophila) homolog-associated protein 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA056533 (delta-like 3 (Drosophila)) has been omitted due to inconsistency with RNA-seq data.
• HPA056563 (myocyte enhancer factor 2A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA056584 (potassium channel, voltage gated eag related subfamily H, member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA056610 (small integral membrane protein 3) has been omitted due to inconsistency with RNA-seq data.
• HPA056613 (small EDRK-rich factor 2) has been omitted due to inconsistency with RNA-seq data.
• HPA056650 (migration and invasion enhancer 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA056919 (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) and member 5) has been omitted due to inconsistency with RNA-seq data.
• HPA056928 (partner of NOB1 homolog) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA056934 (NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA056973 (dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA056985 (glutamate-rich 2) has been omitted due to inconsistency with RNA-seq data.
• HPA057065 (nucleosome assembly protein 1-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA057194 (discoidin domain receptor tyrosine kinase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA057230 (WAP four-disulfide core domain 11) has been omitted due to inconsistency with RNA-seq data.
• HPA057251 (nucleoporin like 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA057278 (solute carrier family 24 (sodium/potassium/calcium exchanger), member 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA057287 (prolyl 3-hydroxylase family member 4 (non-enzymatic)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA057345 (transcription elongation factor A (SII)-like 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA057414 (ubiquitin-conjugating enzyme E2Q family-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA057569 (limb development membrane protein 1-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA057672 (MEF2 activating motif and SAP domain containing transcriptional regulator) has been omitted due to inconsistency with RNA-seq data.
• HPA057766 (solute carrier family 45, member 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA057772 (NACHT and WD repeat domain containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA057838 (potassium channel, calcium activated large conductance subfamily M alpha, member 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA057987 (endothelin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA058038 (minichromosome maintenance domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA058056 (binder of sperm protein homolog 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA058273 (SLC25A51 and SLC25A52) has been omitted due to inconsistency with RNA-seq data.
• HPA058285 (chromosome 1 open reading frame 101) has been omitted due to inconsistency with RNA-seq data.
• HPA058298 (CAP-GLY domain containing linker protein 3) has been omitted due to inconsistency with RNA-seq data.
• HPA058366 (RNA binding protein with multiple splicing 2) has been omitted due to inconsistency with RNA-seq data.
• HPA058456 (septin 14) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA058503 (vitrin) has been omitted due to inconsistency with RNA-seq data.
• HPA058981 (phospholipase A1 member A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA058999 (chromosome 5 open reading frame 46) has been omitted due to inconsistency with RNA-seq data.
• HPA059000 (tripartite motif containing 36) has been omitted due to inconsistency with gene/protein characterization data.
• HPA059038 (proline rich 30) has been omitted due to inconsistency with RNA-seq data.
• HPA059048 (transcription elongation factor A (SII)-like 2) has been omitted due to inconsistency with RNA-seq data.
• HPA059122 (solute carrier family 9, member C2 (putative)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA059189 (N(alpha)-acetyltransferase 38 and NatC auxiliary subunit) has been omitted due to inconsistency with gene/protein characterization data.
• HPA059246 (desumoylating isopeptidase 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA059365 (V-set and transmembrane domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA059486 (putative homeodomain transcription factor 1) has been omitted due to inconsistency with RNA-seq data.
• HPA059513 (sphingosine-1-phosphate receptor 3) has been omitted due to inconsistency with RNA-seq data.
• HPA059540 (importin 9) has been omitted due to inconsistency with RNA-seq data.
• HPA059552 (ribosomal modification protein rimK-like family member B) has been omitted due to inconsistency with RNA-seq data.
• HPA059703 (ribonuclease H2, subunit C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA059748 (SPT4 homolog and DSIF elongation factor subunit) has been omitted due to inconsistency with gene/protein characterization data.
• HPA059948 (hexokinase 3 (white cell)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA059966 (zinc finger protein 571) has been omitted due to inconsistency with RNA-seq data.
• HPA060057 (ras homolog family member F (in filopodia)) has been omitted due to inconsistency with RNA-seq data.
• HPA060059 (glyceronephosphate O-acyltransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA060266 (COMM domain containing 6) has been omitted due to inconsistency with RNA-seq data.
• HPA060288 (zinc finger protein 790) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA060334 (transmembrane protein 150B) has been omitted due to inconsistency with RNA-seq data.
• HPA060355 (cyclic nucleotide gated channel beta 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA060368 (sulfotransferase family, cytosolic, 1C and member 3) has been omitted due to inconsistency with RNA-seq data.
• HPA060396 (V-set and transmembrane domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA060475 (interleukin 17D) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA060492 (transmembrane protein 132A) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA060515 (secretoglobin, family 1D, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA060517 (defensin and beta 110) has been omitted due to inconsistency with RNA-seq data.
• HPA060601 (sphingosine-1-phosphate receptor 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA060665 (SLC25A4, SLC25A5 and SLC25A6) has been omitted due to inconsistency with RNA-seq data.
• HPA060718 (calcium channel, voltage-dependent, gamma subunit 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA060863 (T-box 1) has been omitted due to inconsistency with RNA-seq data.
• HPA060901 (ZNF836, ZNF841) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA060997 (dephospho-CoA kinase domain containing) has been omitted due to inconsistency with RNA-seq data.
• HPA061010 (glutamate-rich 2) has been omitted due to inconsistency with RNA-seq data.
• HPA061206 (chromosome 6 open reading frame 201) has been omitted due to inconsistency with RNA-seq data.
• HPA061317 (calpain and small subunit 2) has been omitted due to inconsistency with RNA-seq data.
• HPA061607 (PQ loop repeat containing 3) has been omitted due to inconsistency with RNA-seq data.
• HPA061929 (C-type lectin domain family 1 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA061957 (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) and member 5) has been omitted due to inconsistency with RNA-seq data.
• HPA061966 (leucine-rich single-pass membrane protein 2) has been omitted due to inconsistency with RNA-seq data.
• HPA062346 (RHOA and RHOC) has been omitted due to inconsistency with RNA-seq data.
• HPA062493 (dynein, axonemal, heavy chain 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA062514 (phospholipid phosphatase 7 (inactive)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA062522 (iroquois homeobox 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA062538 (family with sequence similarity 83 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA062623 (proline/arginine-rich end leucine-rich repeat protein) has been omitted due to inconsistency with gene/protein characterization data.
• HPA062664 (cytoplasmic linker associated protein 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA062822 (selenocysteine lyase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA062893 (musculin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA064157 (PDLIM1 interacting kinase 1 like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA064208 (fucose-1-phosphate guanylyltransferase) has been omitted due to inconsistency with RNA-seq data.
• HPA065435 (zinc finger protein 528) has been omitted due to inconsistency with RNA-seq data.
• HPA065439 (leucine rich repeat containing 32) has been omitted due to inconsistency with gene/protein characterization data.
• HPA065587 (chromosome 8 open reading frame 88) has been omitted due to inconsistency with RNA-seq data.
• HPA065598 (vitrin) has been omitted due to inconsistency with RNA-seq data.
• HPA065745 (family with sequence similarity 229 and member A) has been omitted due to inconsistency with RNA-seq data.
• HPA065747 (ankyrin repeat domain 66) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA065863 (RAS guanyl releasing protein 3 (calcium and DAG-regulated)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA065945 (RAS guanyl releasing protein 3 (calcium and DAG-regulated)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA066585 (chromodomain helicase DNA binding protein 7) has been omitted due to inconsistency with gene/protein characterization data.
• HPA066616 (ankyrin repeat domain 66) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA066669 (coiled-coil glutamate-rich protein 1) has been omitted due to inconsistency with RNA-seq data.
• HPA066750 (actin-like 10) has been omitted due to inconsistency with RNA-seq data.
• HPA066969 (solute carrier family 22 (organic cation/carnitine transporter), member 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA067047 (Down syndrome critical region 8) has been omitted due to inconsistency with RNA-seq data.
• HPA067655 (tetraspanin 5) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA068290 (alanine and arginine rich domain containing protein) has been omitted due to inconsistency with RNA-seq data.
• HPA068437 (ectonucleoside triphosphate diphosphohydrolase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA070565 (X-ray repair complementing defective repair in Chinese hamster cells 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA070619 (transmembrane epididymal protein 1) has been omitted due to inconsistency with RNA-seq data.
• HPA071295 (interleukin 10 receptor, alpha) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA071363 (transmembrane epididymal protein 1) has been omitted due to inconsistency with RNA-seq data.
• CAB000095 (retinoblastoma 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB000105 (BCL2-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA001522 (lumican) has been omitted due to lack of appropriate tissue.
• CAB002312 (SMAD family member 4) has been omitted due to inconsistency with gene/protein characterization data.
• CAB002663 (cell division cycle 25B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB002682 (glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)) has been omitted due to inconsistency with gene/protein characterization data.
• CAB002771 (TIMP metallopeptidase inhibitor 4) has been omitted due to inconsistency with gene/protein characterization data.
• HPA003642 (HEAT repeat containing 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB003690 (testis derived transcript (3 LIM domains)) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB003709 (angiomotin like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB003851 (RAP1 GTPase activating protein) has been omitted due to inconsistency with gene/protein characterization data, other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB004560 (ras homolog family member B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB004649 (FXYD domain containing ion transport regulator 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB004658 (ribosomal protein L39-like) has been omitted due to inconsistency with RNA-seq data.
• CAB004780 (neuropeptide FF receptor 2) has been omitted due to inconsistency with gene/protein characterization data.
• CAB004785 (serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB004786 (neurofibromin 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB004990 (RAB4A, member RAS oncogene family) has been omitted due to inconsistency with gene/protein characterization data.
• CAB005007 (alkB, alkylation repair homolog 3 (E. coli)) has been omitted due to inconsistency with RNA-seq data.
• CAB005285 (cyclin-dependent kinase inhibitor 3) has been omitted due to inconsistency with gene/protein characterization data.
• CAB005373 (tenascin XB) has been omitted due to inconsistency with RNA-seq data.
• CAB005426 (vascular cell adhesion molecule 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB005619 (cholecystokinin A receptor) has been omitted due to inconsistency with gene/protein characterization data.
• CAB006330 (centromere protein M) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB006887 (ryanodine receptor 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA007261 (keratin 9) has been omitted due to lack of appropriate tissue.
• CAB008649 (ribosomal protein S6 kinase, 90kDa, polypeptide 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB009055 (TNF receptor-associated factor 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB009249 (frizzled-related protein) has been omitted due to inconsistency with RNA-seq data.
• HPA009338 (amyloid beta (A4) precursor protein-binding, family A, member 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB009474 (protein phosphatase, Mg2+/Mn2+ dependent, 1D) has been omitted due to inconsistency with gene/protein characterization data.
• CAB009508 (solute carrier family 25, member 27) has been omitted due to inconsistency with gene/protein characterization data.
• CAB009779 (calcium channel, voltage-dependent, beta 1 subunit) has been omitted due to product no longer available in provider's catalogue.
• CAB009808 (epoxide hydrolase 2, cytoplasmic) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB009850 (chaperonin containing TCP1, subunit 2 (beta)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB009906 (phosphatidylethanolamine binding protein 1) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB009948 (tyrosine kinase, non-receptor, 2) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB010346 (neurotrophic tyrosine kinase, receptor, type 2) has been omitted due to lack of appropriate tissue.
• CAB010347 (fibroblast growth factor receptor substrate 2) has been omitted due to inconsistency with RNA-seq data.
• CAB010360 (insulin-like growth factor binding protein 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB010381 (RAD51 recombinase) has been omitted due to lack of appropriate tissue.
• CAB010426 (transcription factor AP-2 beta (activating enhancer binding protein 2 beta)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB010464 (EPH receptor A2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB010908 (transducer of ERBB2, 1) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB011569 (shugoshin-like 1 (S. pombe)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB012247 (RecQ mediated genome instability 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB012356 (centromere protein I) has been omitted due to inconsistency with gene/protein characterization data.
• HPA012657 (phospholipase A2 receptor 1, 180kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB012900 (S100 calcium binding protein P) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB013045 (tumor necrosis factor receptor superfamily, member 1B) has been omitted due to inconsistency with gene/protein characterization data.
• CAB013289 (mitogen-activated protein kinase 8 interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB013455 (proteasome (prosome, macropain) subunit, alpha type, 8) has been omitted due to inconsistency with gene/protein characterization data.
• CAB013471 (presenilin enhancer gamma secretase subunit) has been omitted due to inconsistency with gene/protein characterization data, inconistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• HPA014763 (delta(4)-desaturase, sphingolipid 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB014884 (engrailed homeobox 1) has been omitted due to inconsistency with gene/protein characterization data, inconistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• HPA015607 (KIAA0319) has been omitted due to lack of appropriate tissue.
• HPA015784 (corepressor interacting with RBPJ, 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB015945 (ectodysplasin A2 receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA016004 (carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8) has been omitted due to lack of appropriate tissue.
• CAB016324 (survival of motor neuron 1, telomeric) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB016339 (Kin17 DNA and RNA binding protein) has been omitted due to inconsistency with gene/protein characterization data.
• CAB016383 (complement factor D (adipsin)) has been omitted due to inconsistency with gene/protein characterization data.
• CAB016523 (E2F transcription factor 4, p107/p130-binding) has been omitted due to inconsistency with gene/protein characterization data.
• CAB016688 (diablo, IAP-binding mitochondrial protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB016713 (leptin) has been omitted due to inconsistency with gene/protein characterization data.
• CAB017023 (K(lysine) acetyltransferase 6A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB017039 (slowmo homolog 2 (Drosophila)) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB017489 (solute carrier family 16 (monocarboxylate transporter), member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB017784 (glypican 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB017843 (epidermal growth factor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB018377 (transforming growth factor, beta 3) has been omitted due to inconsistency with RNA-seq data.
• CAB018358 (fms-related tyrosine kinase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB018773 (aldo-keto reductase family 1, member B1 (aldose reductase)) has been omitted due to inconsistency with gene/protein characterization data.
• CAB018966 (sonic hedgehog) has been omitted due to lack of appropriate tissue and inconsistency with gene/protein characterization data.
• CAB019267 (NCK interacting protein with SH3 domain) has been omitted due to inconsistency with gene/protein characterization data.
• CAB019281 (nuclear receptor subfamily 2, group F, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB020790 (myosin VC) has been omitted due to inconsistency with gene/protein characterization data.
• CAB022076 (Sec61 alpha 1 subunit (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data.
• CAB022193 (lumican) has been omitted due to inconsistency with other antibody targeting the same gene.
• CAB022337 (musashi RNA-binding protein 1) has been omitted due to inconsistency with RNA-seq data.
• CAB022700 (oxytocin receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB022770 (5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB022775 (5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB023814 (SATB homeobox 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA024342 (phosphodiesterase 3B, cGMP-inhibited) has been omitted due to lack of appropriate tissue.
• CAB024893 (catenin, beta interacting protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB025086 (unc-5 homolog C (C. elegans)) has been omitted due to inconsistency with gene/protein characterization data.
• CAB025154 (sialic acid binding Ig-like lectin 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB025575 (proprotein convertase subtilisin/kexin type 9) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB025621 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2) has been omitted due to inconsistency with RNA-seq data.
• CAB025665 (wingless-type MMTV integration site family, member 7B) has been omitted due to lack of appropriate tissue and inconsistency with RNA-seq data.
• CAB025879 (peptidoglycan recognition protein 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB026001 (transmembrane protein 123) has been omitted due to inconsistency with gene/protein characterization data.
• CAB026224 (glycoprotein (transmembrane) nmb) has been omitted due to inconsistency with RNA-seq data.
• CAB027385 (interleukin 18) has been omitted due to inconsistency with other antibody targeting the same gene.
• CAB027714 (proline rich 9) has been omitted due to inconsistency with gene/protein characterization data.
• CAB029997 (N-terminal asparagine amidase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB030018 (CD274 molecule) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030899 (leptin receptor) has been omitted due to lack of appropriate tissue.
• CAB031479 (guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA031605 (BEN domain containing 6) has been omitted due to lack of appropriate tissue.
• CAB031925 (regulator of G-protein signaling 19) has been omitted due to inconsistency with RNA-seq data.
• CAB032233 (eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB032277 (metallothionein 1H) has been omitted due to inconsistency with RNA-seq data.
• CAB032529 (acid-sensing (proton-gated) ion channel family member 4) has been omitted due to inconsistency with gene/protein characterization data.
• CAB032802 (serpin peptidase inhibitor, clade B (ovalbumin), member 12) has been omitted due to inconsistency with RNA-seq data.
• CAB033205 (ferrochelatase) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB033298 (leucine-rich repeats and calponin homology (CH) domain containing 4) has been omitted due to inconsistency with gene/protein characterization data.
• CAB033531 (hydroxyacylglutathione hydrolase) has been omitted due to inconsistency with gene/protein characterization data.
• CAB034047 (arrestin, beta 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB034160 (DNA-damage regulated autophagy modulator 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB034215 (testis expressed 29) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035493 (prickle homolog 2 (Drosophila)) has been omitted due to inconsistency with gene/protein characterization data.
• CAB037025 (baculoviral IAP repeat containing 7) has been omitted due to inconsistency with RNA-seq data.
• CAB037026 (early B-cell factor 2) has been omitted due to inconsistency with RNA-seq data.
• CAB037056 (RAB guanine nucleotide exchange factor (GEF) 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB037119 (baculoviral IAP repeat containing 7) has been omitted due to inconsistency with RNA-seq data.
• CAB037199 (uncoupling protein 1 (mitochondrial, proton carrier)) has been omitted due to lack of appropriate tissue.
• CAB037232 (autophagy related 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA037991 (MAP6 domain containing 1) has been omitted due to lack of appropriate tissue.
• HPA039297 (regulating synaptic membrane exocytosis 1) has been omitted due to lack of appropriate tissue.
• HPA039799 (zinc finger protein 385A) has been omitted due to lack of appropriate tissue.
• CAB040294 (cell division cycle associated 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA042028 (IQ motif containing B1) has been omitted due to lack of appropriate tissue.
• HPA042369 (melanoma inhibitory activity) has been omitted due to lack of appropriate tissue.
• HPA043698 (calcium binding protein 5) has been omitted due to lack of appropriate tissue.
• HPA044114 (RIMS binding protein 2) has been omitted due to lack of appropriate tissue.
• HPA044639 (paired-like homeodomain 3) has been omitted due to lack of appropriate tissue.
• CAB045968 (deoxynucleotidyltransferase, terminal, interacting protein 1) has been omitted due to inconsistency with other antibody targeting the same gene and inconsistency with RNA-seq data.
• CAB045996 (NME/NM23 nucleoside diphosphate kinase 4) has been omitted due to inconsistency with gene/protein characterization data.
• CAB046474 (homeobox C10) has been omitted due to inconsistency with RNA-seq data.
• HPA046937 (death associated protein-like 1) has been omitted due to lack of appropriate tissue.
• HPA048450 (fibronectin type III and SPRY domain containing 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA049124 (solute carrier family 1 (glutamate transporter), member 7) has been omitted due to lack of appropriate tissue.
• HPA049791 (regulator of G protein signaling 9 binding protein) has been omitted due to lack of appropriate tissue.
• HPA053869 (clavesin 1) has been omitted due to lack of appropriate tissue.
• HPA056970 (proteasome (prosome, macropain) subunit, beta type, 11) has been omitted due to lack of appropriate tissue.
• HPA059051 (HERV-H LTR-associating 1) has been omitted due to lack of appropriate tissue.
• HPA060697 (family with sequence similarity 9, member C) has been omitted due to inconsistency with gene/protein characterization data.
• CAB069411 (SMAD family member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB000073 & HPA015768 (S100 calcium binding protein B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB000114 (cyclin A2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB032191 & HPA000505 (transketolase-like 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA000556 (cysteine rich transmembrane BMP regulator 1 (chordin-like)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA001079 (neuronal pentraxin receptor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA001323 (epididymal protein 3B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004307, HPA001399 & HPA023884 (adenosine deaminase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA001403 (SIX homeobox 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA001625 (purine nucleoside phosphorylase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA001864 (vav 1 guanine nucleotide exchange factor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB001948 & HPA044496 (protein kinase C, epsilon) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA003298 (RNA binding motif protein 44) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA003314 (Rhox homeobox family, member 2B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB020794 & HPA003314 (Rhox homeobox family, member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004608 (tubulin, gamma 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB015452 & HPA004622 (melanoma antigen family C1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA005788 (GRB2-related adaptor protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA005792 (Purkinje cell protein 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA007133 (adhesion G protein-coupled receptor G5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA008315 (actinin, alpha 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA008411 (ELL associated factor 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB009564 (brain-derived neurotrophic factor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA010575 (chitinase 1 (chitotriosidase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA015313 (NDRG family member 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB017029, HPA043412 & HPA051005 (phenylethanolamine N-methyltransferase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB017042 & HPA047752 (ELOVL fatty acid elongase 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB017615 (interferon induced transmembrane protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA017742 (dopa decarboxylase (aromatic L-amino acid decarboxylase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA020137 (DEAD (Asp-Glu-Ala-Asp) box helicase 25) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA021509 (ectonucleoside triphosphate diphosphohydrolase 8) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA022243 (chromosome 9 open reading frame 9) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB022626 (remodeling and spacing factor 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA023257 (MYCBP associated protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA023307 (family with sequence similarity 166, member A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA023899 (stabilizer of axonemal microtubules 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA024629 (Kruppel-like factor 17) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB025635 (tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB025749, HPA043355 & HPA048460 (calreticulin 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB027391 & HPA026425 (aldo-keto reductase family 1, member B1 (aldose reductase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA028597 & HPA028666 (sperm associated antigen 17) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA028894 (tripartite motif containing 69) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA029458 (peripherin 2 (retinal degeneration, slow)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA030900 (neural cell adhesion molecule 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA032001 (neurotrophin 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB032495 (BMX non-receptor tyrosine kinase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA035582 (immunoglobulin superfamily, member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036338 (tetratricopeptide repeat domain 26) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036762 & HPA036763 (cone-rod homeobox) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036807 (mediator complex subunit 12-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036819 (cadherin-related family member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA038464 (beaded filament structural protein 2, phakinin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA038526 (WD repeat domain 63) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039795 & HPA039866 (GLI pathogenesis-related 1 like 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039805 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA040025 (hyaluronan-mediated motility receptor (RHAMM)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB040310 (laminin, alpha 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA040421 (NUT midline carcinoma, family member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA040671 & HPA056228 (cAMP responsive element binding protein 3-like 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041025 (G protein-coupled receptor 174) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041646 (POU class 1 homeobox 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041733 (neuropeptide VF precursor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA042767 (semenogelin II) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 10) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 12J) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 13) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 2E) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 12C) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 12D) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 12E) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 12F) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 12G) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 12H) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043232 (G antigen 2A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044016 & HPA055352 (calcium-binding protein, spermatid-specific 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044741 (junctional sarcoplasmic reticulum protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046068 & HPA055623 (solute carrier family 28 (concentrative nucleoside transporter), member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA051384 (BTB and CNC homology 1, basic leucine zipper transcription factor 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA054010 (gamma-aminobutyric acid (GABA) A receptor, gamma 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA054126 (solute carrier organic anion transporter family, member 6A1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA054508 (glutathione synthetase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA054694 (gametocyte specific factor 1-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA055177 (VGF nerve growth factor inducible) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA055194 (keratin 33A, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA055194 (keratin 33B, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA055194 (keratin 34, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA055194 (keratin 31, type I) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA060789 (YjeF N-terminal domain containing 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA062468 (chromosome 3 open reading frame 30) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA062866 (cadherin, EGF LAG seven-pass G-type receptor 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA019750 has been omitted due to target gene not found in Ensembl.
• HPA021577 has been omitted due to target gene not found in Ensembl.
• HPA021912 has been omitted due to target gene not found in Ensembl.
• HPA023045 has been omitted due to target gene not found in Ensembl.
• HPA030080 has been omitted due to target gene not found in Ensembl.
• HPA034756 has been omitted due to target gene not found in Ensembl.
• HPA037369 has been omitted due to target gene not found in Ensembl.
• HPA038302 has been omitted due to target gene not found in Ensembl.
• HPA040195 has been omitted due to target gene not found in Ensembl.
• HPA041883 has been omitted due to target gene not found in Ensembl.
• HPA041898 has been omitted due to target gene not found in Ensembl.
• HPA042431 has been omitted due to target gene not found in Ensembl.
• HPA043259 has been omitted due to target gene not found in Ensembl.
• HPA043680 has been omitted due to target gene not found in Ensembl.
• HPA044422 has been omitted due to target gene not found in Ensembl.
• HPA044640 has been omitted due to target gene not found in Ensembl.
• HPA044800 has been omitted due to target gene not found in Ensembl.
• HPA044806 has been omitted due to target gene not found in Ensembl.
• HPA044834 has been omitted due to target gene not found in Ensembl.
• HPA044995 has been omitted due to target gene not found in Ensembl.
• HPA045553 has been omitted due to target gene not found in Ensembl.
• HPA045811 has been omitted due to target gene not found in Ensembl.
• HPA046799 has been omitted due to target gene not found in Ensembl.
• HPA046873 has been omitted due to target gene not found in Ensembl.
• HPA047196 has been omitted due to target gene not found in Ensembl.
• HPA049545 has been omitted due to target gene not found in Ensembl.
• HPA050106 has been omitted due to target gene not found in Ensembl.
• HPA050870 has been omitted due to target gene not found in Ensembl.
• HPA051619 has been omitted due to target gene not found in Ensembl.
• HPA051774 has been omitted due to target gene not found in Ensembl.
• HPA052542 has been omitted due to target gene not found in Ensembl.
• HPA052795 has been omitted due to target gene not found in Ensembl.
• HPA053911 has been omitted due to target gene not found in Ensembl.
• HPA053930 has been omitted due to target gene not found in Ensembl.
• HPA054377 has been omitted due to target gene not found in Ensembl.
• HPA055347 has been omitted due to target gene not found in Ensembl.
• HPA055395 has been omitted due to target gene not found in Ensembl.
• HPA060293 has been omitted due to target gene not found in Ensembl.
• HPA061034 has been omitted due to target gene not found in Ensembl.
• HPA061221 has been omitted due to target gene not found in Ensembl.
• HPA062694 has been omitted due to target gene not found in Ensembl.
• HPA062836 has been omitted due to target gene not found in Ensembl.
• HPA065431 has been omitted due to target gene not found in Ensembl.
• HPA067901 has been omitted due to target gene not found in Ensembl.
• HPA068791 has been omitted due to target gene not found in Ensembl.
• HPA069084 has been omitted due to target gene not found in Ensembl.

• CAB000024 has been omitted due to qualitative reasons. An alternative antibody HPA027802 has been added.
• CAB000032 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA024684 has been added.
• CAB000096 has been omitted due to qualitative reasons.
• CAB000130 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA045697 has been added.
• CAB000132 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB000143 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA000166 has been omitted due to qualitative reasons.
• HPA000262 has been omitted due to qualitative reasons. An alternative antibody HPA006503 has been added.
• HPA000298 has been omitted due to qualitative reasons. An alternative antibody HPA001374 has been added.
• CAB000349 has been omitted due to lack of RNA expression in cell line panel.
• CAB000376 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA000397 has been omitted due to qualitative reasons.
• HPA000428 has been omitted due to qualitative reasons.
• CAB000458 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB000460 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA000522 has been omitted due to qualitative reasons.
• HPA000527 has been omitted due to antibody staining not supported by experimental data.
• HPA000554 has been omitted due to antibody staining not supported by experimental data.
• HPA000817 has been omitted due to antibody staining not supported by experimental data.
• HPA001042 has been omitted due to qualitative reasons.
• HPA001115 has been omitted due to qualitative reasons.
• HPA001136 has been omitted due to qualitative reasons.
• HPA001206 has been omitted due to lack of RNA expression in cell line panel.
• HPA001232 has been omitted due to qualitative reasons. An alternative antibody CAB015397 has been added.
• HPA001383 has been omitted due to qualitative reasons. An alternative antibody HPA001060 has been added.
• HPA001396 has been omitted due to antibody staining not supported by experimental data.
• HPA001399 has been omitted due to qualitative reasons.
• HPA001432 has been omitted due to antibody staining not supported by experimental data.
• HPA001436 has been omitted due to lack of RNA expression in cell line panel.
• CAB001447 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA001472 has been omitted due to lack of RNA expression in cell line panel.
• HPA001499 has been omitted due to qualitative reasons.
• HPA001508 has been omitted due to lack of RNA expression in cell line panel.
• HPA001536 has been omitted due to qualitative reasons.
• HPA001689 has been omitted due to qualitative reasons.
• HPA001756 has been omitted due to qualitative reasons.
• HPA001768 has been omitted due to qualitative reasons. An alternative antibody HPA005924 has been added.
• HPA001804 has been omitted due to qualitative reasons.
• CAB001809 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA001817 has been omitted due to qualitative reasons. An alternative antibody HPA000951 has been added.
• HPA001830 has been omitted due to qualitative reasons.
• HPA001844 has been omitted due to qualitative reasons.
• HPA001847 has been omitted due to qualitative reasons. An alternative antibody HPA065797 has been added.
• HPA001852 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA001860 has been omitted due to lack of RNA expression in cell line panel.
• HPA001908 has been omitted due to qualitative reasons. An alternative antibody HPA001909 has been added.
• HPA001914 has been omitted due to qualitative reasons.
• HPA001942 has been omitted due to qualitative reasons.
• CAB002011 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA002022 has been omitted due to qualitative reasons.
• HPA002038 has been omitted due to qualitative reasons. An alternative antibody HPA002698 has been added.
• HPA002111 has been omitted due to qualitative reasons. An alternative antibody HPA000568 has been added.
• CAB002145 has been omitted due to lack of RNA expression in cell line panel.
• CAB002148 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002151 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002158 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA002188 has been omitted due to qualitative reasons.
• HPA002198 has been omitted due to antibody staining not supported by experimental data.
• CAB002222 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002223 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002226 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA002270 has been omitted due to lack of RNA expression in cell line panel.
• CAB002301 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002302 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA002314 has been omitted due to qualitative reasons.
• HPA002315 has been omitted due to qualitative reasons.
• HPA002327 has been omitted due to qualitative reasons.
• HPA002356 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA002385 has been omitted due to qualitative reasons.
• CAB002418 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002424 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002430 has been omitted due to lack of RNA expression in cell line panel.
• CAB002489 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002491 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002494 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002496 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002499 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002501 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA002549 has been omitted due to qualitative reasons.
• CAB002601 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002624 has been omitted due to lack of RNA expression in cell line panel.
• HPA002642 has been omitted due to qualitative reasons.
• HPA002655 has been omitted due to lack of RNA expression in cell line panel.
• CAB002658 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002661 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002679 has been omitted due to qualitative reasons.
• CAB002681 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB002720 has been omitted due to qualitative reasons.
• HPA002735 has been omitted due to qualitative reasons.
• CAB002781 has been omitted due to qualitative reasons.
• HPA002857 has been omitted due to antibody staining not supported by experimental data.
• HPA002881 has been omitted due to lack of RNA expression in cell line panel.
• HPA002907 has been omitted due to qualitative reasons. An alternative antibody HPA005835 has been added.
• HPA002969 has been omitted due to qualitative reasons.
• HPA002981 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA003010 has been omitted due to antibody staining not supported by experimental data.
• HPA003020 has been omitted due to qualitative reasons.
• HPA003056 has been omitted due to antibody staining not supported by experimental data.
• HPA003184 has been omitted due to qualitative reasons.
• HPA003214 has been omitted due to qualitative reasons.
• HPA003228 has been omitted due to qualitative reasons. An alternative antibody HPA070799 has been added.
• HPA003240 has been omitted due to qualitative reasons. An alternative antibody HPA061783 has been added.
• HPA003335 has been omitted due to qualitative reasons.
• HPA003381 has been omitted due to qualitative reasons. An alternative antibody HPA056308 has been added.
• HPA003413 has been omitted due to qualitative reasons.
• HPA003418 has been omitted due to lack of RNA expression in cell line panel.
• HPA003474 has been omitted due to qualitative reasons.
• HPA003501 has been omitted due to antibody staining not supported by experimental data.
• HPA003525 has been omitted due to qualitative reasons.
• HPA003572 has been omitted due to qualitative reasons.
• HPA003584 has been omitted due to qualitative reasons. An alternative antibody HPA063872 has been added.
• HPA003595 has been omitted due to lack of RNA expression in cell line panel.
• HPA003617 has been omitted due to qualitative reasons.
• HPA003642 has been omitted due to qualitative reasons.
• HPA003656 has been omitted due to qualitative reasons.
• CAB003674 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB003690 has been omitted due to qualitative reasons.
• CAB003695 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB003789 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB003799 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB003809 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA067463 has been added.
• CAB003844 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB003852 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA003883 has been omitted due to lack of RNA expression in cell line panel.
• HPA003995 has been omitted due to antibody staining not supported by experimental data.
• CAB004005 has been omitted due to lack of RNA expression in cell line panel.
• HPA004011 has been omitted due to lack of RNA expression in cell line panel.
• CAB004022 has been omitted due to qualitative reasons.
• CAB004025 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA049174 has been added.
• CAB004031 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA004056 has been omitted due to antibody staining not supported by experimental data.
• HPA004063 has been omitted due to qualitative reasons.
• CAB004080 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA004102 has been omitted due to qualitative reasons.
• HPA004184 has been omitted due to qualitative reasons. An alternative antibody HPA063840 has been added.
• CAB004214 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004216 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004229 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004239 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004283 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004288 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004290 has been omitted due to lack of RNA expression in cell line panel.
• CAB004307 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004318 has been omitted due to qualitative reasons.
• CAB004364 has been omitted due to qualitative reasons.
• CAB004370 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004372 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004395 has been omitted due to antibody staining not supported by experimental data.
• CAB004458 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004464 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004511 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004580 has been omitted due to antibody staining not supported by experimental data.
• CAB004581 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004643 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004645 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004646 has been omitted due to qualitative reasons. An alternative antibody HPA041790 has been added.
• HPA004714 has been omitted due to qualitative reasons.
• HPA004716 has been omitted due to qualitative reasons.
• HPA004723 has been omitted due to qualitative reasons.
• HPA004739 has been omitted due to lack of RNA expression in cell line panel.
• HPA004789 has been omitted due to qualitative reasons.
• HPA004812 has been omitted due to qualitative reasons.
• HPA004820 has been omitted due to qualitative reasons.
• HPA004842 has been omitted due to qualitative reasons.
• HPA004896 has been omitted due to qualitative reasons.
• HPA004917 has been omitted due to qualitative reasons.
• HPA004940 has been omitted due to qualitative reasons.
• CAB004998 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB005123 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB005196 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB005227 has been omitted due to qualitative reasons.
• CAB005268 has been omitted due to qualitative reasons.
• CAB005272 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB005399 has been omitted due to qualitative reasons.
• CAB005429 has been omitted due to qualitative reasons.
• HPA005465 has been omitted due to qualitative reasons. An alternative antibody HPA046786 has been added.
• HPA005534 has been omitted due to antibody staining not supported by experimental data.
• CAB005597 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB005605 has been omitted due to qualitative reasons.
• HPA005625 has been omitted due to qualitative reasons.
• HPA005680 has been omitted due to qualitative reasons.
• HPA005688 has been omitted due to qualitative reasons.
• HPA005696 has been omitted due to qualitative reasons.
• HPA005751 has been omitted due to qualitative reasons. An alternative antibody HPA071988 has been added.
• HPA005788 has been omitted due to lack of RNA expression in cell line panel.
• HPA005841 has been omitted due to qualitative reasons.
• CAB005872 has been omitted due to qualitative reasons. An alternative antibody HPA062262 has been added.
• CAB005875 has been omitted due to qualitative reasons.
• HPA005949 has been omitted due to lack of RNA expression in cell line panel.
• HPA005953 has been omitted due to qualitative reasons.
• HPA005987 has been omitted due to qualitative reasons.
• HPA005990 has been omitted due to lack of RNA expression in cell line panel.
• HPA006092 has been omitted due to qualitative reasons.
• HPA006159 has been omitted due to lack of RNA expression in cell line panel.
• HPA006195 has been omitted due to qualitative reasons.
• CAB006246 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB006252 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA006280 has been omitted due to qualitative reasons.
• HPA006281 has been omitted due to qualitative reasons.
• HPA006293 has been omitted due to qualitative reasons.
• HPA006298 has been omitted due to qualitative reasons.
• HPA006302 has been omitted due to qualitative reasons.
• HPA006353 has been omitted due to qualitative reasons.
• HPA006367 has been omitted due to qualitative reasons.
• HPA006401 has been omitted due to qualitative reasons.
• HPA006426 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA075984 has been added.
• HPA006432 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA006219 has been added.
• HPA006632 has been omitted due to qualitative reasons.
• HPA006641 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA006657 has been omitted due to antibody staining not supported by experimental data.
• HPA006660 has been omitted due to qualitative reasons.
• HPA006669 has been omitted due to qualitative reasons. An alternative antibody HPA006484 has been added.
• HPA006769 has been omitted due to qualitative reasons.
• HPA006779 has been omitted due to qualitative reasons.
• HPA006874 has been omitted due to qualitative reasons.
• HPA006885 has been omitted due to qualitative reasons.
• HPA006996 has been omitted due to qualitative reasons.
• HPA007005 has been omitted due to antibody staining not supported by experimental data.
• CAB007057 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA052386 has been added.
• HPA007072 has been omitted due to qualitative reasons.
• HPA007105 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA007272 has been omitted due to qualitative reasons.
• HPA007318 has been omitted due to lack of RNA expression in cell line panel.
• HPA007319 has been omitted due to lack of RNA expression in cell line panel.
• HPA007326 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA007329 has been omitted due to antibody staining not supported by experimental data.
• HPA007401 has been omitted due to qualitative reasons. An alternative antibody HPA067453 has been added.
• HPA007446 has been omitted due to lack of RNA expression in cell line panel.
• HPA007455 has been omitted due to qualitative reasons.
• HPA007459 has been omitted due to qualitative reasons.
• HPA007570 has been omitted due to antibody staining not supported by experimental data.
• HPA007669 has been omitted due to qualitative reasons.
• CAB007744 has been omitted due to qualitative reasons. An alternative antibody HPA031134 has been added.
• CAB007751 has been omitted due to qualitative reasons. An alternative antibody HPA060074 has been added.
• CAB007766 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB007783 has been omitted due to qualitative reasons.
• CAB007793 has been omitted due to qualitative reasons.
• HPA007847 has been omitted due to qualitative reasons.
• HPA007865 has been omitted due to antibody staining not supported by experimental data.
• HPA007904 has been omitted due to qualitative reasons.
• HPA007932 has been omitted due to qualitative reasons.
• HPA007982 has been omitted due to lack of RNA expression in cell line panel.
• HPA007987 has been omitted due to lack of RNA expression in cell line panel.
• HPA008065 has been omitted due to qualitative reasons.
• HPA008119 has been omitted due to qualitative reasons.
• HPA008206 has been omitted due to lack of RNA expression in cell line panel.
• HPA008241 has been omitted due to qualitative reasons.
• HPA008252 has been omitted due to qualitative reasons.
• HPA008304 has been omitted due to antibody staining not supported by experimental data.
• HPA008320 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA008335 has been omitted due to qualitative reasons. An alternative antibody HPA070756 has been added.
• HPA008405 has been omitted due to qualitative reasons.
• HPA008411 has been omitted due to qualitative reasons.
• HPA008587 has been omitted due to qualitative reasons.
• CAB008594 antibody has been omitted due to target gene not found in Ensembl.
• HPA008622 has been omitted due to qualitative reasons.
• CAB008625 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB008640 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
• HPA008703 has been omitted due to qualitative reasons.
• HPA008718 has been omitted due to qualitative reasons.
• HPA008736 has been omitted due to qualitative reasons. An alternative antibody HPA008797 has been added.
• HPA008877 has been omitted due to qualitative reasons. An alternative antibody HPA016894 has been added.
• HPA008928 has been omitted due to lack of RNA expression in cell line panel.
• CAB008980 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA064763 has been added.
• HPA008994 has been omitted due to qualitative reasons.
• CAB009008 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA009079 has been omitted due to lack of RNA expression in cell line panel.
• HPA009132 has been omitted due to antibody staining not supported by experimental data.
• HPA009177 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA009269 has been omitted due to qualitative reasons.
• HPA009285 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB009344 has been omitted due to antibody staining not supported by experimental data.
• CAB009372 has been omitted due to qualitative reasons.
• HPA009420 has been omitted due to lack of RNA expression in cell line panel.
• CAB009469 has been omitted due to qualitative reasons.
• CAB009587 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA009647 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA009705 has been omitted due to qualitative reasons.
• CAB009751 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB009803 has been omitted due to qualitative reasons. An alternative antibody CAB005044 has been added.
• CAB009805 has been omitted due to qualitative reasons.
• CAB009845 has been omitted due to qualitative reasons.
• CAB009893 has been omitted due to qualitative reasons.
• CAB009936 has been omitted due to qualitative reasons. An alternative antibody HPA059131 has been added.
• CAB009960 has been omitted due to antibody staining not supported by experimental data.
• HPA010132 has been omitted due to qualitative reasons. An alternative antibody HPA051594 has been added.
• CAB010142 has been omitted due to qualitative reasons.
• CAB010207 has been omitted due to qualitative reasons. An alternative antibody HPA069684 has been added.
• CAB010224 has been omitted due to qualitative reasons. An alternative antibody HPA068337 has been added.
• CAB010309 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB010494 has been omitted due to antibody staining not supported by experimental data.
• HPA010533 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA010551 has been omitted due to qualitative reasons.
• HPA010568 has been omitted due to qualitative reasons. An alternative antibody HPA010093 has been added.
• HPA010592 has been omitted due to antibody staining not supported by experimental data.
• HPA010630 has been omitted due to qualitative reasons.
• HPA010644 has been omitted due to qualitative reasons.
• HPA010691 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA010785 has been omitted due to qualitative reasons.
• HPA010800 has been omitted due to qualitative reasons.
• HPA010871 has been omitted due to antibody staining not supported by experimental data.
• HPA010921 has been omitted due to qualitative reasons.
• HPA010926 has been omitted due to qualitative reasons.
• HPA010950 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA010973 has been omitted due to qualitative reasons.
• HPA011026 has been omitted due to qualitative reasons.
• HPA011115 has been omitted due to lack of RNA expression in cell line panel.
• HPA011157 has been omitted due to antibody staining not supported by experimental data.
• HPA011284 has been omitted due to qualitative reasons.
• CAB011458 has been omitted due to qualitative reasons.
• CAB011482 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA071396 has been added.
• CAB011487 has been omitted due to qualitative reasons.
• CAB011532 has been omitted due to qualitative reasons.
• CAB011576 has been omitted due to qualitative reasons.
• CAB011626 has been omitted due to qualitative reasons.
• CAB011690 has been omitted due to qualitative reasons. An alternative antibody HPA068286 has been added.
• HPA011862 has been omitted due to antibody staining not supported by experimental data.
• HPA011933 has been omitted due to lack of RNA expression in cell line panel.
• HPA011977 has been omitted due to antibody staining not supported by experimental data.
• HPA012014 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA012069 has been omitted due to lack of RNA expression in cell line panel.
• HPA012078 has been omitted due to qualitative reasons.
• HPA012086 has been omitted due to qualitative reasons.
• HPA012099 has been omitted due to antibody staining not supported by experimental data.
• HPA012132 has been omitted due to qualitative reasons.
• CAB012237 has been omitted due to lack of RNA expression in cell line panel.
• CAB012249 has been omitted due to antibody staining not supported by experimental data.
• CAB012272 has been omitted due to qualitative reasons.
• CAB012275 has been omitted due to qualitative reasons.
• HPA012383 has been omitted due to qualitative reasons.
• HPA012384 has been omitted due to antibody staining not supported by experimental data.
• HPA012385 has been omitted due to qualitative reasons.
• CAB012459 has been omitted due to qualitative reasons.
• HPA012500 has been omitted due to qualitative reasons.
• HPA012501 has been omitted due to qualitative reasons.
• HPA012601 has been omitted due to qualitative reasons.
• HPA012692 has been omitted due to lack of RNA expression in cell line panel.
• HPA012693 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA012769 has been omitted due to lack of RNA expression in cell line panel.
• HPA012800 has been omitted due to qualitative reasons.
• HPA012863 has been omitted due to qualitative reasons. An alternative antibody HPA064700 has been added.
• HPA012892 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA012893 has been omitted due to antibody staining not supported by experimental data.
• CAB012978 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB013075 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB013087 has been omitted due to antibody staining not supported by experimental data.
• CAB013108 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA013159 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA013191 has been omitted due to qualitative reasons.
• CAB013260 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB013305 has been omitted due to lack of RNA expression in cell line panel.
• HPA013316 has been omitted due to qualitative reasons.
• HPA013397 has been omitted due to qualitative reasons.
• CAB013511 has been omitted due to qualitative reasons.
• CAB013535 has been omitted due to antibody staining not supported by experimental data.
• HPA013659 has been omitted due to lack of RNA expression in cell line panel.
• HPA013750 has been omitted due to qualitative reasons.
• HPA013774 has been omitted due to antibody staining not supported by experimental data.
• HPA013967 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA013995 has been omitted due to qualitative reasons.
• HPA014044 has been omitted due to lack of RNA expression in cell line panel.
• HPA014087 has been omitted due to antibody staining not supported by experimental data.
• HPA014388 has been omitted due to qualitative reasons.
• HPA014405 has been omitted due to qualitative reasons. An alternative antibody HPA065785 has been added.
• HPA014474 has been omitted due to qualitative reasons.
• HPA014499 has been omitted due to qualitative reasons.
• HPA014520 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA014562 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA038631 has been added.
• HPA014563 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA014569 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA014719 has been omitted due to qualitative reasons.
• HPA014741 has been omitted due to qualitative reasons.
• HPA014811 has been omitted due to lack of RNA expression in cell line panel.
• CAB014880 has been omitted due to lack of RNA expression in cell line panel.
• HPA014967 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA015083 has been omitted due to qualitative reasons.
• HPA015085 has been omitted due to antibody staining not supported by experimental data.
• CAB015220 has been omitted due to qualitative reasons. An alternative antibody HPA005436 has been added.
• HPA015243 has been omitted due to qualitative reasons.
• HPA015272 has been omitted due to qualitative reasons.
• HPA015283 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB015386 has been omitted due to qualitative reasons.
• CAB015392 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB015444 has been omitted due to qualitative reasons. An alternative antibody HPA058182 has been added.
• CAB015449 has been omitted due to antibody staining not supported by experimental data.
• CAB015454 has been omitted due to qualitative reasons.
• HPA015497 has been omitted due to qualitative reasons.
• HPA015525 has been omitted due to lack of RNA expression in cell line panel.
• HPA015590 has been omitted due to antibody staining not supported by experimental data.
• HPA015603 has been omitted due to antibody staining not supported by experimental data.
• HPA015636 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA015637 has been omitted due to lack of RNA expression in cell line panel.
• HPA015639 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA015716 has been omitted due to qualitative reasons.
• HPA015819 has been omitted due to qualitative reasons. An alternative antibody HPA015329 has been added.
• HPA015830 has been omitted due to qualitative reasons.
• HPA015858 has been omitted due to qualitative reasons. An alternative antibody HPA029579 has been added.
• CAB015941 has been omitted due to antibody staining not supported by experimental data.
• CAB016132 has been omitted due to qualitative reasons.
• CAB016135 has been omitted due to antibody staining not supported by experimental data.
• CAB016169 has been omitted due to qualitative reasons.
• CAB016231 has been omitted due to qualitative reasons. An alternative antibody HPA067481 has been added.
• CAB016252 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB016253 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB016271 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB016290 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB016348 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB016416 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA016419 has been omitted due to qualitative reasons.
• HPA016424 has been omitted due to qualitative reasons. An alternative antibody HPA058562 has been added.
• HPA016431 has been omitted due to qualitative reasons.
• HPA016450 has been omitted due to qualitative reasons.
• HPA016484 has been omitted due to qualitative reasons.
• HPA016493 has been omitted due to qualitative reasons.
• HPA016560 has been omitted due to qualitative reasons.
• HPA016599 has been omitted due to qualitative reasons.
• HPA016633 has been omitted due to lack of RNA expression in cell line panel.
• CAB016729 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB016734 has been omitted due to qualitative reasons.
• HPA016744 has been omitted due to qualitative reasons.
• HPA016811 has been omitted due to antibody staining not supported by experimental data.
• HPA016960 has been omitted due to qualitative reasons.
• HPA017019 has been omitted due to qualitative reasons.
• CAB017040 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA017046 has been omitted due to antibody staining not supported by experimental data.
• HPA017061 has been omitted due to qualitative reasons.
• HPA017074 has been omitted due to antibody staining not supported by experimental data.
• CAB017133 has been omitted due to qualitative reasons.
• CAB017193 has been omitted due to qualitative reasons.
• HPA017210 has been omitted due to qualitative reasons.
• HPA017291 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA017313 has been omitted due to qualitative reasons.
• CAB017441 has been omitted due to qualitative reasons.
• CAB017452 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
• CAB017486 has been omitted due to qualitative reasons.
• CAB017490 has been omitted due to qualitative reasons.
• CAB017562 has been omitted due to qualitative reasons.
• HPA017572 has been omitted due to antibody staining not supported by experimental data.
• HPA017600 has been omitted due to qualitative reasons.
• HPA017602 has been omitted due to antibody staining not supported by experimental data.
• CAB017617 has been omitted due to qualitative reasons. An alternative antibody HPA010093 has been added.
• CAB017634 has been omitted due to antibody staining not supported by experimental data.
• HPA017646 has been omitted due to antibody staining not supported by experimental data.
• HPA017653 has been omitted due to qualitative reasons.
• HPA017681 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB017712 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA017722 has been omitted due to qualitative reasons.
• HPA017737 has been omitted due to qualitative reasons. An alternative antibody CAB009449 has been added.
• HPA017749 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA017765 has been omitted due to qualitative reasons.
• CAB017779 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB017804 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB017826 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA017851 has been omitted due to qualitative reasons.
• HPA017891 has been omitted due to qualitative reasons. An alternative antibody HPA062067 has been added.
• HPA017903 has been omitted due to qualitative reasons. An alternative antibody HPA069479 has been added.
• HPA017948 has been omitted due to antibody staining not supported by experimental data.
• HPA018003 has been omitted due to lack of RNA expression in cell line panel.
• HPA018107 has been omitted due to qualitative reasons.
• HPA018148 has been omitted due to qualitative reasons.
• HPA018207 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA018216 has been omitted due to qualitative reasons. An alternative antibody HPA019173 has been added.
• HPA018303 has been omitted due to lack of RNA expression in cell line panel.
• HPA018325 has been omitted due to antibody staining not supported by experimental data.
• CAB018389 has been omitted due to qualitative reasons.
• HPA018410 has been omitted due to qualitative reasons.
• HPA018459 has been omitted due to antibody staining not supported by experimental data.
• HPA018517 has been omitted due to qualitative reasons.
• CAB018611 has been omitted due to qualitative reasons.
• CAB018641 has been omitted due to qualitative reasons.
• HPA018673 has been omitted due to qualitative reasons.
• HPA018674 has been omitted due to antibody staining not supported by experimental data.
• CAB018719 has been omitted due to qualitative reasons.
• CAB018737 has been omitted due to qualitative reasons. An alternative antibody CAB018383 has been added.
• HPA018859 has been omitted due to qualitative reasons.
• HPA018885 has been omitted due to qualitative reasons.
• HPA018951 has been omitted due to qualitative reasons.
• CAB018957 has been omitted due to qualitative reasons.
• HPA018995 has been omitted due to qualitative reasons.
• HPA019055 has been omitted due to qualitative reasons. An alternative antibody CAB034170 has been added.
• HPA019097 has been omitted due to antibody staining not supported by experimental data.
• HPA019125 has been omitted due to qualitative reasons.
• HPA019127 has been omitted due to qualitative reasons.
• HPA019155 has been omitted due to qualitative reasons.
• HPA019184 has been omitted due to qualitative reasons.
• HPA019194 has been omitted due to qualitative reasons.
• HPA019215 has been omitted due to qualitative reasons.
• HPA019231 has been omitted due to lack of RNA expression in cell line panel.
• HPA019254 has been omitted due to qualitative reasons.
• HPA019259 has been omitted due to lack of RNA expression in cell line panel.
• CAB019284 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA004799 has been added.
• CAB019296 has been omitted due to qualitative reasons.
• CAB019321 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA019340 has been omitted due to qualitative reasons.
• CAB019381 has been omitted due to qualitative reasons.
• CAB019394 has been omitted due to qualitative reasons.
• CAB019400 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA019487 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA019497 has been omitted due to antibody staining not supported by experimental data.
• HPA019511 has been omitted due to qualitative reasons.
• HPA019527 has been omitted due to qualitative reasons.
• HPA019593 has been omitted due to lack of RNA expression in cell line panel.
• HPA019627 has been omitted due to antibody staining not supported by experimental data.
• HPA019639 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA019652 has been omitted due to lack of RNA expression in cell line panel.
• HPA019675 has been omitted due to qualitative reasons.
• HPA019702 has been omitted due to qualitative reasons. An alternative antibody HPA068560 has been added.
• HPA019767 has been omitted due to qualitative reasons.
• HPA019772 has been omitted due to qualitative reasons.
• HPA019777 has been omitted due to lack of RNA expression in cell line panel.
• HPA019848 has been omitted due to qualitative reasons.
• HPA019862 has been omitted due to qualitative reasons. An alternative antibody HPA047843 has been added.
• HPA019878 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA019946 has been omitted due to qualitative reasons.
• HPA019948 has been omitted due to qualitative reasons.
• HPA019957 has been omitted due to qualitative reasons.
• HPA019965 has been omitted due to antibody staining not supported by experimental data.
• HPA020046 has been omitted due to lack of RNA expression in cell line panel.
• HPA020080 has been omitted due to qualitative reasons.
• HPA020124 has been omitted due to qualitative reasons.
• CAB020308 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA020339 has been omitted due to qualitative reasons.
• HPA020342 has been omitted due to qualitative reasons.
• HPA020457 has been omitted due to qualitative reasons. An alternative antibody HPA000887 has been added.
• HPA020615 has been omitted due to qualitative reasons.
• HPA020735 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB020827 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA020870 has been omitted due to qualitative reasons. An alternative antibody CAB010890 has been added.
• HPA020896 has been omitted due to qualitative reasons.
• HPA021004 has been omitted due to lack of RNA expression in cell line panel.
• HPA021011 has been omitted due to qualitative reasons.
• HPA021019 has been omitted due to qualitative reasons.
• HPA021121 has been omitted due to antibody staining not supported by experimental data.
• HPA021136 has been omitted due to qualitative reasons.
• HPA021146 has been omitted due to qualitative reasons.
• HPA021194 has been omitted due to qualitative reasons.
• HPA021261 has been omitted due to lack of RNA expression in cell line panel.
• HPA021275 has been omitted due to lack of RNA expression in cell line panel.
• HPA021305 has been omitted due to qualitative reasons.
• HPA021317 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA021325 has been omitted due to lack of RNA expression in cell line panel.
• HPA021466 has been omitted due to antibody staining not supported by experimental data.
• HPA021564 has been omitted due to antibody staining not supported by experimental data.
• HPA021565 has been omitted due to antibody staining not supported by experimental data.
• HPA021566 has been omitted due to qualitative reasons.
• HPA021579 has been omitted due to antibody staining not supported by experimental data.
• HPA021586 has been omitted due to lack of RNA expression in cell line panel.
• HPA021612 has been omitted due to qualitative reasons.
• HPA021624 has been omitted due to lack of RNA expression in cell line panel.
• HPA021633 has been omitted due to qualitative reasons.
• HPA021649 has been omitted due to lack of RNA expression in cell line panel.
• HPA021652 has been omitted due to antibody staining not supported by experimental data.
• HPA021662 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA021773 has been omitted due to qualitative reasons.
• HPA021815 has been omitted due to qualitative reasons.
• HPA021831 has been omitted due to qualitative reasons.
• HPA021843 has been omitted due to lack of RNA expression in cell line panel.
• HPA021854 has been omitted due to qualitative reasons.
• HPA021875 has been omitted due to qualitative reasons.
• CAB021888 has been omitted due to qualitative reasons.
• CAB021929 has been omitted due to lack of RNA expression in cell line panel.
• HPA022008 has been omitted due to antibody staining not supported by experimental data.
• CAB022069 has been omitted due to qualitative reasons.
• CAB022073 has been omitted due to lack of RNA expression in cell line panel.
• HPA022138 has been omitted due to qualitative reasons. An alternative antibody CAB007760 has been added.
• CAB022161 has been omitted due to antibody staining not supported by experimental data.
• CAB022187 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB022226 has been omitted due to qualitative reasons.
• HPA022271 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA004799 has been added.
• CAB022343 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB022390 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA022479 has been omitted due to antibody staining not supported by experimental data.
• HPA022538 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA022817 has been omitted due to qualitative reasons. An alternative antibody HPA041810 has been added.
• HPA022818 has been omitted due to antibody staining not supported by experimental data.
• HPA022842 has been omitted due to qualitative reasons.
• HPA022882 has been omitted due to qualitative reasons.
• HPA022924 has been omitted due to antibody staining not supported by experimental data.
• HPA022957 has been omitted due to qualitative reasons.
• HPA022959 has been omitted due to qualitative reasons.
• HPA022963 has been omitted due to qualitative reasons.
• HPA022988 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023031 has been omitted due to antibody staining not supported by experimental data.
• HPA023064 has been omitted due to qualitative reasons. An alternative antibody HPA022532 has been added.
• HPA023092 has been omitted due to qualitative reasons.
• HPA023128 has been omitted due to lack of RNA expression in cell line panel.
• HPA023139 has been omitted due to antibody staining not supported by experimental data.
• HPA023201 has been omitted due to qualitative reasons.
• HPA023249 has been omitted due to qualitative reasons.
• HPA023261 has been omitted due to qualitative reasons.
• HPA023265 has been omitted due to qualitative reasons.
• HPA023292 has been omitted due to antibody staining not supported by experimental data.
• HPA023300 has been omitted due to qualitative reasons.
• HPA023311 has been omitted due to lack of RNA expression in cell line panel.
• HPA023312 has been omitted due to qualitative reasons.
• HPA023313 has been omitted due to lack of RNA expression in cell line panel.
• HPA023389 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023394 has been omitted due to qualitative reasons. An alternative antibody HPA076992 has been added.
• HPA023446 has been omitted due to lack of RNA expression in cell line panel.
• HPA023454 has been omitted due to lack of RNA expression in cell line panel.
• HPA023464 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023501 has been omitted due to qualitative reasons.
• HPA023526 has been omitted due to lack of RNA expression in cell line panel.
• HPA023580 has been omitted due to qualitative reasons.
• HPA023597 has been omitted due to qualitative reasons.
• HPA023636 has been omitted due to qualitative reasons.
• HPA023648 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023778 has been omitted due to qualitative reasons.
• HPA023818 has been omitted due to qualitative reasons. An alternative antibody HPA050794 has been added.
• HPA023820 has been omitted due to qualitative reasons.
• HPA023844 has been omitted due to qualitative reasons.
• HPA023873 has been omitted due to qualitative reasons.
• HPA023884 has been omitted due to qualitative reasons.
• HPA023900 has been omitted due to qualitative reasons.
• HPA023911 has been omitted due to qualitative reasons.
• HPA023920 has been omitted due to qualitative reasons. An alternative antibody HPA067106 has been added.
• HPA023974 has been omitted due to qualitative reasons.
• HPA024006 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA024016 has been omitted due to lack of RNA expression in cell line panel.
• HPA024037 has been omitted due to qualitative reasons.
• HPA024132 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA024207 has been omitted due to lack of RNA expression in cell line panel.
• HPA024227 has been omitted due to qualitative reasons. An alternative antibody CAB007760 has been added.
• HPA024292 has been omitted due to lack of RNA expression in cell line panel.
• HPA024294 has been omitted due to qualitative reasons.
• HPA024295 has been omitted due to lack of RNA expression in cell line panel.
• HPA024313 has been omitted due to lack of RNA expression in cell line panel.
• HPA024343 has been omitted due to lack of RNA expression in cell line panel.
• HPA024353 has been omitted due to qualitative reasons.
• HPA024356 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA024369 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA008789 has been added.
• HPA024424 has been omitted due to antibody staining not supported by experimental data.
• HPA024426 has been omitted due to qualitative reasons. An alternative antibody HPA052386 has been added.
• HPA024430 has been omitted due to qualitative reasons.
• HPA024452 has been omitted due to antibody staining not supported by experimental data.
• HPA024460 has been omitted due to antibody staining not supported by experimental data.
• HPA024544 has been omitted due to lack of RNA expression in cell line panel.
• HPA024549 has been omitted due to qualitative reasons.
• HPA024574 has been omitted due to antibody staining not supported by experimental data.
• HPA024602 has been omitted due to qualitative reasons.
• HPA024621 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA024629 has been omitted due to lack of RNA expression in cell line panel.
• HPA024654 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA024662 has been omitted due to qualitative reasons.
• HPA024676 has been omitted due to qualitative reasons.
• HPA024677 has been omitted due to qualitative reasons.
• HPA024688 has been omitted due to antibody staining not supported by experimental data.
• HPA024729 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA024745 has been omitted due to antibody staining not supported by experimental data.
• HPA024817 has been omitted due to qualitative reasons. An alternative antibody HPA024730 has been added.
• HPA024821 has been omitted due to qualitative reasons.
• HPA024824 has been omitted due to lack of RNA expression in cell line panel.
• CAB024847 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB024865 has been omitted due to lack of RNA expression in cell line panel.
• CAB024949 has been omitted due to qualitative reasons.
• CAB024961 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA025018 has been omitted due to qualitative reasons.
• HPA025060 has been omitted due to qualitative reasons.
• HPA025061 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA073626 has been added.
• HPA025068 has been omitted due to qualitative reasons.
• HPA025072 has been omitted due to qualitative reasons.
• CAB025086 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB025183 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA025226 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA025230 has been omitted due to antibody staining not supported by experimental data.
• HPA025244 has been omitted due to qualitative reasons.
• CAB025361 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB025453 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB025487 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA062452 has been added.
• CAB025503 has been omitted due to qualitative reasons.
• CAB025538 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA062452 has been added.
• CAB025567 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA025696 has been omitted due to qualitative reasons. An alternative antibody HPA061444 has been added.
• HPA025706 has been omitted due to qualitative reasons.
• CAB025746 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA025764 has been omitted due to qualitative reasons.
• CAB025872 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB025882 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB025905 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB025918 has been omitted due to qualitative reasons.
• CAB025972 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB026051 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA026078 has been omitted due to qualitative reasons.
• HPA026088 has been omitted due to lack of RNA expression in cell line panel.
• HPA026091 has been omitted due to qualitative reasons.
• CAB026130 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB026150 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB026151 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB026182 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB026243 has been omitted due to qualitative reasons.
• HPA026272 has been omitted due to qualitative reasons.
• HPA026276 has been omitted due to qualitative reasons.
• HPA026320 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA072229 has been added.
• CAB026383 has been omitted due to qualitative reasons.
• CAB026403 has been omitted due to qualitative reasons.
• HPA026438 has been omitted due to antibody staining not supported by experimental data.
• HPA026439 has been omitted due to qualitative reasons.
• HPA026441 has been omitted due to qualitative reasons.
• HPA026448 has been omitted due to qualitative reasons.
• CAB026456 has been omitted due to antibody staining not supported by experimental data.
• CAB026461 has been omitted due to lack of RNA expression in cell line panel.
• HPA026509 has been omitted due to qualitative reasons. An alternative antibody HPA025059 has been added.
• HPA026517 has been omitted due to qualitative reasons.
• HPA026561 has been omitted due to lack of RNA expression in cell line panel.
• HPA026562 has been omitted due to qualitative reasons. An alternative antibody HPA052429 has been added.
• HPA026581 has been omitted due to qualitative reasons.
• HPA026656 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA026682 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA026693 has been omitted due to lack of RNA expression in cell line panel.
• HPA026721 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA026747 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA026756 has been omitted due to qualitative reasons.
• HPA026761 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA067463 has been added.
• HPA026773 has been omitted due to qualitative reasons.
• HPA026816 has been omitted due to qualitative reasons. An alternative antibody HPA047533 has been added.
• HPA026842 has been omitted due to qualitative reasons.
• HPA026843 has been omitted due to qualitative reasons.
• HPA026846 has been omitted due to antibody staining not supported by experimental data.
• HPA026851 has been omitted due to antibody staining not supported by experimental data.
• HPA026878 has been omitted due to lack of RNA expression in cell line panel.
• HPA026895 has been omitted due to antibody staining not supported by experimental data.
• HPA026900 has been omitted due to lack of RNA expression in cell line panel.
• HPA026905 has been omitted due to qualitative reasons.
• HPA026918 has been omitted due to qualitative reasons.
• HPA026966 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063538 has been added.
• HPA027099 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA027124 has been omitted due to qualitative reasons.
• HPA027134 has been omitted due to lack of RNA expression in cell line panel.
• HPA027150 has been omitted due to lack of RNA expression in cell line panel.
• HPA027158 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA027172 has been omitted due to antibody staining not supported by experimental data.
• HPA027273 has been omitted due to antibody staining not supported by experimental data.
• HPA027279 has been omitted due to qualitative reasons.
• HPA027281 has been omitted due to qualitative reasons.
• HPA027299 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA027312 has been omitted due to qualitative reasons.
• HPA027322 has been omitted due to antibody staining not supported by experimental data.
• HPA027331 has been omitted due to qualitative reasons. An alternative antibody HPA067113 has been added.
• HPA027337 has been omitted due to antibody staining not supported by experimental data.
• HPA027345 has been omitted due to qualitative reasons.
• HPA027369 has been omitted due to antibody staining not supported by experimental data.
• HPA027377 has been omitted due to qualitative reasons. An alternative antibody HPA029801 has been added.
• HPA027381 has been omitted due to qualitative reasons.
• HPA027431 has been omitted due to qualitative reasons.
• HPA027461 has been omitted due to antibody staining not supported by experimental data.
• HPA027494 has been omitted due to qualitative reasons.
• HPA027515 has been omitted due to qualitative reasons.
• HPA027519 has been omitted due to qualitative reasons.
• HPA027529 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA027534 has been omitted due to qualitative reasons.
• HPA027587 has been omitted due to qualitative reasons.
• HPA027597 has been omitted due to antibody staining not supported by experimental data.
• HPA027598 has been omitted due to qualitative reasons.
• HPA027608 has been omitted due to lack of RNA expression in cell line panel.
• HPA027609 has been omitted due to qualitative reasons.
• HPA027614 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA027657 has been omitted due to qualitative reasons.
• HPA027708 has been omitted due to antibody staining not supported by experimental data.
• HPA027718 has been omitted due to qualitative reasons. An alternative antibody HPA028545 has been added.
• HPA027734 has been omitted due to qualitative reasons.
• HPA027762 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA027801 has been omitted due to qualitative reasons. An alternative antibody HPA027802 has been added.
• HPA027808 has been omitted due to qualitative reasons.
• HPA027814 has been omitted due to qualitative reasons.
• HPA027869 has been omitted due to qualitative reasons.
• HPA027976 has been omitted due to qualitative reasons. An alternative antibody HPA029801 has been added.
• HPA027983 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA027992 has been omitted due to lack of RNA expression in cell line panel.
• HPA028016 has been omitted due to qualitative reasons.
• HPA028049 has been omitted due to lack of RNA expression in cell line panel.
• HPA028064 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA028083 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA028084 has been omitted due to qualitative reasons. An alternative antibody HPA029801 has been added.
• HPA028122 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA052427 has been added.
• HPA028134 has been omitted due to qualitative reasons. An alternative antibody HPA067137 has been added.
• HPA028176 has been omitted due to lack of RNA expression in cell line panel.
• HPA028197 has been omitted due to qualitative reasons.
• HPA028251 has been omitted due to qualitative reasons.
• HPA028255 has been omitted due to qualitative reasons. An alternative antibody HPA041673 has been added.
• HPA028258 has been omitted due to qualitative reasons.
• HPA028285 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA028327 has been omitted due to antibody staining not supported by experimental data.
• HPA028357 has been omitted due to qualitative reasons.
• HPA028377 has been omitted due to qualitative reasons.
• HPA028392 has been omitted due to qualitative reasons.
• HPA028423 has been omitted due to qualitative reasons.
• HPA028432 has been omitted due to lack of RNA expression in cell line panel.
• HPA028441 has been omitted due to qualitative reasons.
• HPA028443 has been omitted due to qualitative reasons.
• HPA028446 has been omitted due to qualitative reasons.
• HPA028470 has been omitted due to qualitative reasons.
• HPA028472 has been omitted due to qualitative reasons.
• HPA028500 has been omitted due to antibody staining not supported by experimental data.
• HPA028518 has been omitted due to qualitative reasons. An alternative antibody HPA028308 has been added.
• HPA028523 has been omitted due to qualitative reasons.
• HPA028526 has been omitted due to qualitative reasons.
• HPA028528 has been omitted due to qualitative reasons.
• HPA028549 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
• HPA028550 has been omitted due to lack of RNA expression in cell line panel.
• CAB028574 has been omitted due to qualitative reasons.
• HPA028628 has been omitted due to lack of RNA expression in cell line panel.
• HPA028639 has been omitted due to qualitative reasons. An alternative antibody HPA068312 has been added.
• HPA028642 has been omitted due to qualitative reasons.
• HPA028662 has been omitted due to qualitative reasons. An alternative antibody HPA068312 has been added.
• HPA028676 has been omitted due to qualitative reasons.
• HPA028692 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA028758 has been omitted due to qualitative reasons.
• HPA028783 has been omitted due to qualitative reasons.
• HPA028894 has been omitted due to lack of RNA expression in cell line panel.
• HPA028895 has been omitted due to lack of RNA expression in cell line panel.
• HPA028921 has been omitted due to qualitative reasons.
• HPA028941 has been omitted due to antibody staining not supported by experimental data.
• HPA028979 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029005 has been omitted due to antibody staining not supported by experimental data.
• HPA029014 has been omitted due to qualitative reasons.
• HPA029025 has been omitted due to qualitative reasons.
• HPA029058 has been omitted due to qualitative reasons.
• HPA029082 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029092 has been omitted due to qualitative reasons.
• HPA029100 has been omitted due to antibody staining not supported by experimental data.
• HPA029103 has been omitted due to qualitative reasons.
• HPA029131 has been omitted due to qualitative reasons.
• HPA029254 has been omitted due to antibody staining not supported by experimental data.
• HPA029272 has been omitted due to antibody staining not supported by experimental data.
• HPA029282 has been omitted due to qualitative reasons.
• HPA029289 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029314 has been omitted due to qualitative reasons.
• HPA029384 has been omitted due to qualitative reasons. An alternative antibody HPA028557 has been added.
• HPA029397 has been omitted due to qualitative reasons.
• HPA029412 has been omitted due to qualitative reasons. An alternative antibody HPA069480 has been added.
• HPA029415 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029418 has been omitted due to lack of RNA expression in cell line panel.
• HPA029468 has been omitted due to qualitative reasons.
• HPA029505 has been omitted due to lack of RNA expression in cell line panel.
• HPA029506 has been omitted due to lack of RNA expression in cell line panel.
• HPA029569 has been omitted due to qualitative reasons.
• HPA029600 has been omitted due to antibody staining not supported by experimental data.
• HPA029631 has been omitted due to qualitative reasons.
• HPA029694 has been omitted due to lack of RNA expression in cell line panel.
• HPA029695 has been omitted due to lack of RNA expression in cell line panel.
• HPA029719 has been omitted due to qualitative reasons.
• HPA029720 has been omitted due to qualitative reasons.
• HPA029724 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029759 has been omitted due to qualitative reasons.
• HPA029774 has been omitted due to qualitative reasons. An alternative antibody HPA078220 has been added.
• HPA029797 has been omitted due to lack of RNA expression in cell line panel.
• HPA029798 has been omitted due to lack of RNA expression in cell line panel.
• HPA029799 has been omitted due to qualitative reasons.
• HPA029830 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029831 has been omitted due to lack of RNA expression in cell line panel.
• HPA029832 has been omitted due to lack of RNA expression in cell line panel.
• HPA029842 has been omitted due to qualitative reasons.
• HPA029849 has been omitted due to qualitative reasons.
• HPA029853 has been omitted due to qualitative reasons.
• HPA029859 has been omitted due to lack of RNA expression in cell line panel.
• HPA029871 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029910 has been omitted due to qualitative reasons.
• HPA029914 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029944 has been omitted due to qualitative reasons.
• HPA029960 has been omitted due to qualitative reasons.
• HPA029974 has been omitted due to qualitative reasons.
• HPA029975 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA029976 has been omitted due to qualitative reasons.
• CAB030012 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA067463 has been added.
• HPA030061 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA030069 has been omitted due to antibody staining not supported by experimental data.
• HPA030076 has been omitted due to lack of RNA expression in cell line panel.
• HPA030085 has been omitted due to qualitative reasons.
• HPA030090 has been omitted due to qualitative reasons.
• HPA030095 has been omitted due to qualitative reasons.
• HPA030096 has been omitted due to qualitative reasons.
• HPA030103 has been omitted due to qualitative reasons.
• HPA030118 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA030162 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA030170 has been omitted due to qualitative reasons. An alternative antibody HPA030173 has been added.
• HPA030175 has been omitted due to qualitative reasons.
• HPA030176 has been omitted due to antibody staining not supported by experimental data.
• HPA030202 has been omitted due to qualitative reasons. An alternative antibody CAB037133 has been added.
• HPA030218 has been omitted due to qualitative reasons.
• HPA030226 has been omitted due to qualitative reasons.
• HPA030247 has been omitted due to qualitative reasons.
• HPA030251 has been omitted due to qualitative reasons.
• HPA030252 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA030270 has been omitted due to lack of RNA expression in cell line panel.
• HPA030271 has been omitted due to lack of RNA expression in cell line panel.
• HPA030301 has been omitted due to qualitative reasons.
• HPA030356 has been omitted due to qualitative reasons.
• HPA030388 has been omitted due to qualitative reasons.
• HPA030436 has been omitted due to qualitative reasons. An alternative antibody HPA063533 has been added.
• HPA030458 has been omitted due to qualitative reasons.
• HPA030506 has been omitted due to qualitative reasons.
• HPA030523 has been omitted due to qualitative reasons.
• HPA030560 has been omitted due to qualitative reasons.
• HPA030712 has been omitted due to antibody staining not supported by experimental data.
• HPA030728 has been omitted due to qualitative reasons. An alternative antibody HPA066901 has been added.
• HPA030746 has been omitted due to antibody staining not supported by experimental data.
• HPA030757 has been omitted due to antibody staining not supported by experimental data.
• HPA030817 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA030893 has been omitted due to qualitative reasons. An alternative antibody CAB004028 has been added.
• HPA030968 has been omitted due to qualitative reasons. An alternative antibody HPA030969 has been added.
• HPA030997 has been omitted due to qualitative reasons.
• HPA031021 has been omitted due to qualitative reasons. An alternative antibody HPA061394 has been added.
• HPA031032 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA031033 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA031037 has been omitted due to qualitative reasons. An alternative antibody HPA069654 has been added.
• HPA031053 has been omitted due to antibody staining not supported by experimental data.
• HPA031066 has been omitted due to antibody staining not supported by experimental data.
• HPA031079 has been omitted due to qualitative reasons.
• HPA031092 has been omitted due to qualitative reasons.
• HPA031152 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA066330 has been added.
• HPA031168 has been omitted due to qualitative reasons.
• HPA031169 has been omitted due to qualitative reasons.
• HPA031179 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA031180 has been omitted due to lack of RNA expression in cell line panel.
• HPA031184 has been omitted due to qualitative reasons.
• HPA031213 has been omitted due to qualitative reasons. An alternative antibody HPA031212 has been added.
• HPA031215 has been omitted due to qualitative reasons.
• HPA031256 has been omitted due to qualitative reasons.
• HPA031262 has been omitted due to qualitative reasons.
• HPA031273 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA031325 has been omitted due to lack of RNA expression in cell line panel.
• HPA031326 has been omitted due to lack of RNA expression in cell line panel.
• HPA031380 has been omitted due to qualitative reasons.
• HPA031381 has been omitted due to qualitative reasons.
• HPA031402 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA068554 has been added.
• HPA031404 has been omitted due to qualitative reasons. An alternative antibody HPA068554 has been added.
• HPA031415 has been omitted due to qualitative reasons.
• HPA031417 has been omitted due to antibody staining not supported by experimental data.
• HPA031464 has been omitted due to antibody staining not supported by experimental data.
• CAB031489 has been omitted due to qualitative reasons. An alternative antibody HPA067188 has been added.
• HPA031525 has been omitted due to qualitative reasons. An alternative antibody HPA068560 has been added.
• HPA031605 has been omitted due to qualitative reasons. An alternative antibody HPA052973 has been added.
• HPA031641 has been omitted due to qualitative reasons. An alternative antibody HPA076526 has been added.
• HPA031657 has been omitted due to qualitative reasons.
• HPA031659 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA031660 has been omitted due to antibody staining not supported by experimental data.
• HPA031661 has been omitted due to qualitative reasons.
• HPA031686 has been omitted due to antibody staining not supported by experimental data.
• HPA031720 has been omitted due to qualitative reasons.
• HPA031725 has been omitted due to qualitative reasons.
• HPA031769 has been omitted due to qualitative reasons.
• HPA031777 has been omitted due to qualitative reasons. An alternative antibody HPA068568 has been added.
• HPA031790 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA031953 has been omitted due to antibody staining not supported by experimental data.
• HPA031958 has been omitted due to lack of RNA expression in cell line panel.
• HPA032000 has been omitted due to qualitative reasons.
• HPA032032 has been omitted due to qualitative reasons.
• HPA032052 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA032053 has been added.
• HPA032069 has been omitted due to qualitative reasons. An alternative antibody HPA032068 has been added.
• HPA032078 has been omitted due to qualitative reasons.
• HPA032096 has been omitted due to qualitative reasons.
• HPA032130 has been omitted due to qualitative reasons.
• HPA032134 has been omitted due to qualitative reasons. An alternative antibody HPA069678 has been added.
• HPA032145 has been omitted due to antibody staining not supported by experimental data.
• HPA032146 has been omitted due to antibody staining not supported by experimental data.
• HPA032148 has been omitted due to qualitative reasons.
• CAB032815 has been omitted due to qualitative reasons. An alternative antibody HPA052504 has been added.
• CAB032907 has been omitted due to qualitative reasons.
• CAB033237 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA072319 has been added.
• CAB033276 has been omitted due to qualitative reasons.
• CAB033911 has been omitted due to qualitative reasons.
• CAB034128 has been omitted due to qualitative reasons.
• CAB034319 has been omitted due to qualitative reasons.
• CAB034342 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA028867 has been added.
• HPA034515 has been omitted due to qualitative reasons.
• HPA034525 has been omitted due to antibody staining not supported by experimental data.
• HPA034535 has been omitted due to qualitative reasons.
• HPA034585 has been omitted due to qualitative reasons. An alternative antibody HPA065172 has been added.
• HPA034597 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA034598 has been added.
• HPA034621 has been omitted due to qualitative reasons.
• HPA034683 has been omitted due to qualitative reasons. An alternative antibody HPA062942 has been added.
• HPA034715 has been omitted due to qualitative reasons. An alternative antibody HPA064945 has been added.
• HPA034752 has been omitted due to qualitative reasons.
• HPA034779 has been omitted due to antibody staining not supported by experimental data.
• HPA034792 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA060655 has been added.
• HPA034804 has been omitted due to antibody staining not supported by experimental data.
• HPA034805 has been omitted due to qualitative reasons.
• HPA034807 has been omitted due to qualitative reasons. An alternative antibody HPA034808 has been added.
• HPA034809 has been omitted due to lack of RNA expression in cell line panel.
• HPA034845 has been omitted due to qualitative reasons.
• HPA034861 has been omitted due to qualitative reasons.
• HPA034958 has been omitted due to qualitative reasons.
• HPA034980 has been omitted due to qualitative reasons.
• HPA035026 has been omitted due to qualitative reasons. An alternative antibody HPA017327 has been added.
• HPA035063 has been omitted due to qualitative reasons.
• HPA035069 has been omitted due to antibody staining not supported by experimental data.
• HPA035089 has been omitted due to qualitative reasons.
• HPA035116 has been omitted due to qualitative reasons. An alternative antibody HPA069684 has been added.
• HPA035117 has been omitted due to qualitative reasons.
• HPA035199 has been omitted due to qualitative reasons. An alternative antibody HPA068961 has been added.
• HPA035297 has been omitted due to antibody staining not supported by experimental data.
• HPA035305 has been omitted due to qualitative reasons.
• HPA035326 has been omitted due to lack of RNA expression in cell line panel.
• HPA035434 has been omitted due to qualitative reasons.
• HPA035481 has been omitted due to qualitative reasons.
• HPA035501 has been omitted due to qualitative reasons.
• HPA035528 has been omitted due to qualitative reasons.
• HPA035630 has been omitted due to antibody staining not supported by experimental data.
• HPA035672 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA035676 has been omitted due to qualitative reasons.
• HPA035720 has been omitted due to lack of RNA expression in cell line panel.
• HPA035721 has been omitted due to lack of RNA expression in cell line panel.
• HPA035758 has been omitted due to qualitative reasons. An alternative antibody HPA013569 has been added.
• HPA035759 has been omitted due to qualitative reasons. An alternative antibody HPA013569 has been added.
• HPA035814 has been omitted due to qualitative reasons.
• HPA035869 has been omitted due to qualitative reasons.
• HPA035876 has been omitted due to qualitative reasons.
• HPA035877 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA035878 has been omitted due to antibody staining not supported by experimental data.
• HPA035901 has been omitted due to qualitative reasons.
• HPA035970 has been omitted due to antibody staining not supported by experimental data.
• CAB035999 has been omitted due to qualitative reasons.
• HPA036016 has been omitted due to antibody staining not supported by experimental data.
• HPA036070 has been omitted due to qualitative reasons. An alternative antibody HPA036071 has been added.
• HPA036145 has been omitted due to qualitative reasons.
• HPA036166 has been omitted due to antibody staining not supported by experimental data.
• HPA036174 has been omitted due to qualitative reasons. An alternative antibody HPA038153 has been added.
• HPA036175 has been omitted due to qualitative reasons. An alternative antibody HPA038153 has been added.
• HPA036205 has been omitted due to qualitative reasons.
• HPA036292 has been omitted due to qualitative reasons.
• HPA036314 has been omitted due to qualitative reasons.
• HPA036337 has been omitted due to qualitative reasons.
• HPA036390 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA036391 has been omitted due to lack of RNA expression in cell line panel.
• HPA036398 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA044860 has been added.
• HPA036443 has been omitted due to qualitative reasons.
• HPA036468 has been omitted due to qualitative reasons.
• HPA036469 has been omitted due to antibody staining not supported by experimental data.
• HPA036480 has been omitted due to qualitative reasons.
• HPA036626 has been omitted due to qualitative reasons.
• HPA036664 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA036665 has been omitted due to lack of RNA expression in cell line panel.
• HPA036680 has been omitted due to qualitative reasons.
• HPA036697 has been omitted due to antibody staining not supported by experimental data.
• HPA036705 has been omitted due to qualitative reasons.
• HPA036715 has been omitted due to qualitative reasons. An alternative antibody HPA036714 has been added.
• HPA036734 has been omitted due to lack of RNA expression in cell line panel.
• HPA036735 has been omitted due to lack of RNA expression in cell line panel.
• HPA036749 has been omitted due to qualitative reasons.
• HPA036750 has been omitted due to qualitative reasons.
• HPA036767 has been omitted due to qualitative reasons.
• HPA036838 has been omitted due to qualitative reasons.
• HPA036853 has been omitted due to qualitative reasons.
• HPA036863 has been omitted due to qualitative reasons.
• HPA036864 has been omitted due to antibody staining not supported by experimental data.
• HPA036885 has been omitted due to qualitative reasons. An alternative antibody HPA058185 has been added.
• HPA036894 has been omitted due to qualitative reasons.
• HPA036909 has been omitted due to qualitative reasons.
• HPA036912 has been omitted due to qualitative reasons. An alternative antibody HPA036911 has been added.
• HPA036934 has been omitted due to qualitative reasons. An alternative antibody CAB011596 has been added.
• HPA036991 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA066081 has been added.
• HPA036992 has been omitted due to qualitative reasons. An alternative antibody HPA066081 has been added.
• HPA037369 antibody has been omitted due to target gene not found in Ensembl.
• HPA037398 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA037429 has been omitted due to qualitative reasons.
• HPA037430 has been omitted due to qualitative reasons.
• HPA037465 has been omitted due to lack of RNA expression in cell line panel.
• HPA037469 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA037470 has been omitted due to qualitative reasons.
• HPA037481 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA037556 has been omitted due to lack of RNA expression in cell line panel.
• HPA037587 has been omitted due to qualitative reasons.
• HPA037596 has been omitted due to qualitative reasons.
• HPA037694 has been omitted due to lack of RNA expression in cell line panel.
• HPA037757 has been omitted due to qualitative reasons.
• HPA037772 has been omitted due to qualitative reasons. An alternative antibody HPA037773 has been added.
• HPA037795 has been omitted due to qualitative reasons.
• HPA037824 has been omitted due to lack of RNA expression in cell line panel.
• HPA037828 has been omitted due to antibody staining not supported by experimental data.
• HPA037829 has been omitted due to antibody staining not supported by experimental data.
• HPA037857 has been omitted due to antibody staining not supported by experimental data.
• HPA037858 has been omitted due to antibody staining not supported by experimental data.
• HPA037874 has been omitted due to antibody staining not supported by experimental data.
• HPA037875 has been omitted due to antibody staining not supported by experimental data.
• HPA037881 has been omitted due to qualitative reasons.
• HPA037929 has been omitted due to qualitative reasons.
• HPA037930 has been omitted due to qualitative reasons.
• HPA037938 has been omitted due to qualitative reasons. An alternative antibody HPA037937 has been added.
• HPA037959 has been omitted due to qualitative reasons. An alternative antibody HPA061506 has been added.
• HPA037997 has been omitted due to qualitative reasons.
• HPA037998 has been omitted due to qualitative reasons.
• HPA038015 has been omitted due to qualitative reasons.
• HPA038030 has been omitted due to qualitative reasons.
• HPA038052 has been omitted due to qualitative reasons.
• HPA038053 has been omitted due to antibody staining not supported by experimental data.
• HPA038080 has been omitted due to lack of RNA expression in cell line panel.
• HPA038081 has been omitted due to lack of RNA expression in cell line panel.
• HPA038093 has been omitted due to qualitative reasons. An alternative antibody HPA028336 has been added.
• HPA038115 has been omitted due to antibody staining not supported by experimental data.
• HPA038231 has been omitted due to qualitative reasons.
• HPA038248 has been omitted due to qualitative reasons. An alternative antibody HPA077591 has been added.
• HPA038249 has been omitted due to qualitative reasons. An alternative antibody HPA077591 has been added.
• HPA038258 has been omitted due to qualitative reasons.
• HPA038259 has been omitted due to antibody staining not supported by experimental data.
• HPA038287 has been omitted due to qualitative reasons.
• HPA038296 has been omitted due to lack of RNA expression in cell line panel.
• HPA038297 has been omitted due to qualitative reasons.
• HPA038302 antibody has been omitted due to target gene not found in Ensembl.
• HPA038396 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA038446 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA038475 has been omitted due to qualitative reasons.
• HPA038486 has been omitted due to qualitative reasons. An alternative antibody HPA003311 has been added.
• HPA038520 has been omitted due to qualitative reasons. An alternative antibody HPA057573 has been added.
• HPA038525 has been omitted due to antibody staining not supported by experimental data.
• HPA038533 has been omitted due to antibody staining not supported by experimental data.
• HPA038548 has been omitted due to qualitative reasons.
• HPA038577 has been omitted due to qualitative reasons.
• HPA038591 has been omitted due to new images pending.
• HPA038599 has been omitted due to qualitative reasons.
• HPA038615 has been omitted due to qualitative reasons. An alternative antibody HPA058227 has been added.
• HPA038624 has been omitted due to antibody staining not supported by experimental data.
• HPA038653 has been omitted due to lack of RNA expression in cell line panel.
• HPA038654 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA038675 has been omitted due to qualitative reasons. An alternative antibody HPA045912 has been added.
• HPA038686 has been omitted due to antibody staining not supported by experimental data.
• HPA038725 has been omitted due to qualitative reasons.
• HPA038787 has been omitted due to qualitative reasons.
• HPA038875 has been omitted due to qualitative reasons.
• HPA038915 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA038922 has been added.
• HPA038928 has been omitted due to antibody staining not supported by experimental data.
• HPA038929 has been omitted due to antibody staining not supported by experimental data.
• HPA039043 has been omitted due to qualitative reasons. An alternative antibody HPA064572 has been added.
• HPA039044 has been omitted due to qualitative reasons. An alternative antibody HPA064572 has been added.
• HPA039064 has been omitted due to qualitative reasons. An alternative antibody HPA066488 has been added.
• HPA039076 has been omitted due to qualitative reasons.
• HPA039105 has been omitted due to qualitative reasons.
• HPA039138 has been omitted due to qualitative reasons.
• HPA039162 has been omitted due to qualitative reasons.
• HPA039169 has been omitted due to antibody staining not supported by experimental data.
• HPA039190 has been omitted due to qualitative reasons.
• HPA039208 has been omitted due to lack of RNA expression in cell line panel.
• HPA039232 has been omitted due to qualitative reasons.
• CAB039239 has been omitted due to qualitative reasons.
• HPA039253 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA069055 has been added.
• HPA039330 has been omitted due to antibody staining not supported by experimental data.
• HPA039342 has been omitted due to antibody staining not supported by experimental data.
• HPA039372 has been omitted due to qualitative reasons.
• HPA039403 has been omitted due to qualitative reasons.
• HPA039407 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA070737 has been added.
• HPA039416 has been omitted due to antibody staining not supported by experimental data.
• HPA039451 has been omitted due to qualitative reasons.
• HPA039461 has been omitted due to antibody staining not supported by experimental data.
• HPA039467 has been omitted due to qualitative reasons.
• HPA039480 has been omitted due to qualitative reasons.
• HPA039533 has been omitted due to antibody staining not supported by experimental data.
• HPA039543 has been omitted due to antibody staining not supported by experimental data.
• HPA039562 has been omitted due to qualitative reasons.
• HPA039566 has been omitted due to qualitative reasons.
• HPA039588 has been omitted due to antibody staining not supported by experimental data.
• HPA039613 has been omitted due to antibody staining not supported by experimental data.
• HPA039617 has been omitted due to qualitative reasons.
• HPA039627 has been omitted due to qualitative reasons.
• HPA039671 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039681 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039691 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039698 has been omitted due to qualitative reasons. An alternative antibody HPA040267 has been added.
• HPA039704 has been omitted due to qualitative reasons.
• HPA039736 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039738 has been omitted due to qualitative reasons.
• HPA039778 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039780 has been omitted due to qualitative reasons.
• HPA039825 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039860 has been omitted due to lack of RNA expression in cell line panel.
• HPA039908 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039928 has been omitted due to qualitative reasons.
• HPA039951 has been omitted due to qualitative reasons.
• HPA040005 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040028 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040051 has been omitted due to qualitative reasons.
• HPA040057 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA070737 has been added.
• HPA040096 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040103 has been omitted due to antibody staining not supported by experimental data.
• HPA040109 has been omitted due to antibody staining not supported by experimental data.
• HPA040117 has been omitted due to lack of RNA expression in cell line panel.
• HPA040143 has been omitted due to lack of RNA expression in cell line panel.
• HPA040155 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040159 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040172 has been omitted due to antibody staining not supported by experimental data.
• HPA040229 has been omitted due to qualitative reasons.
• HPA040293 has been omitted due to qualitative reasons.
• HPA040301 has been omitted due to qualitative reasons.
• HPA040315 has been omitted due to qualitative reasons. An alternative antibody HPA063498 has been added.
• HPA040336 has been omitted due to qualitative reasons.
• HPA040355 has been omitted due to antibody staining not supported by experimental data.
• HPA040386 has been omitted due to antibody staining not supported by experimental data.
• HPA040390 has been omitted due to qualitative reasons.
• HPA040391 has been omitted due to qualitative reasons.
• HPA040410 has been omitted due to qualitative reasons.
• HPA040411 has been omitted due to qualitative reasons.
• HPA040419 has been omitted due to qualitative reasons.
• HPA040439 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040450 has been omitted due to qualitative reasons.
• HPA040511 has been omitted due to qualitative reasons.
• CAB040552 has been omitted due to qualitative reasons.
• HPA040593 has been omitted due to qualitative reasons. An alternative antibody HPA069773 has been added.
• HPA040595 has been omitted due to qualitative reasons.
• HPA040650 has been omitted due to qualitative reasons.
• HPA040661 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040675 has been omitted due to qualitative reasons.
• HPA040679 has been omitted due to qualitative reasons.
• HPA040691 has been omitted due to qualitative reasons.
• HPA040695 has been omitted due to lack of RNA expression in cell line panel.
• HPA040726 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA038922 has been added.
• HPA040735 has been omitted due to qualitative reasons.
• HPA040750 has been omitted due to qualitative reasons.
• HPA040753 has been omitted due to qualitative reasons.
• HPA040774 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040803 has been omitted due to qualitative reasons. An alternative antibody HPA074173 has been added.
• HPA040816 has been omitted due to antibody staining not supported by experimental data.
• HPA040848 has been omitted due to qualitative reasons. An alternative antibody HPA066169 has been added.
• HPA040855 has been omitted due to qualitative reasons.
• HPA040868 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040887 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040891 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040902 has been omitted due to qualitative reasons. An alternative antibody HPA069773 has been added.
• HPA040915 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040942 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040959 has been omitted due to antibody staining not supported by experimental data.
• HPA040967 has been omitted due to qualitative reasons. An alternative antibody HPA041553 has been added.
• HPA040988 has been omitted due to qualitative reasons.
• HPA040991 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA041005 has been omitted due to qualitative reasons.
• HPA041016 has been omitted due to qualitative reasons.
• HPA041023 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA041028 has been omitted due to qualitative reasons.
• HPA041060 has been omitted due to qualitative reasons.
• HPA041071 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA041072 has been omitted due to lack of RNA expression in cell line panel.
• HPA041076 has been omitted due to qualitative reasons. An alternative antibody HPA048213 has been added.
• HPA041131 has been omitted due to qualitative reasons.
• HPA041222 has been omitted due to qualitative reasons.
• HPA041228 has been omitted due to qualitative reasons.
• HPA041343 has been omitted due to antibody staining not supported by experimental data.
• HPA041412 has been omitted due to qualitative reasons. An alternative antibody HPA043503 has been added.
• HPA041428 has been omitted due to qualitative reasons.
• HPA041452 has been omitted due to qualitative reasons.
• HPA041549 has been omitted due to qualitative reasons.
• HPA041550 has been omitted due to antibody staining not supported by experimental data.
• HPA041576 has been omitted due to lack of RNA expression in cell line panel.
• HPA041592 has been omitted due to qualitative reasons. An alternative antibody HPA007200 has been added.
• HPA041622 has been omitted due to qualitative reasons. An alternative antibody HPA064827 has been added.
• HPA041646 has been omitted due to lack of RNA expression in cell line panel.
• HPA041683 has been omitted due to qualitative reasons.
• HPA041689 has been omitted due to qualitative reasons. An alternative antibody HPA061560 has been added.
• HPA041699 has been omitted due to qualitative reasons.
• HPA041719 has been omitted due to qualitative reasons.
• HPA041749 has been omitted due to qualitative reasons.
• HPA041811 has been omitted due to qualitative reasons.
• HPA041824 has been omitted due to qualitative reasons. An alternative antibody HPA064645 has been added.
• HPA041867 has been omitted due to qualitative reasons.
• HPA041891 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA041925 has been omitted due to qualitative reasons. An alternative antibody HPA043219 has been added.
• HPA041938 has been omitted due to qualitative reasons.
• HPA041944 has been omitted due to qualitative reasons.
• HPA041948 has been omitted due to antibody staining not supported by experimental data.
• HPA041966 has been omitted due to qualitative reasons.
• HPA041967 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA041992 has been omitted due to antibody staining not supported by experimental data.
• HPA042001 has been omitted due to qualitative reasons.
• HPA042005 has been omitted due to antibody staining not supported by experimental data.
• HPA042009 has been omitted due to lack of RNA expression in cell line panel.
• HPA042014 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042026 has been omitted due to qualitative reasons.
• HPA042058 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042068 has been omitted due to qualitative reasons.
• HPA042096 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042098 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042109 has been omitted due to antibody staining not supported by experimental data.
• HPA042137 has been omitted due to qualitative reasons.
• HPA042182 has been omitted due to qualitative reasons.
• HPA042193 has been omitted due to qualitative reasons. An alternative antibody HPA061805 has been added.
• HPA042231 has been omitted due to qualitative reasons.
• HPA042275 has been omitted due to qualitative reasons. An alternative antibody HPA067433 has been added.
• HPA042282 has been omitted due to qualitative reasons.
• HPA042344 has been omitted due to antibody staining not supported by experimental data.
• HPA042360 has been omitted due to qualitative reasons.
• HPA042455 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042481 has been omitted due to qualitative reasons. An alternative antibody HPA066764 has been added.
• HPA042504 has been omitted due to qualitative reasons.
• HPA042546 has been omitted due to qualitative reasons.
• HPA042567 has been omitted due to qualitative reasons. An alternative antibody HPA048658 has been added.
• HPA042598 has been omitted due to qualitative reasons.
• HPA042601 has been omitted due to qualitative reasons. An alternative antibody HPA035157 has been added.
• HPA042603 has been omitted due to qualitative reasons. An alternative antibody HPA057952 has been added.
• HPA042613 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042631 has been omitted due to lack of RNA expression in cell line panel.
• HPA042654 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042658 has been omitted due to qualitative reasons. An alternative antibody HPA041427 has been added.
• HPA042685 has been omitted due to antibody staining not supported by experimental data.
• HPA042709 has been omitted due to antibody staining not supported by experimental data.
• HPA042779 has been omitted due to qualitative reasons.
• HPA042813 has been omitted due to qualitative reasons. An alternative antibody HPA042759 has been added.
• HPA042839 has been omitted due to qualitative reasons.
• HPA042844 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA042910 has been omitted due to qualitative reasons.
• HPA042975 has been omitted due to qualitative reasons.
• HPA043004 has been omitted due to lack of RNA expression in cell line panel.
• HPA043047 has been omitted due to qualitative reasons.
• HPA043066 has been omitted due to qualitative reasons.
• HPA043121 has been omitted due to lack of RNA expression in cell line panel.
• HPA043140 has been omitted due to qualitative reasons.
• HPA043198 has been omitted due to qualitative reasons. An alternative antibody HPA017327 has been added.
• HPA043208 has been omitted due to qualitative reasons.
• HPA043237 has been omitted due to qualitative reasons. An alternative antibody HPA056980 has been added.
• HPA043260 has been omitted due to antibody staining not supported by experimental data.
• HPA043266 has been omitted due to qualitative reasons. An alternative antibody HPA060174 has been added.
• HPA043270 has been omitted due to qualitative reasons.
• HPA043358 has been omitted due to antibody staining not supported by experimental data.
• HPA043368 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA076524 has been added.
• HPA043437 has been omitted due to antibody staining not supported by experimental data.
• HPA043470 has been omitted due to qualitative reasons.
• HPA043478 has been omitted due to qualitative reasons. An alternative antibody HPA060158 has been added.
• HPA043582 has been omitted due to antibody staining not supported by experimental data.
• HPA043606 has been omitted due to qualitative reasons.
• HPA043613 has been omitted due to qualitative reasons.
• HPA043665 has been omitted due to antibody staining not supported by experimental data.
• HPA043680 antibody has been omitted due to target gene not found in Ensembl.
• HPA043701 has been omitted due to qualitative reasons.
• HPA043737 has been omitted due to antibody staining not supported by experimental data.
• HPA043741 has been omitted due to qualitative reasons. An alternative antibody HPA061441 has been added.
• HPA043810 has been omitted due to qualitative reasons. An alternative antibody HPA053554 has been added.
• HPA043833 has been omitted due to qualitative reasons.
• HPA043839 has been omitted due to qualitative reasons. An alternative antibody HPA066490 has been added.
• HPA043847 has been omitted due to antibody staining not supported by experimental data.
• HPA043852 has been omitted due to antibody staining not supported by experimental data.
• HPA043915 has been omitted due to qualitative reasons.
• HPA044004 has been omitted due to new images pending.
• HPA044113 has been omitted due to qualitative reasons. An alternative antibody HPA040396 has been added.
• HPA044133 has been omitted due to qualitative reasons.
• HPA044145 has been omitted due to lack of RNA expression in cell line panel.
• HPA044201 has been omitted due to qualitative reasons.
• HPA044231 has been omitted due to qualitative reasons.
• HPA044232 has been omitted due to qualitative reasons.
• HPA044322 has been omitted due to antibody staining not supported by experimental data.
• HPA044378 has been omitted due to qualitative reasons.
• HPA044440 has been omitted due to qualitative reasons.
• HPA044460 has been omitted due to qualitative reasons.
• HPA044550 has been omitted due to lack of RNA expression in cell line panel.
• HPA044581 has been omitted due to qualitative reasons. An alternative antibody HPA057498 has been added.
• HPA044592 has been omitted due to antibody staining not supported by experimental data.
• HPA044676 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA044731 antibody has been omitted due to target gene not found in Ensembl.
• HPA044736 has been omitted due to qualitative reasons.
• HPA044806 antibody has been omitted due to target gene not found in Ensembl.
• HPA044834 antibody has been omitted due to target gene not found in Ensembl.
• HPA044858 has been omitted due to qualitative reasons. An alternative antibody HPA034609 has been added.
• HPA044867 has been omitted due to qualitative reasons. An alternative antibody HPA035957 has been added.
• HPA044875 has been omitted due to qualitative reasons.
• HPA044885 has been omitted due to lack of RNA expression in cell line panel. An alternative antibody HPA051925 has been added.
• HPA044978 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA044982 has been omitted due to qualitative reasons.
• HPA045018 has been omitted due to qualitative reasons.
• HPA045056 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA045165 has been omitted due to qualitative reasons. An alternative antibody HPA071709 has been added.
• HPA045224 has been omitted due to antibody staining not supported by experimental data.
• HPA045282 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA050325 has been added.
• HPA045377 has been omitted due to qualitative reasons.
• HPA045473 has been omitted due to qualitative reasons.
• HPA045549 has been omitted due to qualitative reasons.
• HPA045579 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA045663 has been omitted due to qualitative reasons. An alternative antibody HPA050553 has been added.
• HPA045753 has been omitted due to qualitative reasons. An alternative antibody HPA054396 has been added.
• HPA045781 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA045827 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA045899 has been omitted due to qualitative reasons.
• HPA045909 has been omitted due to qualitative reasons.
• HPA046076 has been omitted due to antibody staining not supported by experimental data.
• HPA046094 has been omitted due to qualitative reasons. An alternative antibody HPA040427 has been added.
• HPA046223 has been omitted due to qualitative reasons.
• HPA046300 has been omitted due to qualitative reasons.
• HPA046398 has been omitted due to qualitative reasons. An alternative antibody HPA042759 has been added.
• HPA046440 has been omitted due to qualitative reasons.
• HPA046546 has been omitted due to qualitative reasons. An alternative antibody CAB005337 has been added.
• HPA046570 has been omitted due to qualitative reasons.
• HPA046571 has been omitted due to qualitative reasons.
• HPA046628 has been omitted due to qualitative reasons. An alternative antibody HPA028957 has been added.
• HPA046679 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA030843 has been added.
• HPA046724 has been omitted due to qualitative reasons.
• HPA046751 has been omitted due to qualitative reasons.
• HPA046756 has been omitted due to antibody staining not supported by experimental data.
• HPA046784 has been omitted due to qualitative reasons. An alternative antibody HPA072371 has been added.
• HPA046791 has been omitted due to qualitative reasons.
• HPA046795 has been omitted due to qualitative reasons.
• HPA046797 has been omitted due to qualitative reasons.
• HPA046880 has been omitted due to lack of RNA expression in cell line panel.
• HPA046888 has been omitted due to qualitative reasons.
• HPA046909 has been omitted due to antibody staining not supported by experimental data.
• HPA047036 has been omitted due to qualitative reasons. An alternative antibody HPA058554 has been added.
• HPA047037 has been omitted due to qualitative reasons. An alternative antibody HPA064515 has been added.
• HPA047117 has been omitted due to qualitative reasons. An alternative antibody HPA060198 has been added.
• HPA047126 has been omitted due to qualitative reasons.
• HPA047148 has been omitted due to antibody staining not supported by experimental data.
• HPA047151 has been omitted due to antibody staining not supported by experimental data.
• HPA047207 has been omitted due to qualitative reasons.
• HPA047213 has been omitted due to qualitative reasons.
• HPA047228 has been omitted due to qualitative reasons.
• HPA047290 has been omitted due to qualitative reasons.
• CAB047318 has been omitted due to qualitative reasons.
• CAB047327 has been omitted due to qualitative reasons.
• CAB047339 has been omitted due to qualitative reasons.
• CAB047340 has been omitted due to qualitative reasons.
• HPA047368 has been omitted due to qualitative reasons.
• HPA047546 has been omitted due to antibody staining not supported by experimental data.
• HPA047554 has been omitted due to qualitative reasons. An alternative antibody HPA074408 has been added.
• HPA047562 has been omitted due to antibody staining not supported by experimental data.
• HPA047605 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA039601 has been added.
• HPA047793 has been omitted due to qualitative reasons.
• HPA047798 has been omitted due to qualitative reasons.
• HPA047859 has been omitted due to antibody staining not supported by experimental data.
• HPA047862 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA047903 has been omitted due to qualitative reasons.
• HPA047904 has been omitted due to qualitative reasons.
• HPA047922 has been omitted due to qualitative reasons.
• HPA048121 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA048253 has been omitted due to qualitative reasons.
• HPA048306 has been omitted due to antibody staining not supported by experimental data.
• HPA048332 has been omitted due to qualitative reasons.
• HPA048340 has been omitted due to qualitative reasons.
• HPA048440 has been omitted due to qualitative reasons.
• HPA048472 has been omitted due to qualitative reasons.
• HPA048494 has been omitted due to qualitative reasons.
• HPA048531 has been omitted due to qualitative reasons. An alternative antibody HPA066469 has been added.
• HPA048549 has been omitted due to qualitative reasons. An alternative antibody HPA074132 has been added.
• HPA048566 has been omitted due to qualitative reasons.
• HPA048582 has been omitted due to lack of RNA expression in cell line panel.
• HPA048635 has been omitted due to lack of RNA expression in cell line panel.
• HPA048801 has been omitted due to qualitative reasons.
• HPA048808 has been omitted due to qualitative reasons. An alternative antibody HPA072587 has been added.
• HPA048818 has been omitted due to antibody staining not supported by experimental data.
• HPA048866 has been omitted due to qualitative reasons.
• HPA048871 has been omitted due to qualitative reasons.
• HPA048939 has been omitted due to qualitative reasons. An alternative antibody HPA057749 has been added.
• HPA049079 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA049081 has been omitted due to qualitative reasons.
• HPA049101 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA027530 has been added.
• HPA049105 has been omitted due to qualitative reasons.
• HPA049143 has been omitted due to qualitative reasons. An alternative antibody HPA070386 has been added.
• HPA049272 has been omitted due to qualitative reasons.
• HPA049277 has been omitted due to qualitative reasons. An alternative antibody HPA063895 has been added.
• HPA049361 has been omitted due to qualitative reasons. An alternative antibody HPA067487 has been added.
• HPA049447 has been omitted due to qualitative reasons.
• HPA049549 has been omitted due to antibody staining not supported by experimental data.
• HPA049560 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA066330 has been added.
• HPA049564 has been omitted due to qualitative reasons.
• HPA049622 has been omitted due to antibody staining not supported by experimental data.
• HPA049634 has been omitted due to qualitative reasons.
• HPA049651 has been omitted due to qualitative reasons. An alternative antibody CAB037133 has been added.
• HPA049655 has been omitted due to antibody staining not supported by experimental data.
• HPA049657 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA049678 has been omitted due to antibody staining not supported by experimental data.
• HPA049777 has been omitted due to qualitative reasons.
• HPA049809 has been omitted due to antibody staining not supported by experimental data.
• HPA049811 has been omitted due to qualitative reasons. An alternative antibody HPA065052 has been added.
• HPA049815 has been omitted due to qualitative reasons. An alternative antibody HPA070386 has been added.
• HPA049832 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA049974 has been omitted due to qualitative reasons.
• HPA050270 has been omitted due to qualitative reasons. An alternative antibody HPA067491 has been added.
• HPA050344 has been omitted due to qualitative reasons.
• HPA050359 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA050414 has been omitted due to qualitative reasons.
• HPA050480 has been omitted due to qualitative reasons.
• HPA050528 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063577 has been added.
• HPA050541 has been omitted due to lack of RNA expression in cell line panel.
• HPA050560 has been omitted due to qualitative reasons.
• HPA050593 has been omitted due to qualitative reasons.
• HPA050647 has been omitted due to qualitative reasons.
• HPA050796 has been omitted due to qualitative reasons.
• HPA051061 has been omitted due to qualitative reasons. An alternative antibody HPA018945 has been added.
• HPA051105 has been omitted due to qualitative reasons.
• HPA051123 has been omitted due to qualitative reasons.
• HPA051208 has been omitted due to qualitative reasons. An alternative antibody HPA060565 has been added.
• HPA051384 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058384 has been added.
• HPA051397 has been omitted due to qualitative reasons.
• HPA051421 has been omitted due to qualitative reasons.
• HPA051427 has been omitted due to qualitative reasons. An alternative antibody HPA059960 has been added.
• HPA051487 has been omitted due to qualitative reasons. An alternative antibody HPA060238 has been added.
• HPA051492 has been omitted due to qualitative reasons. An alternative antibody HPA059518 has been added.
• HPA051582 has been omitted due to qualitative reasons.
• HPA051592 has been omitted due to qualitative reasons. An alternative antibody HPA021661 has been added.
• HPA051606 has been omitted due to qualitative reasons.
• HPA051620 has been omitted due to qualitative reasons.
• HPA051627 has been omitted due to antibody staining not supported by experimental data.
• HPA051638 has been omitted due to antibody staining not supported by experimental data.
• HPA051639 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA051677 has been omitted due to qualitative reasons.
• HPA051748 has been omitted due to qualitative reasons. An alternative antibody CAB016326 has been added.
• HPA051749 has been omitted due to antibody staining not supported by experimental data.
• HPA051885 has been omitted due to qualitative reasons. An alternative antibody HPA062852 has been added.
• HPA051900 has been omitted due to qualitative reasons. An alternative antibody HPA060251 has been added.
• HPA051912 has been omitted due to qualitative reasons. An alternative antibody HPA063283 has been added.
• HPA051948 has been omitted due to qualitative reasons.
• HPA051998 has been omitted due to qualitative reasons.
• HPA052061 has been omitted due to qualitative reasons.
• HPA052147 has been omitted due to lack of RNA expression in cell line panel.
• HPA052154 has been omitted due to antibody staining not supported by experimental data.
• HPA052157 has been omitted due to qualitative reasons. An alternative antibody HPA044383 has been added.
• HPA052170 has been omitted due to qualitative reasons. An alternative antibody HPA016812 has been added.
• HPA052205 has been omitted due to qualitative reasons. An alternative antibody HPA042932 has been added.
• HPA052242 has been omitted due to qualitative reasons.
• HPA052246 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058335 has been added.
• HPA052278 has been omitted due to qualitative reasons.
• HPA052329 has been omitted due to lack of RNA expression in cell line panel.
• HPA052458 has been omitted due to qualitative reasons. An alternative antibody HPA046189 has been added.
• HPA052461 has been omitted due to antibody staining not supported by experimental data.
• HPA052542 antibody has been omitted due to target gene not found in Ensembl.
• HPA052596 has been omitted due to qualitative reasons.
• HPA052603 has been omitted due to qualitative reasons.
• HPA052663 has been omitted due to qualitative reasons. An alternative antibody HPA048174 has been added.
• HPA052690 has been omitted due to qualitative reasons.
• HPA052751 has been omitted due to qualitative reasons.
• HPA052758 has been omitted due to antibody staining not supported by experimental data.
• HPA052776 has been omitted due to qualitative reasons. An alternative antibody HPA074408 has been added.
• HPA052782 has been omitted due to qualitative reasons.
• HPA052862 has been omitted due to qualitative reasons.
• HPA052977 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA046537 has been added.
• HPA053037 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA044383 has been added.
• HPA053038 has been omitted due to qualitative reasons.
• HPA053047 has been omitted due to qualitative reasons.
• HPA053051 has been omitted due to qualitative reasons.
• HPA053052 has been omitted due to qualitative reasons. An alternative antibody HPA023948 has been added.
• HPA053097 has been omitted due to antibody staining not supported by experimental data.
• HPA053136 has been omitted due to antibody staining not supported by experimental data.
• HPA053141 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA072532 has been added.
• HPA053162 has been omitted due to qualitative reasons.
• HPA053177 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA072399 has been added.
• HPA053233 has been omitted due to qualitative reasons.
• HPA053237 has been omitted due to qualitative reasons.
• HPA053280 has been omitted due to qualitative reasons.
• HPA053290 has been omitted due to qualitative reasons. An alternative antibody HPA049852 has been added.
• HPA053299 has been omitted due to antibody staining not supported by experimental data.
• HPA053367 has been omitted due to qualitative reasons.
• HPA053383 has been omitted due to antibody staining not supported by experimental data.
• HPA053389 has been omitted due to qualitative reasons. An alternative antibody HPA043930 has been added.
• HPA053413 has been omitted due to qualitative reasons.
• HPA053419 has been omitted due to antibody staining not supported by experimental data.
• HPA053444 has been omitted due to lack of RNA expression in cell line panel.
• HPA053515 has been omitted due to antibody staining not supported by experimental data.
• HPA053523 has been omitted due to qualitative reasons. An alternative antibody HPA065052 has been added.
• HPA053533 has been omitted due to qualitative reasons. An alternative antibody HPA069684 has been added.
• HPA053616 has been omitted due to qualitative reasons. An alternative antibody HPA063157 has been added.
• HPA053651 has been omitted due to qualitative reasons. An alternative antibody HPA075134 has been added.
• HPA053656 has been omitted due to qualitative reasons.
• HPA053686 has been omitted due to qualitative reasons.
• HPA053702 has been omitted due to antibody staining not supported by experimental data.
• HPA053703 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA053815 has been omitted due to qualitative reasons. An alternative antibody HPA063982 has been added.
• HPA053841 has been omitted due to antibody staining not supported by experimental data.
• HPA053893 has been omitted due to qualitative reasons.
• HPA053905 has been omitted due to antibody staining not supported by experimental data.
• HPA053976 has been omitted due to antibody staining not supported by experimental data.
• HPA054041 has been omitted due to qualitative reasons. An alternative antibody HPA011318 has been added.
• HPA054132 has been omitted due to antibody staining not supported by experimental data.
• HPA054236 has been omitted due to qualitative reasons.
• HPA054237 has been omitted due to qualitative reasons.
• HPA054272 has been omitted due to qualitative reasons. An alternative antibody HPA074011 has been added.
• HPA054290 has been omitted due to qualitative reasons.
• HPA054302 has been omitted due to qualitative reasons.
• HPA054309 has been omitted due to antibody staining not supported by experimental data.
• HPA054330 has been omitted due to qualitative reasons.
• HPA054371 has been omitted due to qualitative reasons.
• HPA054419 has been omitted due to qualitative reasons.
• HPA054444 has been omitted due to qualitative reasons.
• HPA054464 has been omitted due to qualitative reasons.
• HPA054479 has been omitted due to qualitative reasons.
• HPA054562 has been omitted due to qualitative reasons.
• HPA054601 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA054743 has been omitted due to antibody staining not supported by experimental data.
• HPA054746 has been omitted due to qualitative reasons.
• HPA054755 has been omitted due to qualitative reasons.
• HPA054759 has been omitted due to qualitative reasons. An alternative antibody HPA051823 has been added.
• HPA054836 antibody has been omitted due to target gene not found in Ensembl.
• HPA054857 has been omitted due to qualitative reasons. An alternative antibody HPA070550 has been added.
• HPA054895 has been omitted due to qualitative reasons.
• HPA054916 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA067881 has been added.
• HPA054917 has been omitted due to qualitative reasons.
• HPA054936 has been omitted due to qualitative reasons.
• HPA054960 has been omitted due to qualitative reasons.
• HPA055002 has been omitted due to lack of RNA expression in cell line panel.
• HPA055116 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA055160 has been omitted due to qualitative reasons. An alternative antibody HPA071396 has been added.
• HPA055288 has been omitted due to antibody staining not supported by experimental data.
• HPA055297 has been omitted due to qualitative reasons. An alternative antibody HPA015794 has been added.
• HPA055361 has been omitted due to antibody staining not supported by experimental data.
• HPA055372 has been omitted due to qualitative reasons. An alternative antibody HPA078659 has been added.
• HPA055444 has been omitted due to qualitative reasons. An alternative antibody HPA047929 has been added.
• HPA055483 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA055536 has been omitted due to antibody staining not supported by experimental data.
• HPA055550 has been omitted due to antibody staining not supported by experimental data.
• HPA055579 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA030288 has been added.
• HPA055599 has been omitted due to qualitative reasons. An alternative antibody HPA063472 has been added.
• HPA055664 has been omitted due to antibody staining not supported by experimental data.
• HPA055678 has been omitted due to qualitative reasons. An alternative antibody HPA043275 has been added.
• HPA055693 has been omitted due to qualitative reasons.
• HPA055757 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA055795 has been omitted due to antibody staining not supported by experimental data.
• HPA055847 has been omitted due to qualitative reasons. An alternative antibody HPA072469 has been added.
• HPA055904 has been omitted due to new images pending.
• HPA056046 has been omitted due to qualitative reasons.
• HPA056056 has been omitted due to qualitative reasons.
• HPA056112 has been omitted due to qualitative reasons.
• HPA056125 has been omitted due to qualitative reasons.
• HPA056297 has been omitted due to qualitative reasons. An alternative antibody HPA049933 has been added.
• HPA056304 has been omitted due to qualitative reasons. An alternative antibody HPA047860 has been added.
• HPA056393 has been omitted due to lack of RNA expression in cell line panel.
• HPA056449 has been omitted due to qualitative reasons.
• HPA056509 has been omitted due to antibody staining not supported by experimental data.
• HPA056548 has been omitted due to qualitative reasons.
• HPA056563 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA056574 has been omitted due to antibody staining not supported by experimental data.
• HPA056609 has been omitted due to qualitative reasons.
• HPA056650 has been omitted due to antibody staining not supported by experimental data.
• HPA056782 has been omitted due to qualitative reasons.
• HPA056862 has been omitted due to antibody staining not supported by experimental data.
• HPA056911 has been omitted due to qualitative reasons. An alternative antibody HPA069214 has been added.
• HPA056920 has been omitted due to qualitative reasons.
• HPA056933 has been omitted due to qualitative reasons.
• HPA056951 has been omitted due to antibody staining not supported by experimental data.
• HPA056990 has been omitted due to qualitative reasons. An alternative antibody CAB034019 has been added.
• HPA057135 has been omitted due to qualitative reasons.
• HPA057165 has been omitted due to qualitative reasons.
• HPA057168 has been omitted due to qualitative reasons.
• HPA057275 has been omitted due to qualitative reasons. An alternative antibody HPA021166 has been added.
• HPA057276 has been omitted due to qualitative reasons. An alternative antibody HPA066190 has been added.
• HPA057284 has been omitted due to qualitative reasons. An alternative antibody HPA052217 has been added.
• HPA057293 has been omitted due to qualitative reasons.
• HPA057300 has been omitted due to qualitative reasons.
• HPA057315 has been omitted due to qualitative reasons.
• HPA057469 has been omitted due to qualitative reasons.
• HPA057480 has been omitted due to qualitative reasons. An alternative antibody HPA068537 has been added.
• HPA057489 has been omitted due to qualitative reasons.
• HPA057518 has been omitted due to qualitative reasons.
• HPA057540 has been omitted due to qualitative reasons.
• HPA057541 has been omitted due to qualitative reasons.
• HPA057578 has been omitted due to qualitative reasons.
• HPA057607 has been omitted due to qualitative reasons.
• HPA057793 has been omitted due to qualitative reasons.
• HPA057913 has been omitted due to qualitative reasons.
• HPA057939 has been omitted due to qualitative reasons.
• HPA058060 has been omitted due to qualitative reasons. An alternative antibody HPA067575 has been added.
• HPA058149 has been omitted due to qualitative reasons.
• HPA058159 has been omitted due to qualitative reasons. An alternative antibody HPA036283 has been added.
• HPA058193 has been omitted due to qualitative reasons.
• HPA058198 has been omitted due to antibody staining not supported by experimental data.
• HPA058279 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA058375 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA001400 has been added.
• HPA058376 has been omitted due to qualitative reasons.
• HPA058473 has been omitted due to qualitative reasons.
• HPA058561 has been omitted due to qualitative reasons.
• HPA058573 has been omitted due to antibody staining not supported by experimental data.
• HPA058611 has been omitted due to qualitative reasons.
• HPA058659 has been omitted due to qualitative reasons.
• HPA058745 has been omitted due to qualitative reasons.
• HPA058842 has been omitted due to antibody staining not supported by experimental data.
• HPA058848 has been omitted due to qualitative reasons.
• HPA058854 has been omitted due to antibody staining not supported by experimental data.
• HPA058875 has been omitted due to antibody staining not supported by experimental data.
• HPA059000 has been omitted due to qualitative reasons. An alternative antibody HPA061321 has been added.
• HPA059005 has been omitted due to qualitative reasons. An alternative antibody HPA022432 has been added.
• HPA059014 has been omitted due to qualitative reasons. An alternative antibody HPA029311 has been added.
• HPA059057 has been omitted due to qualitative reasons. An alternative antibody HPA070326 has been added.
• HPA059202 has been omitted due to qualitative reasons.
• HPA059247 has been omitted due to qualitative reasons. An alternative antibody HPA067042 has been added.
• HPA059318 has been omitted due to antibody staining not supported by experimental data.
• HPA059333 has been omitted due to qualitative reasons.
• HPA059359 has been omitted due to qualitative reasons.
• HPA059460 has been omitted due to qualitative reasons. An alternative antibody HPA071287 has been added.
• HPA059476 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA067071 has been added.
• HPA059607 has been omitted due to qualitative reasons.
• HPA059734 has been omitted due to qualitative reasons. An alternative antibody HPA076168 has been added.
• HPA059851 has been omitted due to qualitative reasons.
• HPA059881 has been omitted due to qualitative reasons.
• HPA059970 has been omitted due to qualitative reasons. An alternative antibody HPA068156 has been added.
• HPA060132 has been omitted due to qualitative reasons.
• HPA060215 has been omitted due to qualitative reasons.
• HPA060360 has been omitted due to qualitative reasons.
• HPA060475 has been omitted due to qualitative reasons.
• HPA060554 has been omitted due to antibody staining not supported by experimental data.
• HPA060559 has been omitted due to qualitative reasons.
• HPA060614 has been omitted due to qualitative reasons. An alternative antibody HPA072319 has been added.
• HPA060685 has been omitted due to qualitative reasons. An alternative antibody HPA068337 has been added.
• HPA060806 has been omitted due to qualitative reasons.
• HPA061073 has been omitted due to qualitative reasons.
• HPA061075 has been omitted due to qualitative reasons.
• HPA061140 has been omitted due to qualitative reasons.
• HPA061191 has been omitted due to qualitative reasons. An alternative antibody HPA048142 has been added.
• HPA061243 has been omitted due to qualitative reasons. An alternative antibody HPA071252 has been added.
• HPA061332 has been omitted due to qualitative reasons.
• HPA061344 has been omitted due to antibody staining not supported by experimental data.
• HPA061413 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA061434 has been omitted due to qualitative reasons.
• HPA061533 has been omitted due to antibody staining not supported by experimental data.
• HPA061570 has been omitted due to qualitative reasons.
• HPA061761 has been omitted due to antibody staining not supported by experimental data.
• HPA061793 has been omitted due to qualitative reasons. An alternative antibody HPA020626 has been added.
• HPA061812 has been omitted due to qualitative reasons.
• HPA061845 has been omitted due to antibody staining not supported by experimental data.
• HPA061854 has been omitted due to qualitative reasons.
• HPA061923 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA077474 has been added.
• HPA062047 has been omitted due to qualitative reasons. An alternative antibody HPA072587 has been added.
• HPA062249 has been omitted due to antibody staining not supported by experimental data.
• HPA062365 has been omitted due to qualitative reasons.
• HPA062439 has been omitted due to qualitative reasons. An alternative antibody HPA066670 has been added.
• HPA062620 has been omitted due to qualitative reasons.
• HPA062644 has been omitted due to antibody staining not supported by experimental data.
• HPA062723 has been omitted due to antibody staining not supported by experimental data.
• HPA062735 has been omitted due to qualitative reasons.
• HPA062915 has been omitted due to lack of RNA expression in cell line panel.
• HPA062933 has been omitted due to qualitative reasons.
• HPA062936 has been omitted due to antibody staining not supported by experimental data.
• HPA062987 has been omitted due to qualitative reasons. An alternative antibody CAB011596 has been added.
• HPA063019 has been omitted due to qualitative reasons.
• HPA063020 has been omitted due to qualitative reasons. An alternative antibody HPA036739 has been added.
• HPA063069 has been omitted due to qualitative reasons.
• HPA063073 has been omitted due to qualitative reasons. An alternative antibody HPA045646 has been added.
• HPA063102 has been omitted due to qualitative reasons. An alternative antibody HPA072291 has been added.
• HPA063258 has been omitted due to qualitative reasons. An alternative antibody HPA046428 has been added.
• HPA063478 has been omitted due to antibody staining not supported by experimental data.
• HPA063512 has been omitted due to qualitative reasons.
• HPA063861 has been omitted due to qualitative reasons.
• HPA063899 has been omitted due to qualitative reasons.
• HPA063918 has been omitted due to qualitative reasons.
• HPA063976 has been omitted due to qualitative reasons. An alternative antibody HPA069750 has been added.
• HPA063991 has been omitted due to qualitative reasons.
• HPA064147 has been omitted due to qualitative reasons.
• HPA064166 has been omitted due to qualitative reasons.
• HPA064211 has been omitted due to qualitative reasons. An alternative antibody HPA069119 has been added.
• HPA064429 has been omitted due to qualitative reasons.
• HPA064441 has been omitted due to qualitative reasons.
• HPA064527 has been omitted due to antibody staining not supported by experimental data.
• HPA064560 has been omitted due to qualitative reasons.
• HPA064566 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA036739 has been added.
• HPA064746 has been omitted due to qualitative reasons.
• HPA064837 has been omitted due to qualitative reasons. An alternative antibody HPA040427 has been added.
• HPA064854 has been omitted due to qualitative reasons. An alternative antibody HPA069752 has been added.
• HPA064857 has been omitted due to qualitative reasons.
• HPA065223 has been omitted due to qualitative reasons. An alternative antibody HPA055132 has been added.
• HPA065278 has been omitted due to qualitative reasons. An alternative antibody HPA026305 has been added.
• HPA065391 has been omitted due to qualitative reasons. An alternative antibody HPA056308 has been added.
• HPA065459 has been omitted due to qualitative reasons.
• HPA065682 has been omitted due to qualitative reasons. An alternative antibody HPA068819 has been added.
• HPA065734 has been omitted due to qualitative reasons.
• HPA065758 has been omitted due to qualitative reasons.
• HPA065777 has been omitted due to qualitative reasons. An alternative antibody HPA069119 has been added.
• HPA065832 has been omitted due to qualitative reasons.
• HPA065870 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058870 has been added.
• HPA066008 has been omitted due to qualitative reasons. An alternative antibody HPA059495 has been added.
• HPA066144 has been omitted due to qualitative reasons.
• HPA066188 has been omitted due to antibody staining not supported by experimental data.
• HPA066326 has been omitted due to qualitative reasons.
• HPA066374 has been omitted due to qualitative reasons. An alternative antibody HPA058532 has been added.
• HPA066466 has been omitted due to antibody staining not supported by experimental data.
• HPA066618 has been omitted due to qualitative reasons.
• HPA066721 has been omitted due to qualitative reasons.
• HPA066797 has been omitted due to qualitative reasons.
• HPA066888 has been omitted due to antibody staining not supported by experimental data.
• HPA066926 has been omitted due to antibody staining not supported by experimental data.
• HPA067377 has been omitted due to qualitative reasons. An alternative antibody HPA072229 has been added.
• HPA067471 has been omitted due to qualitative reasons.
• HPA067558 has been omitted due to qualitative reasons. An alternative antibody HPA039601 has been added.
• HPA067579 has been omitted due to qualitative reasons. An alternative antibody HPA060537 has been added.
• HPA067596 has been omitted due to qualitative reasons. An alternative antibody HPA060593 has been added.
• HPA067671 has been omitted due to antibody staining not supported by experimental data.
• HPA067895 has been omitted due to qualitative reasons.
• HPA067913 has been omitted due to antibody staining not supported by experimental data.
• HPA068036 has been omitted due to antibody staining not supported by experimental data.
• HPA068463 has been omitted due to antibody staining not supported by experimental data. An alternative antibody CAB015186 has been added.
• HPA068473 has been omitted due to antibody staining not supported by experimental data.
• HPA068671 has been omitted due to qualitative reasons. An alternative antibody HPA061017 has been added.
• HPA069105 has been omitted due to qualitative reasons.
• HPA069252 has been omitted due to qualitative reasons.
• HPA069346 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA057484 has been added.
• HPA069517 has been omitted due to antibody staining not supported by experimental data.
• HPA070119 antibody has been omitted due to target gene not found in Ensembl.
• HPA071268 has been omitted due to qualitative reasons. An alternative antibody HPA065332 has been added.
• HPA071327 has been omitted due to qualitative reasons. An alternative antibody HPA053275 has been added.
• HPA071536 has been omitted due to qualitative reasons. An alternative antibody HPA073875 has been added.
• HPA071556 has been omitted due to qualitative reasons. An alternative antibody HPA074736 has been added.
• HPA071662 has been omitted due to qualitative reasons. An alternative antibody HPA028917 has been added.
• HPA072377 has been omitted due to qualitative reasons. An alternative antibody HPA037773 has been added.
• CAB072802 has been omitted due to qualitative reasons.
• CAB072824 has been omitted due to qualitative reasons.
• CAB072847 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA028957 has been added.
• CAB072848 has been omitted due to qualitative reasons. An alternative antibody HPA028957 has been added.
• HPA073454 has been omitted due to qualitative reasons.
• HPA073653 has been omitted due to qualitative reasons. An alternative antibody HPA076187 has been added.
• HPA073710 has been omitted due to qualitative reasons. An alternative antibody HPA065620 has been added.